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1.  TOTAL MOTHERS ATTENDING Totals 2015
Mothers who have delivered babies weighing >500 grams 8361
Mothers who have delivered babies weighing <500 grams {including
miscarriages} 1528  
Hydatidiform Moles * 20  
Ectopic Pregnancies 169  
Total Mothers Delivered 10078
*This figure includes complete & Partial Hydatidform Moles 
2.  MATERNAL DEATHS Totals 2015 
Maternal Deaths 1
3.  BIRTHS Totals 2015 
Singletons 8191 
Twins                                                                                           322
Triplets                                                                                              21 
Quadruplets                                                                                     4 
Total Babies Delivered weighing> 500 grams 8538
* 1 less than 500g
4.  OBSTETRIC OUTCOME Totals 2015
Spontaneous Vaginal Delivery 51% 4268 
Forceps 5% 424
Ventouse 12% 973
Caesarean Section 32% 2696
Induction of Labour 29% 2430
Breech Deliveries included in spontaneaous vaginal delivery
5.  PERINATAL DEATHS Totals 2015
Antepartum Deaths 44    
Intrapartum Deaths 0    
Stillbirths 44  
Early Neonatal Deaths 27
Late Neonatal Deaths 1
Congenital Anomalies 30        3
D U B L I N M AT E R N I T Y H O S P I TA L S
C O M B I N E D  C L I N I CA L  D ATA
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6.  PERINATAL MORTALITY RATES                                                      Totals 2015
Overall Perinatal Mortality Rate per 1,000 Births 8.3  
Perinatal Mortality Rate Corrected For Lethal Congenital Anomalies 4.8
Perinatal Mortality Rate Including Late Neonatal Deaths 8.6       
Perinatal Mortality Rate Excluding Unbooked Cases 8.3
Corrected Perinatal Mortality Rate Excluding Unbooked Cases 4.8   
7.  AGE OF WOMEN
Nullips Multips             Total Mothers  Delivered>500g 
<20 yrs 152 22 174
20-24 yrs 513 301 814
25-29 yrs 831 881 1712
30-34 yrs 1196 1676 2872
35-39 yrs 666 1598 2264
40+ yrs 156 369 525
Total 3514 4847 8361
8.  PARITY
Totals 2015   % from Total Mothers  Delivered >500g 
Para 0 3514 42.0%
Para 1 2930 35.0%
Para 2-4 1822 21.8%
Para 5+ 95 1.1%
Total 8361 100% 
9. COUNTRY OF BIRTH & NATIONALITY AT DELIVERY - 2015
2014 % 2015 %
Irish 5,451 62.03% 4,420 52.86%
EU 1,613 18.36% 1,263 15.10%
NonEU 1,106 12.59% 870 10.40%
Unknown /Unrecorded 617 7.02% 1,808 21.63%
Total 8,787 100.00% 8,361 100.00%
4
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10. SOCIO-ECONOMIC GROUP
Socio-Group 2013 % 2014 % 2015 %
1 559 6.46% 636 7.24% 350 4.19%
2 1,989 23.00% 1,891 21.52% 1,225 14.65%
3 1,384 16.00% 1,270 14.45% 825 9.87%
4 437 5.05% 400 4.55% 275 3.29%
5 528 6.11% 468 5.33% 299 3.58%
6 317 3.67% 314 3.57% 187 2.24%
7 2,476 28.63% 1,782 20.28% 1,174 14.04%
8 0 0.00% 0 0.00% 3,369 40.30%
9 0 0.00% 2 0.02% 1 0.01%
10 958 11.08% 2,024 23.03% 656 7.85%
TOTAL 8,648 100.00% 8,787 100.00% 8,361 100.00%
"**8 - Information not completed on booking visit 3,369 unknown."
11. BIRTH WEIGHT  
Weights Totals 2015      
500 - 999 gms 49
1,000 - 1,499 75
1,500 - 1,999 141
2,000 - 2,499 332
2,500 - 2,999 1115
3,000 - 3,499 2825
3,500 - 3,999 2835
4,000 - 4,499 1018
4,500 - 4,999 141
>5,000 7
Total 8538
12. GESTATIONAL AGE   
Nullips Multips Totals 2015 
<26 weeks 15 7 22
26 - 29 weeks + 6 days 23 25 48
30 - 33 weeks + 6 days 66 51 117
34 - 36 weeks + 6 days 178 208 386
37 - 41 weeks + 6 days 3205 4548 7753
42 + weeks 28 7 35
Total 3515 4846 8361
5
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13. PERINEAL TRAUMA AFTER ALL VAGINAL DELIVERIES (Numbers & Percentages)
Nullips Multips  Totals 2015
Episiotomy & Extended Episiotomy 1140 292 1432
First Degree Laceration 161 475 636
Second Degree Laceration 614 1027 1641
Third Degree Anal Sphincter/Mucosa 105 55 160
Fourth Degree 5 2 7
Other { Lacerations/Grazes not 236 570 806
requiring sutures}
Intact 110 872 982
Totals 2371 3293 5664
CS Deliveries not included in the above. Total Vaginal deliveries: 5664
14.  THIRD DEGREE TEARS *  
Nullips Multips Totals 2015 
Occurring Spontaneously 52 41 93
Associated with Episiotomy 18 3 21
Associated with Forceps 22 3 25
Associated with Ventouse 25 9 34
Associated with Ventouse & Forceps 1 4 15
Associated with O.P. position 16 7 23
*Total 3rd Degree not listed as some women have a 3rd degree Tear with Both Episiotomy &
Instrumental Delivery.Table 13 have totals listed.
15.  PERINATAL MORTALITY IN ANTEPARTUM NORMALLY FORMED 
STILLBORN INFANTS
Nullips Multips Totals
Placental 5 5 10
Cord Accident 2 4 6
Feto Maternal Haemorhage 0 1 1
Infection 2 3 5
Unexplained 2 5 7 
Total 11 18 29
Autopsy Totals
Autopsy Rate  19/29 65.5%
6
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16.  PERINATAL MORTALITY IN CONGENITALLY MALFORMED INFANTS
Nullips Multips            Totals
CNS Lesions 1 1 2
Cardiac 0 1 1
Renal 0 3 3
Chromosomal 7 6 13           
Diaphragmatic Hernia 2 2 4
Other 3 4 7  
Totals 13 17 30
17.  EARLY NEONATAL DEATHS
Nullips Multips Totals 
Congenital 5 10 15
Prematurity / Infection 4 1 5
Placental 1 6 7
Totals 10 17 27
Full Autopsy 8/27
Overall Full Autopsy total for all Perinatal Deaths    30
Overall Autopsy Rate 42%
18.  HYPOXIC ISCHAEMIC ENCEPHALOPATHY
Grades Grade 1   Grade 2             Grade 3  
9 6 1
19.  SEVERE MATERNAL MORBIDITY
Nullips Multips Totals 
Massive Obstetric Haemorrhage     12 13 25
Emergency Hysterectomy 0 1 1    
Transfer To ICU/CCU 2 1 3
Uterine Rupture 0 4 4    
Eclampsia 1 0 1
Acute Renal & Liver Dysfunction 4 3 7
Acute Respiratory Dysfunction 2 0 2
Septic Shock 5 6 11
Other 8 3 11
7
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21.  FINANCIAL INFORMATION: Non-capital income and expenditure account
For the year ended 31 December 2015
2015 2014
€'000 €'000
Cumulative non-capital deficit/(surplus) 
brought forward from previous year 182 80
Pay
Salaries 47,375 46,535
Superannuation and gratuities 4,570 3,394
Total Pay 51,945 49,929
Non-Pay
Direct patient care 5,300 5,679
Support services 5,578 4,858
Financial and administrative 3,470 3,485
Total Non Pay 14,348 14,022
Gross expenditure for the year 66,293 64,031
Income (18,161) (18,862)
Net expenditure for the year 48,314 45,169
HSE Funding notified for the year (48,095) (44,987)
Deficit for the year carried forward 
to following year 219 182
8
20. BODY MASS INDEX
Body Mass Index 2012 2013 2014 2015
Underweight: <18.5 224 (2.5%) 215 (2.5%) 168 (1.9%) 168 (2.0%)
Healthy: 18.5 - 24.9 4661 (52.7%) 4619 (53.4%) 4762 (54.2%) 4454 (53.3%)
Overweight: 25 - 29.9 2259 (25.5%) 2283 (26.4%) 2342 (26.7%) 2323 (27.8%)
Obese class 1: 30 - 34.9 790 (8.9%) 804 (9.3%) 890 (10.1%) 838 (10.0%)
Obese class 2: 35 - 39.9 261 (3.0%) 267 (3.1%) 288 (3.3%) 294 (3.5%)
Obese class 3: >40 84 (1.0%) 83 (1.0%) 117 (1.3%) 116 (1.4%)
Unrecorded 567 (6.4%) 377 (4.4%) 220 (2.5%) 168 (2.0%)
Total Deliveries 8846 8648 8787 8361
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The Master
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I N T R O D U C T I O N
It has been an honour and a privilege to serve as Master of the Rotunda for the
seven years from 2009 to 2015 inclusive.  These seven years have been
remarkable in many ways.  They have been seven of the busiest years for the
hospital in terms of the unprecedented demand for maternity services.  A time
where we have seen a very significant financial recession, which has affected
not just the Country but the Health Service and those working within the
service.  This has had a direct effect on the funding of the Health Service.  The
financial measures taken to deal with this recession have directly impacted on
the staffing of the hospital, making it extremely difficult for us to retain and
attract the best quality staff to our service.  This is an issue that has effected not
just the Rotunda, but every hospital and health institution right across the
country.  
Maternity services have been in the spotlight over the last number of years,
with significant focus on clinical governance, openness, accountability and
transparency.  This has all happened at a time when the oversight of the Health
Service has undergone a significant transition moving from the Department of
Health to the HSE and now to Hospital Groups.  In addition to the increased
demand for maternity services the demand for gynaecology has also increased
substantially, with the demand for gynaecology out-patient appointments
almost doubling.
Over the course of 2015, 10,591 patients registered for antenatal care, which was
3 % less than 2014.  We delivered 8,361 women of 8,538 babies greater than or
equal to 500g in weight.  The corrected perinatal mortality rate for 2015 was 4.8
per 1,000.  There were 1 indirect maternal death in 2015.
Over the course of the last two years the hospital has been working with the
HSE to validate the gynaecological waiting lists.  The Board funded a very
successful waiting list initiative with the Mater Private Hospital to address
these waiting lists.  In tandem with these initiatives the hospital worked with
the RCSI Hospitals Group, particularly with Connolly Hospital to set-up a
hysteroscopy out-patient service which commenced early in 2016.  A further
initiative took place, with a collaborative effort involving the Irish College of
General Practitioners, a GP Led Evening Gynae Clinic is now in existence,
principally for insertion of Mirena devices for contraception and management
of menorrhagia.  This has proved to be an extremely popular and useful
initiative.  
In May of this year the Minister for Health Dr. Leo Varadakar came to the
hospital to announce the decision to relocate and co-locate the Rotunda
Hospital to the Connolly Campus in Blanchardstown.  This was a welcome
acknowledgement of the fact that the Rotunda needs to move to a new facility
in order to provide safe and efficient care to our patients, however it was
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disappointing that no funding was identified at the time.  The hospital
continues to work with the HSE, the Department of Health and the Group in
order to pursue the ultimate aim of co-locating with Connolly.  In the meantime
it is very important that the Rotunda continues to be able to provide top class
care to all of its mothers and babies and it must be recognised that there will be
interim developments required to improve facilities here on Parnell Square
while the move to Connolly is being pursued.
Over the course 2015 we were successful in negotiating several new consultant
posts in obstetrics and gynaecology, pathology and neonatal paediatrics.   It is
anticipated these posts will be filled early in 2016.  We will continue to work
with our partners within the RCSI Hospitals Group to facilitate the provision of
sub-specialist services to both Drogheda and Cavan particularly in the area of
perinatal pathology and fetal medicine.  It was therefore fitting that the new
mortuary facility based in the Rotunda opened late in 2015. 
The Research and Academic Affairs Department headed by Dr. Joanna Griffin
continues to work with the RCSI Academic Department and has been very
successful in terms of research output.  The relocation of the Research
Department to one area within the Nurse’s Home has enabled a much more
cohesive and efficient set up which is already paying dividends.
Over the course of the year we have been working very hard to get new
additional consultant posts and we look forward to the appointment of three
new consultants to assist with the new gynae services based in Connolly and
the obstetric services based in the Rotunda.  We have also been fortunate in
achieving new appointments in anaesthesia and neonatal paediatrics.
The Bartholomew Mosse Charter Day Lecture was delivered by Professor
Michael Geary, now based in Toronto.  His lecture entitled 'Enhancing Patient
Safety and Quality of Maternity Care - New Directions' was very well received. 
The Friends of the Rotunda had a busy year working extremely hard to support
research within the Hospital.  The organisation is currently being re-invigorated
with the genesis of the Rotunda Foundation.  A great deal of credit and thanks
go to Sheila Thompson and all of the people who work in the Friends of the
Rotunda for all of the hard work that they put in to supporting what we do.
The Rotunda's partnership with the RCSI Institute of Leadership programme
continues to go from strength to strength with a second cohort of staff
completing their leadership training programme within the RCSI.  Many of
these projects have lead to significant strategic improvement within the
hospital.
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Given that this is my last annual report I would like to take this opportunity to
thank all those who have contributed to the support and provision of the
services to our patients during my time as Master.  The Hospital remains
significantly under staffed and it is a tribute to the dedication and skill of our
front line staff who despite all of the constraints continue to maintain quality
services in increasingly difficult circumstances.  To all of those staff who come in
to do additional shifts when requested, who stay late and miss breaks and meals,
your efforts are appreciated and I am eternally grateful for your dedication to the
jobs that you do so well. 
It would be impossible to do the job as Master of the hospital without the
support and assistance of the hospital administrative management team led by
Ms. Pauline Treanor, the Secretary General Manager.  Pauline and all of her
support staff work incredibly hard to ensure that the hospital's administrative
processes are as lean and efficient as possible and they do a wonderful job.  My
sincere thanks to Pauline and her team.  
To my midwifery colleagues, led by Ms. Margaret Philbin, our Director of
Midwifery, I would like to express my sincere gratitude.  The midwifery team
have shown extraordinary dedication over the last number of years in very
difficult circumstances.  
To all of the Heads of Department for the enormous work that they do in
contributing to the life and running of the hospital, I am also extremely grateful.
Again it would be impossible to run the hospital without the help and assistance
of consultant colleagues in all specialties.  Each and every one of them puts in a
huge effort to keep the hospital safe and on an even keel.  Over the years there
have been some extraordinarily skilled and dedicated NCHDs who have gone
through the system.  To all of the Assistant Masters and all of our Registrars and
SHOs, I would like to thank them for their hard work and dedication.
The Board of the Rotunda Hospital plays a hugely important role in the oversight
and running of the hospital.  I would like to pay particular tribute to all of the
members of the Board but especially to the Chair of the Board Ms. Hilary Prentice
who has always been there for advice and support when required.  As I have said
in previous reports, the Rotunda Hospital is a voluntary institution overseen by
a voluntary Board.  This model of governance has proved to be effective and very
positive for the running of the hospital over the years and it is a model that
needs to be maintained and built on in the face of increasing challenges to the
voluntary hospital sector in the future.  
I think it is appropriate at the end of seven years to look back over this period of
time and take stock of what's happened in terms of maternity outcomes.  Over
the course of seven years, we looked after 71,453 mothers, 61,101 of them delivered
I N T R O D U C T I O N
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62,423 babies.  The caesarean section rate has gone from  28.5%  to  32%.  The
perinatal mortality rate has ranged from 6.5 to 8.4, with a mean of  7.6 per
1,000.  Over the course of seven years the complexity of the workload that we
face has significantly increased.  The number of patients transferred from the
Rotunda to acute medical services for investigation and management has
increased significantly and it is vitally important that as we plan towards a
new Rotunda Hospital in partnership with an acute adult hospital that the
facilities required to manage this level of complexity are put in place in
tandem with any planned move.
Last but not least I would like to pay particular tribute to Mary O'Grady in the
Master's Office, without whose help, assistance, guidance and expertise my job
as Master would have been all but impossible.
At the time of going to print Professor Malone will have completed his first six
months as the new Master of the Rotunda.  I would like to wish him every
success in his seven year tenure.  I sincerely hope and believe that he will get
all of the help and support that I received during my time as Master.
Dr. Sam Coulter-Smith.
Master.
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Y E A R S 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015
Babies
Born 7325 8456 8799 8912 8792 9319 9041 8841 8980 8538
Perinatal
Deaths 50 
+ 13 * 66 + 10 * 64 + 7* 56+ 5* 69+5* 59+2* 66+2* 63+6* 68+2* 71
Perinatal
Mortality
Rate
8.6 9.0 8.1 6.8 8.4 6.5 7.5 7.8 7.8 8.3
Mothers
Attending 8,036 9,290 9,655 9,709 9,594 10,547 10,397 10,314 10,814 10,078
Maternal
Deaths 0 0 1 2 3 3 2 3 2 1
Caesarean
Section
%
27.7 27.1 26.2 28.5 27.9 29 29 31 31 32
Forceps/
Ventouse
%
16.8 17 20 19.8 20.5 19.4 18 17 17 17
Epidural
% 47 47 49 49.2 46.6 46 48 47 47 47
Induction
% 20 20 21 23.27 27 29 28 29 30 29
* Unbooked
16
C O M PA R A T I V E  R E S U L T S  F O R
1 0  Y E A R S
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S T A T I S T I C A L  S U M M A R I E S
1.  TOTAL MOTHERS ATTENDING Totals 2015
Mothers who have delivered babies weighing >500 grams 8361
Mothers who have delivered babies weighing <500 grams {including
miscarriages} 1528  
Hydatidiform Moles * 20  
Ectopic Pregnancies 169 
Total Mothers Delivered 10078
*This figure includes complete & Partial Hydatidform Moles 
2.  MATERNAL DEATHS Totals 2015
Maternal Deaths 1
3.  BIRTHS Totals 2015
Singletons 8190 
Twins                                                                                                   326 
Triplets                                                                                             18 
Quadruplets                                                                                     4 
Total Babies Delivered weighing> 500 grams 8538
4.  OBSTETRIC OUTCOME Totals 2015
Spontaneous Vaginal Delivery 51% 4268 
Forceps 5% 424
Ventouse 12% 973
Caesarean Section 32% 2696
Induction of Labour 29% 2430
Breech Deliveries included in spontaneaous vaginal delivery
5.  PERINATAL DEATHS Totals 2015
Antepartum Deaths 44    
Intrapartum Deaths 0    
Stillbirths 44  
Early Neonatal Deaths 27
Late Neonatal Deaths 1
Congenital Anomalies 30
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6.  PERINATAL MORTALITY RATES                                                      Totals 2015
Overall Perinatal Mortality Rate per 1,000 Births 8.3  
Perinatal Mortality Rate Corrected For Lethal Congenital Anomalies 4.8 
Perinatal Mortality Rate Including Late Neonatal Deaths 8.6      
Perinatal Mortality Rate Excluding Unbooked Cases 8.3
Corrected Perinatal Mortality Rate Excluding Unbooked Cases 4.8  
7.  STATISTICAL ANALYSIS OF HOSPITAL POPULATION
AGE AT DELIVERY 2009 2010 2011 2012 2013 2014 2015
<20 3.8% 3.5% 3.0% 2.8% 2.5% 2.5% 2.1%
20-24 14.6% 13.1% 12.4% 11.6% 11.0% 10.1% 9.7%
25-29 24.7% 24.6% 23.6% 23.2% 21.5% 20.8% 20.5%
30-34 31.6% 31.6% 33.6% 34.8% 34.8% 35.1% 34.3%
35-39 21.3% 22.2% 22.5% 22.0% 24.3% 25.1% 27.1%
>=40 4.0% 5.0% 4.9% 5.5% 5.9% 6.5% 6.3%
PARITY 2009 2010 2011 2012 2013 2014 2015
0 47.3% 45.5% 45.5% 44.4% 42.6% 43.1% 42.0%
1 31.2% 32.3% 32.8% 34.1% 34.1% 34.3% 35.0%
2-4 20.4% 21.1% 20.7% 20.3% 22.1% 21.2% 21.8%
5+ 1.1% 1.1% 1.0% 1.2% 1.2% 1.4% 1.1%
BIRTHWEIGHT 2009 2010 2011 2012 2013 2014 2015
(grams)
500-999 0.5% 0.6% 0.5% 0.7% 0.8% 0.6% 0.6%
1000-1499 0.9% 0.7% 0.8% 1.0% 0.9% 0.8% 0.9%
1500-1999 1.6% 1.4% 1.6% 1.5% 1.7% 1.5% 1.7%
2000-2499 3.4% 4.0% 3.8% 4.0% 4.1% 3.8% 3.9%
2500-2999 13.6% 13.1% 13.8% 12.9% 13.0% 13.1% 13.1%
3000-3499 33.5% 32.1% 32.4% 31.5% 32.6% 33.4% 33.1%
3500-3999 34.4% 32.9% 33.0% 34.1% 32.4% 32.9% 33.2%
4000-4499 10.0% 12.7% 11.8% 12.2% 12.2% 12.0% 11.9%
4500-4999 1.9% 2.3% 2.1% 2.0% 2.2% 1.8% 1.7%
>5000 0.2% 0.2% 0.2% 0.1% 0.1% 0.1% 0.1%
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GESTATION 2009 2010 2011 2012 2013 2014 2015
(Weeks) 
<26 weeks 0.2% 0.3% 0.2% 0.3% 0.3% 0.3% 0.3%
26 - 29 weeks + 6 days 0.6% 0.6% 0.8% 0.7% 0.7% 0.6% 0.6%
30 - 33 weeks + 6 days 1.4% 1.4% 1.3% 1.5% 1.5% 1.4% 1.4%
34 - 36 weeks + 6 days 4.1% 4.3% 4.4% 4.4% 4.4% 4.9% 4.6%
37 - 41 weeks + 6 days 92.6% 92.8% 93.2% 93.0% 93.0% 92.6% 92.7%
42 + weeks 1.1% 0.6% 0.2% 0.2% 0.1% 0.1% 0.4%
19
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NOTES ON PERINATAL MORTALITY
• The overall rate applies to all babies weighing greater than or equal to 
500g who were stillborn  or died in the first seven days of life (71).
• The corrected perinatal mortality rate is when congenital malformations 
are excluded (71-30 = 41).  This gives a corrected rate of  4.8 and an overall 
rate of 8.3.
STILLBIRTHS
Stillbirths 44
Congenital 15
Placental 10
Cord 6
Infection 5
Feto Maternal Haemorrhage 1
Unexplained 7
F E T A L  L O S S
T h e  M a s t e r
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Congenital (15)
1. Para 0.  BMI 20.  Booked at 10 weeks.   Med hx systemic lupus.  Anatomy scan
at 20+4 weeks revealed multiple abnormalities.  All measurements  < 5th
centile, lemon shaped head, sacral spina bifida, Arnold Chiari malformation,
bilateral rocker bottom feet, VSD.  Decision to proceed to amniocentesis,
Karyotype 47 XX, Trisomy 19.  Scanned regularly until 34 weeks at which
time no FH detected.  Induced.  SVD stillborn female infant weighing 1190g.
PM declined given antenatal diagnosis. 
2. Para 1+0.  Previous forceps at term.  BMI 27.4.  History of depression.  Booked
at 12 weeks.  Anatomy scan at 21 weeks - abnormal heart views.  Repeat
anatomy and fetal ECHO, Aortic arch hypoplasia, absent stomach bubble,
clenched hands.  Amniocentesis - Trisomy 18.  Attended at 28 weeks for
RAADP - no FH.  IUD confirmed.  IOL.  Assisted breech delivery of stillborn
male infant weighing 600g.  Normal IUD bloods. PM declined.  Cause of
death Trisomy 18. 
3. Para 1.  SVD.  BMI 19.3. Booked at 14 weeks.  Anatomy scan at 24+6 - symmetric
IUGR, borderline ventriculomegaly, echogenic bowel.  Referred to Fetal
Medicine Department.  Review 25+3 agreed with scan findings,
uncomplicated amniocentesis, maternal bloods for TORCH screen.  CMV
DNA detected by PCR on amnio.  Likely prognosis congenital CMV.  Regular
follow-up in Fetal Medicine Department.  MRI at 28+5 - severe
tetraventricular hydrocephalus, cystic change in both cerebellar hemispere,
evidence of hyrdops.  Review at 30+5, IUD confirmed.  IOL.  Assisted breech
delivery of a stillborn male infant weighing 1400g.  TORCH CMV IgV
positive.  Group B strep in placenta.  PM performed.  Cause of death
congenital CMV.
4. Para 2.  Stillbirths x 2 at 25 and 28 weeks.  BMI 22.  Booked at 16 weeks.  Patient
and partner are carriers of pathogenic variants in RYRI gene.  Anatomy scan
at 20 weeks - bilateral talipes, wrists flexed.  Amniocentesis at 21+6.  Amnio-
reduction at 30+6 weeks.  IUD confirmed at 32 weeks.  IOL.  Compound
presentation - arm, transverse lie, proceeded to emergency LSCS.  Stillborn
female infant delivered weighing 1430g.  PM declined.  Cause of death
congenital arthrogryposis. 
5. Para 2+2.  Previous forceps and Ventouse.  BMI 26.  Booked at 12.  Ultrasound
at 21+1 weeks - multiple anomalies detected.  Amniocentesis PCR - T18.  Failed
IOL at 37 weeks.  IOL at 39+6.  Assisted breech delivery of stillborn female
infant weighing 1.77 kg.  PM declined.  Cause of death Trisomy 18.
6. Para 0+1.  Booked at 12 weeks.  At 13+2 CVS - T21.  Regular attend at ANC.
Presented at 39 weeks with decreased FM - oligohydramnios.  IUD confirmed
on scan.  IOL.  SVD of stillborn female infant weighing 2.98 kg. PM declined.
Cause of death Trisomy 21.
21
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7. Para 1, previous elective caesarean section at term because of displaced
fractured pelvis.  BMI 21. Booked at 13 weeks.  Anatomy scan at 21 weeks
revealed possible cardiac defect with intra-cardiac echogenic foci in the left
ventricle and bilateral hydronephrosis, femur length on the 5th centile.
Amniocentesis confirmed Trisomy 21.  Patient attended at 28 weeks, no FH
detected.  Following extensive discussion and in view of previous caesarean
section and displaced fractured pelvis, delivered by elective caesarean.
Stillborn male infant 1.46 kilograms.  Post-mortem declined. Cause of death
Trisomy 21. 
8. Para 0.  BMI 23.  Booked at another hospital.  Referred at 20+6 following scan
suggesting congenital anomaly.  USS at 21+2 - abnormal four chamber view
(large VSD, ventricular discordance, marked thickening of right ventricular
wall, pleural effusion), bilateral rocker-bottom feet, small for gestation age.
Amniocentesis - PCR unbalanced translocation between Chromosome 7 and
13, 46XX.  IOL at 37+6, assisted breech delivery of stillborn female infant
weighing 1780g.  PM declined.  Likely cause of death unbalanced
translocation between chromosome 7 and 13, 46XX.
9. Para 2+4 (SVD x 2).  BMI 43.2.  Booked at 10.  Smoker.  Difficult anatomy scan
at 19 and 23 weeks because of BMI.  USS at 25+1, major cardiac anomaly.
Amniocentesis - Trisomy 13.  Presented at 35+6, feeling unwell, no FH on
ultrasound.  IOL.  SVD stillborn female infant weighing 2040g.  PM declined.
Cause of death Trisomy 13.
10. Para 0.  Booked 12+3 weeks.  Anatomy scan at 20+5 and 23+3 weeks - no
obviously anomaly. USS at 28+4 and 30+4 - reassuring interval growth.  Seen
regularly in the ANC.  At last ANC visit at 40+4 - reduced AFV.  Plan to admit
for IOL.  Admitted for IOL at 40+6, no FM since the morning.  IUD confirmed
on scan.  IOL.  SVD, stillborn male infant weighing 2600g.  PM performed.
Karyotype and placental histology - an  abnormal male karyotype with a
complement of 47 chromosomes, including three copies of chromosomes 21
(Trisomy 21).  Placenta from a case of Trisomy 21 with IUGR, small placenta,
delayed villous maturation, hypoxia, chronic - chorangiosis and nucleated
red blood cells in the fetal circulation.  Cause of death - Trisomy 21.
11. Para 0.  Booking bloods normal.  Booked at 14 weeks.  Scan confirmed dates.
Anatomy scan at 21 weeks - poor cardiac views, heart displaced to left side,
estimated fetal weight < 5th centile.  Large mass noted in the chest cavity.
Suspected large right sided diaphragmatic hernia confirmed in the Fetal
Medicine Unit.  Follow-up in the combined Rotunda/Coombe Cardiac Clinic.
Amniocentesis normal karyotype.  Scan at 29 weeks, growth remained less
< 5th centile, absent end dystolic flow.  Scan at 31 weeks - reversed end
diastolic flow.  IUD noted at 32 weeks.  Induction of labour.  Spontaneous
vaginal delivery of a stillborn female infant weighing 1.0 kgs.  Cause of
death large congenital right sided diaphragmatic hernia.  PM declined.
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12. Para 0+1.  Transferred from another hospital with fetal hydrops diagnosed
at 29 weeks gestation.  IUD diagnosed at 30 weeks.  Induction of labour.
Stillborn female infant weighing 1.81 kilograms delivered. Manual removal
of placenta required.  Consent for post-mortem.  PM showed no evidence of
any congenital malformation.  There was no evidence of viral intra nuclear
inclusions.  Immuno staining for parvovirus was negative.  Placenta showed
diffuse hydropic change.  Cause of death unexplained non immune hydrops.
13. Para 2+3 (SVD x 2, 1 NND, 3 early miscarriages).  BMI 25.  Booked at 11+4.  USS
at 16+5 revealed infantile polycystic kidneys, no other structural
abnormality.  USS at 20+5 - massively enlarged kidneys with evolving heart
failure and ascites.  USS at 21+2 - IUD.  IOL.  SVD of stillborn male infant
weighing 565g.  PM declined.  Likely cause of death diffuse cystic renal
dysplasia.
14.& 15.Para 0+1 (early mis.) BMI 26.6.  Booked in another hospital.  Smoker.  MCDA
pregnancy.  Referred with increased NT. Seen at 16+4, USS showed extensive
cyst hygroma on both fetuses with significant hydrops, but no evidence of
TTTS.   Amniocentesis - 45X.  Ultrasound at 22+4, fetal demise x 2, gross fetal
hydrops.  IOL. SVD of stillborn female infant weighing 660 and stillborn
female infant weighing 550g.  No PM.  Likely cause of death 45X, Turner
Syndrome.
Placental  ( 10 )
1. Para 0+1.  Previous first trimester miscarriage. BMI 25.  Booked at 12+4
weeks.  Smoker 10 per day.  Anatomy scan at 20+5 weeks.  All biometry <5th
centile.  No obvious fetal defect.  Repeat scan at 23+2 weeks.  Biometry
remained below 5th centile.  Amniocentesis declined.  Repeat scan at 25+2,
biometry remained below 5th centile, oligohydramnios noted, absent end-
diastolic flow with evidence of cerebral redistribution.  Discussion with
patient regarding prognosis.  Risk of IUD explained.  TORCH screen sent.
Further scan at 25+5, oligohydramnios, intermittent absent end diastolic
flow.  Further scan at 26+2, persistent absent EDF.  Admitted for daily
monitoring.  Obstetric and Paediatric discussion with patient and family.
Conservative management agreed.  Scan at 31+2 confirmed IUD.
Mifepristone given.  Assisted breech delivery of a stillborn male infant
weighing 660g.  TORCH screen negative.  HVS - Bacterial vaginosis.  PM
declined.  Cause of death placental insufficiency.
2. Para 2.  Previous SVD x 2.  BMI 25.  Smoker 10 per day.  Booked at 14 weeks.
Anatomy scan at 20 weeks NAD.  Seen at 28 weeks NAD.  Presented to ER at
31 weeks with decreased fetal movements.  IUD confirmed.  IOL.  SVD male
infant weighing 1.2 kg.  TORCH screen negative.  Maternal toxicology
positive for opiates and cannabis. PM performed. Cause of death chronic
utero placenta insufficiency.
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3. Para 1 (SVD at 41/40, 3.64 kg). BMI 27.9.  Booked at 12+5 weeks.  Anatomy scan
at 20 weeks - normal.  USS at 29+2 all measurements <5 centile,
oligohydramnios, normal Doppler, normal CTG.  Steroid given. TORCH
screen: CMV IgM (Architect -weak positive, Vidas - equivocal), CMV IgG
positive (IgG avidity index - 0.864, strongly suggesting primary infection
dating > 3 months).  Amniocentesis - normal PCR, 46XY.  Regular follow-up,
guarded prognosis explained.  USS at 30+6 - new findings of  pulmonary
valve abnormality with post valvular dilatation of PA (? Pulm stenosis).
Presented at 31+4 with small pv bleed, no pain, USS - no FH,
oligohydramnios, breech.  IOL. Assisted breech delivery of stillborn male
infant weighing 1080g.  Post-mortem performed - macerated stillbirth,
IUGR, hypoxia/stress effect, chronic uteroplacental insufficiency.  Small
placenta.  Negative for congenital malformation of congenital infection.
4. Para 0.  BMI 30.23.  Booked at 10 weeks.  Anatomy scan at 20 weeks.  Regular
attender at ANC.  Presented to ER at 38+2 weeks with no FM for 3 days.  IUD
confirmed on scan.  Contracting.  SVD of stillborn male infant weighing 2.69
kg.  PM declined.  Cause of death extensive villitis in the placenta.
5. Para 1.  (Em LSCS at 39 weeks).  Booked at 11+5.  Anatomy scan at 20+6, normal.
Transferred to ER at 33+3 weeks with severe abdo pain.  IUD confirmed.  NIEL.
Consumptive coagulopathy.  Decision for GA  - CS, intrauterine balloon, HDU
care, EBL 2.5 litres.  Stillborn female infant weighing 2.29 kg delivered.  Post
CS sepsis.  PM performed.  Cause of death abruption.
6. Para 0.  BMI 26. Booked at 12+3 weeks.  Leucocytes noted.  Bacteruria screen
each visit.  2 x ecoli UTI this pregnancy, nitrofurantoin prophylaxis.
Anatomy scan at 21+3 weeks normal.  Repeat USS for cardiac review.  Cardiac
ultrasound at 26+1 normal.  ER at 27 with no FM.  IUD confirmed.  IOL.
Assisted breech delivery of a stillborn female infant weighing 780g.  Limited
PM performed.  Cause of death retroplacental haemorrhage.
7. Para 0.  BMI 26.  Booked at 14+6.  Poor English.  History of Migraines and RTA
- ongoing musculo skeletal pains.  Scan at 21+2, placenta low lying for re-scan
at 34 weeks.  Presented to ED at 38+2 with ? labour pains by 1 day.  Unable to
auscultate FH.  Scan confirmed no FH.  Induced.  SVD stillborn male infant
weighing 2.5 kg.  PM performed.  Cause of death fetal thrombotic
vasculopathy.
8. Para 0+1.  BMI 22.5.  Booked at 12 weeks.  Unexplained secondary infertility.
IVF pregnancy.  Normal anatomy scan at 20+3 weeks.  Regular ANC follow-
up.  At 39+5 presented with reduced FM x 1 day.  USS confirmed no FH.  IOL.
SVD of stillborn male infant weighing 3630g.  PM performed.  Negative for
congenital malformation.  Likely cause of death fetal thrombotic
vasculopathy.
24
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9 & 10 Para 1+1.  Previous Ventouse delivery at 41+2.  BMI 22.5.  Booked at 12 weeks.  Early
scan at 9+4 confirmed MCD twin pregnancy.  Serial scans performed.  Doppler
and LV normal at 33+4.  At 33+5 presented with no fetal movements since
morning.  Double fetal demise confirmed.  No clinical evidence of infection or
abruption.  Mifepristone given. IOL at 34 weeks.  SVD of twin girls weighing 2.25
and 1.96 kg.  TORCH screen negative.  TFTs normal.  PMs performed.  Cause of
death probable twin to twin transfusion.
Cord  (6 )
1. Para 1. SVD. BMI 38.  Booked at 17 weeks.  Anatomy scan at 22+6 - restricted
view due to BMI, cardiac views not obtained. Repeat scan at 25+6 - good
cardiac views.  Negative GTT at 26 weeks.  Presented to ER at 26+2 - no FM
for 2 days.  Scan confirmed IUD.  IOL.  SVD of stillborn female infant
weighing 850g. PM performed.  Cause of death probably cord accident.
2. Para 1. SVD.  BMI 24.  Booked at 13 weeks.  Anatomy scan at 20 weeks - 2
vessel cord noted.  Growth scans at 28 and 32 weeks normal.  Presented to
ER at 38+3 with decreased FM.  Seen in ANC at 40 week - NAD.  Presented
at 40+1 with decreased FM.  IUD confirmed.  IOL.  SVD stillborn male infant
weighing, 4.46 kg.  Consent to PM.  Cause of death cord accident.
3. Para 1. (El LSCS - placental insufficiency).  BMI 40.  Booked at 14.  NIDDM, PCOS.
Anatomy scan at 20, anterior low lying placenta.   Admitted for BSL stabilisation.
ANC at 22 weeks.  USS at 24 weeks, normal fetal echo.  ER at 26+5, no FM x 1 day.
IUD confirmed.  IOL.  Breech delivery of stillborn male infant weighing 1000g.
Nuchal cord.  Consented for PM.  Cause of death - cord accident.
4. Para 1. (LSCS).  BMI 23.  Booked at 8+4 weeks.  Anatomy scan at 21+2 no
obvious abnormality.  Regular attender at ANC.  Presented at 39 weeks
with no FM for 1 day.  USS revealed IUD.  IOL.  SVD stillborn male infant
weighing 2850g.  PM declined.  Histology - cord accident - umbilical vein
thrombosis, fetal thrombotic vasculopathy, diffuse moderated delayed
villous maturation.  Multifocal villitis of unknown aetiology.  Likely cause
of death - cord accident.
5. Para 0.  BMI 20.5.  Booked at 15+3 weeks.  Anatomy scan at 20+3, growth < 5th
centile.  Scan at 22+3 - good growth.  Regular antenatal attendances. Seen in ANC
at 36 weeks - ? PPROM.  Presented at 38 weeks with 3 day history of decreased
fetal movements.  IUD confirmed.  SVD of a stillborn female infant weighing
2440g.  PM performed.  Cause of death cord accident, stricture of the cord with
almost occlusive thromi in 2 vessels.
6. Para 0+1 (ectopic).  BMI 26.4.  Booked at  12 weeks. Presented to EPAU at 8
weeks, dates confirmed.  Posterior fibroid uterus 4.5 cm.  Anatomy scan at
20 weeks normal.  Attended at 28 weeks for RAADP.  Seen in antenatal
clinic at 32 and 34 weeks - uneventful.  Attended ER at 35+1 with decreased
FM.  IUD confirmed.  IOL.  SVD stillborn male infant weighing 2.29 kg,
nuchal cord x 2 tight.  TORCH screen negative.  PM declined.  Unexplained
IUD. 25
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Infect ion  (5 )
1. Para 1.  Previous LSCS.  Presented to Cavan Hospital with PPROM at 22+5.
Transferred to Rotunda at 23+3.  At 24+1 CTG showed decreased variability,
with unprovoked decelerations.  Transferred to delivery suite for
continuous monitoring.  Vaginal breech delivery of a stillborn female
infant weighing 590g.  PM declined.  Histology revealed ascending
infection and hypoxia. Cause of death extreme prematurity/infection.
2. Para 0+1 (Missed Misc).  BMI25.  Booked at 7 weeks.  Hypermesis, IV
hydration.  ER at 8+ weeks, threatened miscarriage, reassured.  ANC at 11
weeks, T1 screening - low risk.  Anatomy scan at 18+ weeks normal.  ER at
20+2 weeks with PPROM.  21+4 USS - anhydramnios.  Day 11 post PPROM
clinical chorioamnioitis .  IOL.  SVD stillborn infant weighing 510g.  HVS GBS
isolated.  Placental swab GBS. PM declined.  Cause of death extreme
prematurity/infection.
3. Para 0.  BMI 21.  Booked at 13 weeks.  Presented to ER at 19, 19+3, 20+3 weeks
with PV bleeding.  At 21+2 weeks presented and admitted with PPROM.
Started on erythromycin.  USS at 21+3, no obvious anomaly, anhydramnios,
posterior low lying placenta.  Swab - light growth of GBS.  At 23+3 weeks
cord prolapse noted and patient advised on the likely course of events and
prognosis.  USS the following morning - no FH, breech.  IOL.  Assisted breech
delivery of a stillborn female infant weighing 555g.  PM performed.  Likely
cause of death cord prolapse with a background of pre-viable PPROM.
4. Para 1+0.  Previous SVD, third degree tear, PPH.  BMI 23.  Booked at 13 weeks.
Anatomy scan at 22+6 - no abnormalities noted.  Presented to ER at 23+1 -
feeling unwell, lower back and abdominal pain, pv spotting x 1 day, fluid
draining.  Impression PPROM.  Admitted for expectant management.  SVD
delivery of a female stillborn infant weighing 520g.  MSU HVS and rectal
swab from admission grew Group B strep.  PM declined.  Cause of death
ascending infection/prematurity.
5. Para 3 (term SVD x 3).  BMI 20.1.  Smoker 10 per day.  History of depression.
Booked in another hospital.  Admitted with PPROM at 22 weeks.
Transferred to Rotunda at 24+2. WCC and CRP persistently raised. 26+2
reviewed for pain, no evidence of choriamniotis.  At 26+3 passed a large
clot, difficult to auscultate FH.  VE - cord prolapse.  Cat 1 CS under GA.
Stillborn female infant weighing 750 gms delivered.  Limited PM
performed.  Cause of death ascending infection with cord prolapse.
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Feto  Maternal  Haemorrhage  ( 1 )
1. Para 1.  BMI 23.5.  Booked at 11 weeks.  Seen in ED at 17/40 weeks following a fall.
Denied any direct abdominal trauma.  Scan at 21+3 and 24+4 normal.  Seen in
antenatal clinic at 30 and 34 weeks, all well.  Referred to ED by GP at 35+2 with
decreased fetal movements.  Unable to auscultate FH.  Scan confirmed absent
FH.  Mifepristone given.  SVD stillborn male infant weighing 2.96 kg.  PM
performed.  Cause of death massive feto-maternal haemorrhage. 
Unexplained  (7 )
1. Para 1+0.  SVD at 37+5 weeks, 3rd degree tear and PPH. BMI 20.  Booked at 12+4.
Anatomy scan at 22+4 weeks - no abnormalities noted.   Seen in Perineal Clinic
at 29+3, decision for SVD.  Referred to ER by GP with decreased fetal movements.
Unable to auscultate FH.  Scan confirmed IUD.  Mifepristone given.  SVD male
stillborn infant weighing 2070g.  Cord noted around baby's leg and neck.
TORCH screen negative.  PM performed.  Cause of death - unexplained.
2. Para 4. SVD x 3, LSCS x 1 (PET at 31/40).  BMI 34.  Booked at 12+5 weeks.
Ultrasound confirmed DCDA twins.  Anatomy scan at 20+5 - no
abnormalities noted, poor renal and cardiac views.  Repeat scan at 24+6 -
normal views.  Regular attender at ANC.  GTT at 26 weeks normal.  Seen at
32+5 - FDIU twin II, EFW 1433g, anhydramnios; twin II, 2069 g, normal AFI
and Doppler.  Admitted for monitoring and steroids.  Booked for elective
LSCS at 37 weeks.  Twin 1 male infant weighing 3.03 kg, Apgars 9 and 10.
Twin 2, stillborn male infant weighing 900g.  PM performed. Cause of
death - unexplained.
3. Para 1.  Term delivery complicated by gestational hypertension.  Family
history of non-insulin dependent diabetes mellitus.  Late booker at 25 weeks.
Anatomy scan negative for malformations.  Regular attendance at clinic.
Routine visit at 38+5 weeks, no fetal heart detected.  Induction of labour.
Spontaneous vaginal delivery of a stillborn male, weighing 2.82 kilograms.
Post-mortem declined.  Placental histology showed hypercoiling of cord,
coiling index 0.42.  No evidence of inflammation or thrombus formation.  No
evidence of ascending infection.  Cause of death unexplained.
4. Para 2 (LSCSx2).  BMI 34.5.  Booked at 12+4.  Stable anti D antibody 9.83 at
booking, 9.23 at 21 weeks, 10.20 at 29+4 weeks,  9.60 at 32+4 weeks.  Anti C
titre remained < 1.  Anatomy USS at 21 , no obvious abnormality, no evidence
of fetal anaemia.  Had regular ANC follow-up.  USS at 23, 25, 27, 28+4, 29+4,
30+4, 32, 32+4, normal growth.  At 33+4 reported reduced FM for 1 day.  USS
revealed no FH.  Elective LSCS at 34 weeks.  Stillborn male infant weighing
2500g delivered.  PM performed.  Cause of death unexplained.
5. Para 0+1.  Booked at 13 weeks.  Smoker 10/day.  Threatened miscarriage at 5+
weeks.  EPAU 7+ and 9+ weeks - viable IUP.  ER at 17+ weeks leaking fluid.
Anatomy scan at 22+4, normal.  ER at 27 weeks with no FM.  IUD confirmed.
IOL.  SVD stillborn female infant weighing 930g. PM performed.  Cause of
death - unexplained. 27
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6. Para 0.  BMI 26.3.  Booked at 16+3.  US confirmed dates and multiple fibroids
noted.  Admitted at 17+5 with pain, ? degenerating fibroid.  Regular scans
and ANC attendances..  Attended ANC at 37+4 - 2+ glucose, fasting sample
next day normal.  Presented at 38+2 with decreased fetal movements for 1
day and SROM draining mec grade III.  IUD confirmed on ultrasound.  IOL.
SVD complicated by severe should dystocia.  Stillborn male infant weighing
3.96 kg delivered. PM performed.  Features of an acute hypoxic event - acute
petechial haemorrhages in lungs, heart and pericardium.  CNS - hypoxic
ischaemic encephalopathic changes. Heart - myocardial contraction bands.
Placenta - nucleated RBCs in fetal circulation.  Ribs - focal growth arrests.
Negative for congenital anomalies.  Long umbilical cord with coiling index
at the upper limit of normal.  No definite thrombus identified.  Possibility of
cord accident superimposed on a small placenta.
7. Para 2.  Two previous elective caesarean sections.  Booked at 12 weeks.  Scan
confirmed dates.  Booking bloods normal.  MCDA twin pregnancy.  Regular
follow-up in Fetal Medicine Twin Clinic.  Concordant growth.  Anatomy scan
negative for malformations.  Forth nightly growth scans.  At 34 weeks estimated
weighs 2.8 and 2.7 kilograms.  Blood pressure mildly elevated at 35+ weeks.
Reviewed in Day Care Unit and admitted for observation with planned delivery
next day.  Delivery by caesarean section.  Twin I male, 3.27 kg, good Apgar scores.
Twin II unexpected stillborn male infant weighing 2.53 kg.  Placental histology
showed no evidence of gross or histological evidence of vascular anastomosis,
no evidence of cord accident or ascending infection.  Cord insertion of twin II
was villamentous.  There was some evidence of impaired fetal blood flow
possibly due to compression of villamentous cord insertion.  Coroners post-
mortem.  Result unavailable at time of preparation of report.
EARLY  NEONATAL  DEATH
Early Neonatal Deaths                                      27
Congenital 15
Prematurity 5
Other 7
Congenital  ( 15 )
1.  Para 1.  BMI 25.  Previous SVD.  Booked at 13 weeks.  Anatomy scan at 22
weeks revealed left sided cystic adenomatoid malformation.  Further scan
at 23 weeks confirmed left sided diaphraghmatic hernia, absent right
hand, shortened left forearm with small hand and absent digits.
Subsequent confirmation of Cornelia de Lange Syndrome.  Presented at
31+4 weeks in labour.  Delivered a female infant weighing 1110g.  NND day
1.  PM declined. 
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2.  Para 1+1.  BMI 27.  Previous first trimester miscarriage in 2014 and SVD in
2012.  Referred from OLOL to Prenatal Diagnosis Clinic at 23+4, re: family
history of Osteogenesis imperfecta.  Scan revealed cardiac circumference
>50% thoracic diameter; bilateral short humeri; bilateral short femurs;
bowing and fracture of right femur.  Further scans at 30, 35, 38 and 39
weeks.  Multiple fractures noted.  Small thorax noted.  Seen at 40+4 and
noted to be breech presentation.  Decision for delivery by LSCS.  Liveborn
male infant weighing 2.42 kg with Apgars of 1, 4 and 3.  NND day 1.  PM
declined.
3. Para 2.  BMI 39.  SVD of stillborn female infant at 36 weeks and EM LSCS
for fetal distress at 38 weeks of live born male.  Referred from OLOL at 32+1
with ? diaphragmatic hernia.  Scan findings, some views suggestive of
congenital diaphragmatic hernia, MRI recommended.  MRI at 37 weeks,
symmetrically raised hemidiaphragms, small lungs bilaterally, fluid
around both kidneys suggestive of retroperitoneal urinary tract rupture,
no definitive hernia seen.  Plan for elective LSCS at 39 weeks.  Presented at
38+5 in labour.  Decision for vaginal delivery and transferred to LW.  Slow
progress, blood stained noted, decision for EM LSCS.  Re-examined in
Theatre and fully dilated.  Forceps delivery of liveborn female infant
weighing 3.38 kilograms.  Cord pH 7.25 and 7.35.  NND day 3.  PM declined.
4. Para 0+0.  BMI 37.  Referred to Fetal Medicine at 20 weeks, multiple
abnormalities noted on scan in OLOL.  Scan revealed oligohydramnios,
bilateral ventriculomegaly, Banana shaped cerebellum, cystic structure at
base of spine, pericardial effusions, left sided echogenic focus, echogenic
myocardium.  Impression: severe ventriculomegaly with spina bifida.
Patient counselled regarding likely poor prognosis.  IOL at 40 weeks.  SVD
of live born male infant weighing 1750g.  NND day 1.  PM declined.
5. Para 1+1.  SVD live born male infant weighing 3.5 kg in 2013; TOP in 2010.
BMI 25.  Booked at 21+6.  Scan at 23+4 - abnormal cardiac views.  24+3
weeks Fetal Echo, hypoplastic left heart noted, mitral atresia diminutive
aortic outflow with retrograde flow in aortic arch, reversed flow across
foramen.  Decision to proceed with amniocentesis.  Repeat Echo at 26+4
with cardiologist.  Amniocentesis - Mosaic Turner Karyotype, hypoplastic
left heart, mitral and aortic atresia.  MDT review and decision that
surgery would not be offered.  Plan for comfort care at birth.  Presented to
ER at 38+6 in labour.  Live female infant weighing 2.77 kg delivered.  NND
day 1.  No PM.  Diagnosis from amniocentesis and US.
6. Para 0+6.  Recurrent 1st trimester miscarriages.  BMI 23.3.  Clomid
pregnancy.  Booked at 16 weeks.  Anatomy scan at 20 weeks - growth <
10th centile, right choroid plexus cysts, left ventricolumegaly, ? small VSD
and polyhydramnios.  Amniocentesis - Trisomy 18.  Scans at 25, 33 and
weekly thereafter.  Breech with polyhydramnios.  IOL at term +10.  Breech
delivery of  live born female infant weighing 1830g. NND day 1.  PM
declined.
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7. Para O.  BMI 23.4.  Booked at 15 weeks.  Smoker 10 per day.  History of
depression, not on treatment.  Anatomy scan at 22+3 - right sided CDH,
long heart ratio - 0.5, bright kidneys, since vessel cord.  Amniocentesis at
23+6 - IUFR, normal karyotype and microarray.  MRI - large right CDH,
herniation of the right lobe of liver, stomach and loops of bowel.  Deviation
of heart and mediastinum to left hemithorax, miminal lung tissue visible
in the right hemithorax suggestive of right lung hypoplasia.  Fetal echo at
28+6 - cardiac dextroposition with no structural abnormality.  Seen
regularly in FAU up to 38 weeks.  Booked at for LSCS at 38+4. Live born
female infant weighing 2.49 kg was delivered.  RIP day 1.  Post-mortem
declined.  Cause of death congenital diaphragmatic hernia.
8. Para 0.  BMI 20.  Booked at 13 weeks.  Medical history of hypothyroidism,
on Eltroxin 75mcg daily. Anatomy scan at 20+4 - Holoprosencephaly,
abnormal facies including cleft lip and palate, abnormal 4 chamber view
of heart, large VSD, clinical impression of Pateu's syndrome.
Amniocentesis performed at 23+1.  46XY.  MRI - alobar holoprosencephaly
which communicates with a sizeable dorsal cyst, crescent of brain tissue
anterior and lateral to ventricles is thinned and smooth.  Midline cleft
noted.  Discussion with parent re poor prognosis despite normal
karyotype.  Decision for comfort care at delivery.  Presented to ER in labour
at 39+6.  SVD of live born male infant weighing 2340g.  NND day 4.  PM
declined. 
9. Para 1+1. Em LSCS/first trimester miscarriage.  BMI 21.  Booked at 11+4.  Anatomy
scan at 20+2 - anencephaly.  Regular scans throughout pregnancy. Plan for
VBAC.  No SOL at 42+3, decision to proceed to LSCS.  Live born male infant
weighing 2870g delivered.  NND the following day. Limited PM performed.
10. Para 1.  Previous forceps.  BMI 22.  Booked at 20.  Smoker - 5 per day.
Ultrasound at 26 weeks - asymmetric IUGR, polyhydramnios, VSD.
Amniocentesis - 47 XY + 18.  PPROM at 31+6.  Admitted, decision made for
IOL, SVD live born male infant weighing 1070g.  NND at 1 hour.  PM
declined.  Cause of death Trisomy 18.
11. Para 2.  SVD x 2.  1 NND renal agenesis.  Booked at 12 weeks.  USS at 16 weeks
- oligohydramnios.  17+1 - CVS.  17+2 - Anhydramnios, central previa, BOO
Hx PPROM, Amnisure neg.  18+3 - Anhydramnios, Echogenic kidneys,
megacysts.  31+1 complained of cramps, soft cervix, NIEL.  Presented to ER
at 33+4 in ? labour - NIEL.  At 33+6 presented to ER in labour.  SVD of a male
infant weighing 1.36 kg.  NND at 2 hours of life.  PM performed.  Bladder
outlet obstruction.
12. Para 2+2.  SVD x 2 at term.  Booked at 12 weeks.  Hyperprolactinemia.  At
booking NT 3.5 mm referred to Fetal Medicine.   At 14 weeks NIPT, cystic
hygroma - 'low risk' Harmony result. At 15+1 - body wall oedema offered
invasive testing.  At 17+1 - shortened long bones.  At 19+1 - All long bones
shortened.  For NIPD (FGFR3 mutation). Scanned at 24, 28+3 and 31+1.  At
34+1 - polyhdyramnios, HC increased.  Offered IOL.  SVD of male infant
weighing 2.54 kg.  NND day 1.  PM declined.30
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13.  Para 2+1 (SVD x2).  BMI 28.6.  Booked at 12+5.  DCDA.  Anatomy scan at 21+6,
fetus 1 normal, restricted view of fetus 2 due to position.  Further scan at
28 weeks, oligohydramnios (fetus 2), suspected renal dysgenesis.  MRI
confirmed renal agenesis in Twin 2.  Regular follow-up in Fetal Medicine.
SOL at 37 weeks, twin 1, live born SVD weighed 3190g and twin 2, assisted
breech delivery of live born infant weighing 1900g, NND shortly
afterward birth.  PM declined.
14. Para 0+3.  Recurrent miscarriage.  BMI 22.7.  Booked at 12+6 weeks.
Hypothryroidism (Eltroxin).  Partner carrier of osteogenesis imperfecta gene
(type 1).  Booked USS - large omphalocele.  Declined NIPT/invasive testing.
Follow up in Fetal Medicine.  Presented at 31+1 weeks with abdominal pain
and bulging membranes.  Steroids.  Emergency LSCS.  Avulsion of umblical
cord during delivery, cystic dilatation of part o f cord.  Male infant weighing
2000g delivered.  RIP despite active resuscitation. PM performed. Likely cause
of death - bilateral pulmonary hypoplasia due to large omphalocele.
15. Para 1.  Previous term delivery.  Known fibroid uterus.  Suspected fetal
abnormality diagnosed in Drogheda, transferred to Rotunda for Fetal
Medicine follow-up.  Bilateral ventriomegaly,  generalised oedema,
clenched hands with polyhdyramnios noted on scan.  No stomach bubble
identified.  Suspected trachael oesophageal fistuala or oesophageal
atresia.  Amniocentesis 46XY.   Induction of labour at 39 weeks.
Emergency caesarean section for fetal distress.  Male infant 3.48
kilograms.  Apgars 0 at 1, 2 at 5, 2 at 10.  Placental histology confirmed
massive placental abruption.  Early neonatal death.  Congenital
malformation with placental abruption.  Coroner PM.
Prematur ity  ( 5 )
1. Para 1+3.  SVD x1, 1st trimester miscarriage x 2, ectopic x 1.  BMI 24.5.  Booked
at 13 weeks.  Presented to ER with PV bleed at 15 weeks.  Anatomy scan at
21+1 weeks normal.  Presented at 21+6 with SROM.  Commenced on oral
erythromycin.  Swabs taken - no GBS isolated.  Scan 22+1 - Breech,
anhydramnios, FM present.  At 22+2 developed abdominal pain and flu
like symptoms, clinical impression of evolving chorioamnionitis.
Decision made to proceed to IOL.  Vaginal breech delivery of live born male
infant weighing 540g.  NND shortly after delivery.  PM declined.  Cause of
death ascending infection/prematurity.
2. Para 0.  BMI 31.  Booked at 11 weeks. Presented to ER with PV spotting at 12+5
weeks, 14+5 weeks and 17 weeks.  Anatomy scan at 20+3 weeks, no fetal
abnormalities noted, restricted view of heart, placenta low lying and two
fibroids noted.  Repeat scan at 25+3, heart view obtained no abnormality noted.
At 26 weeks presented to ER with diarrhoea and vomiting.  Admitted and
commenced on IV fluids.  Had episode of PV blood on ward.  VE fully effaced,
bulging membranes,  breech presentation.  Commenced on Dexamethasone.
Labour progressed.  Decision for EM LSCS in view of footling breech presentation.
Difficult breech extraction.  Live female infant delivered weighing 1.035
kilograms.  NND day 4.  PM declined.  Cause of death prematurity.
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3. Para 0+1.  BMI 31.  Booked at 12 weeks.  History of secondary infertility,
hypothyroid - on Eltroxin.  Anatomy scan at 21+3 normal.  Plan for rescan to
complete cardiac view.  Presented to ER at 23+6 with heavy pv bleed.
Dexamethasone given.  Transferred to LW.  Expectant management.  SVD of
live born female infant weighing 510g.  NND day 4.  PM declined. Placental
histology: Acute ascending infection and retroplacental haemorrhage with
secondary inflammation.
4 & 5. Para 0.  BMI 44.  Booked at 7 weeks.  IVF DCDA twin pregnancy.  Partner has
Marfan's syndrome.  Regular ANC attendances at 10, 12, 13, 15, 18 (anatomy
scan - normal)  and 22 weeks. Presented to ER at 23+2 with pressure, PPROM.
Twin 1 SVD live born infant weighing 660g.  NND day 1.  Twin 2 planned
interval delivery, 2 days later SVD of live born male infant weighing 800g.
NND day 3.  HVS - E coli.  PM declined.  Cause of death infection/extreme
prematurity.
Other  ( 7 )
1.  Para 4+1.  Four previous term vaginal deliveries.  Past history of depression and
unexplained seizures.  On Methadone maintenance programme.  Booked at 9
weeks.  Irregular attender at antenatal clinic.  Anatomy scan at 20 weeks,
negative for malformations.  Multiple DNAs at antenatal clinic.  Spontaneous
labour at 38+4 weeks.  SVD of a male infant weighing 2.62 kilograms.  Mother
and baby discharged home well following liaison with Social Work.  Baby
unexpected death at home on day 6.  PM ordered by State Pathologist.  Results
unavailable at the time of going to press.
2. Para 3 (LSCS x3).  Booked in another hospital.  MCDA twins confirmed on scan at
13 weeks.  Heavy smoker.  Personality disorder, was on Olanzapine and Pregablin
up to 18 weeks and Prozac thereafter.  Referred to the Rotunda at 24+3 with ? TTS.
Reviewed at 26+5, stage 1 TTTS, admitted and given steroids.  Review 27+2 -
Normal Dopplers.  Review at 27+6 - unable to auscultate both FH on ward -
intermitted AEDF T2, DP - 20cm.  At 28+1 decreased FM overnight, non reassuring
CTG - decreased variability.  USS - FH x2 seen, normal HR, no movement.
Proceeded to emergency CS.  Twin 1 - live born female infant weighing, 830g.
Twin 11 live born female infant weighing 1.16 kg. Twin II NND day 1.  Coroners
PM performed.  No results at time of going to press.
3. Para 1.  SVD.  BMI 29.6.  Booked at 10+3. Scan confirmed dates.  Booking bloods
normal.  Anatomy scan at 20+3 - negative for malformations.  Regular
attendance at clinic.   Presented to ER at 40 weeks with decreased FM x 1 day.
Monitoring fetal heart revealed a fetal bradycardia of 60 beats per minute.
Immediate transfer to theatre for emergency caesarean section.  Female infant
weighing 3.38 kilograms delivered.  Apgars scores 0 at 1, 0 at 5 and 2 at 25.
Transferred to NICU.  RIP day 1.  Coroners post-mortem.  Cause of death invasive
group B strep infection in the absence of ruptured membranes.
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4. Para 6+2.  SVD x 4, LSCS x 2, VBAC x 3.  Smoker 40-50 day.  Booked at 8 weeks.
Background history of alcoholism, IVDA, PUD, Gallstones, Cirrhosis and ?
CVA.  Multiple presentations to ER with abdo pain and spotting in first
trimester.  Anatomy scan at 21+6 - NAD.  Attended DOVE clinic.  Presented to
ER at 29 weeks with abdo pain and SOB.  Admitted overnight, for ultrasound
- absconded.  Presented to ER at 29+2 with increasing abdominal pain.  Fetal
bradycardia.  Cat 1 CS - ruptured uterus.  Male infant weighing 1035g.  NND
day 2.  No PM.  Cause of death hypoxia secondary uterine rupture.
5. Para 0.  BMI 31.31.  Booked at 16+6 in another hospital.  Seen in FAU at 18+1 -
DCTA triplets with reassuring growth MCDA pair.  Seen again in FAU at 22+1
- reassuring interval growth in all three fetuses.  FAU again at 24+1, normal.
Seen again at 26+1 - severe IUGR with anhydramnios and REDF in fetus 3.
Expectant management agreed.  FAU review 28+2, fetus 3 severe IUGR.
Decision made to proceed with delivery.  Male infants x 3 delivered, weighing
1.5, 1.2 and 640g.  Triplet 3 NND day 4.  PM performed - complications of
prematurity, RDS and IUGR secondary to features of chronic uteroplacental
insufficiency. 
6. Para 1.  Booked at another institution, transferred to the Rotunda for
management of MCAD twins with 25% growth discrepancy at 17 weeks
gestation.  Twin to twin transfusion syndrome confirmed.  Laser oblation
and amnio reduction performed.  Re-presented to the Rotunda at 23+4 weeks
gestation with vaginal bleeding.  Admitted for observation.  Spontaneous
labour at 23+5.  Twin 1, male weighing 0.39 kg, apgars 4 at 1 and 1 at 5.  RIP.
Twin 2, male, assisted breech, weighing 0.75 kg, Apgars 6 at 1, 4 at 5 and 1 at
50.  Early neonatal death.  Cause of death extreme prematurity complicated
by acute suppurative chorioamnionitis with chorionic plate vasculitis. PM
declined.
7. Para 1 (SVD at 39/40, 2.96kg).  BMI 23.  Booked at 11+6.  Anatomy scan at 20
weeks - multiple abnormalities.  Amniocentesis showed normal PCR, 46XY.
USS at 23 - symmetrical IUGR.  Echocardiography at 26+3, normal.  At 27+4
IUGR with interval growth, polyhydramnios.  Presented at 32+4 in advanced
labour, SVD, male infant weighing 1420g.  NND day 1.  PM revealed multiple
contractures involving elbows, knees, wrists, and hips.  Bilateral talipes
equinovarus, scoliosis of spine, camptylodactyly with long tapering fingers
and poor nail development, hypertelorism, micrognathia, CNS
abnormalities.  Karyotype 46XY.  Micro array - normal with no significant
copy number variants but with low resolution.  Likely cause of death -
congenital malformation due to ischemic CNS damage. 
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MATERNAL MORTALITY 1
M a t e r n a l  M o r t a l i t y  
T h e  M a s t e r
There was one indirect maternal death during 2015. A single woman, gravida 3,
para 2+0, previously an emergency caesarean section and a Ventouse delivery,
booked at 15 weeks gestation.  Uncertain of dates, past history of significant mental
health issues and hepatitis C positive.  Smoker 20 per day.  Regular attendance at
antenatal clinic.  Followed up by Medical Social Workers and DOVE support team.
Delivered by elective caesarean section at 39 weeks gestation.  Live born female
infant weighing 2.95 kilos.  Day 5 post delivery discharged to Community Services.
Eight weeks following delivery the hospital was informed that the patient had
tragically died of a drug overdose.
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WHO Definitions:  
Direct obstetric deaths are those resulting from obstetric complications of the
pregnant state {pregnancy, labour and the puerperium} from interventions,
omissions, incorrect treatment or from a chain of events resulting from the
above.  
Indirect obstetric deaths are those resulting from previous existing disease or
disease that developed during pregnancy and which are not due to direct
obstetric causes, but are aggravated by the Physiologic effects of pregnancy.  
Maternal Mortality   
Year Total Total Number of Mothers Attending      
2006 0 8036
2007 0 9290
2008 1 9655
2009 2 9709
2010 3 9594
2011 3 10547
2012 2 10397
2013 3 10314
2014 2 10814
2015 1 10078
Total 17 95874
Maternal Mortality Rate 17.3/100,000
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The Rotunda continued to prospectively monitor severe maternal morbidity
during 2015. 
In total there were 63 patients (6 gynaecology) reported on and 73 events. The
incidence of severe maternal morbidity in pregnancy for 2015 was 0.68% 
Our number of women with major morbidity events was higher in 2015, this is
largely contributed to by an increase in women attending with complex pre-
existing medical conditions that required inpatient multidisciplinary care and an
increase in women attending with gynaecology complications, for example
Ovarian Hyperstimulation following assisted fertility treatments elsewhere.
Our number of cases with major obstetric haemorrhage fell in 2015 and we had no
case of pulmonary embolism. Two of our women had interventional radiology in
the Mater Hospital for bleeding, one of which was delivered in the Mater with
placenta accreta and preoperative interventional radiology.
In line with previous years we report “near-miss” cases for prompt identification
of learning points for all providing maternity care in Ireland.
Major Morbidity Number Number
of cases 2014 of cases 2015
Transfusion more than 5 units or 
Estimated Blood loss more than 2.5L 
or treated for coagulopathy 30 25
Uterine rupture 0 4
Peripartum hysterectomy 0 1
Eclampsia 0 1
Renal or liver dysfunction 14 7
Pulmonary oedema or acute 
respiratory dysfunction 5 2
Pulmonary embolism 1 0
Cardiac arrest 2 1
Coma 1 0
Cerebrovascular accident 1 0
Status epilepticus 1 1
Septicaemic shock 10 11
Anaesthetic issue 2 0
ICU/CCU Transfer 17 5
Maternal deaths 1 1
Interventional Radiology 2
Other 13
S E V E R E  M O R B I D I T Y
D r .  S h a r o n  C o o l e y
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Major  Obstetr ic  Haemorrhage  (25 )
1.  Para 2, non-smoker, non drinker. Booked in Sligo General Hospital.
Transferred from Sligo General Hospital at 26 weeks gestation with  preterm
premature rupture of membranes (PPROM) and placenta praevia. In patient
in Sligo at 20 weeks for PPROM, inpatient for 3 weeks. Two previous live
births, one pre-term at 36+3. MRSA positive axilla and groin swab so
prophylaxis commenced. Antepartum haemorrhage at 28+5, blood loss of
one litre. Emergency caesarean performed with total blood loss of 2.5 litres.
Male infant weighing 1.57 kilograms delivered, transferred to NICU. Mother
transfused with two units red cells and 2 grams fibrinogen.  High
dependency unit care for 48 hours. Discharged home well day 5 postnatally.
2. Para 0+1, BMI 23, non-smoker, booked at 12 weeks gestation for combined
antenatal care. No significant medical history, previous ovarian cystectomy
2014. Presented in labour at 39+3 weeks gestation. Ventouse delivery of liveborn
female infant weighing 3.86kg. Subsequent retained placenta requiring a
manual removal of placenta in theatre. Uterine balloon inserted.  Total blood
loss 2.5 litres, transfused 3 units of red cells. High dependency care for 24 hours
post operatively. Discharged home well on day 5.
3. Para 1, BMI 20, Non-smoker, booked at 13+6 weeks gestation for combined
antenatal care. History of pregnancy induced thrombocytopenia and
emergency caesarean section undertaken at full dilatation in the previous
pregnancy. Four units red cells received at that time and total blood loss
700mls. Received Kiovig (Human Normal Immunoglogulin) infusion at 39+2
weeks gestation in this pregnancy. Presented in labour at 39+5 weeks
gestation. Subsequent emergency caesarean section at full dilatation for
failure to progress.  Live born female 4.2kgs, Apgars 9@1, 9@5. Total blood loss
3 litres, two units red cells transfused. High dependency care for 24 hours
post operatively. Discharged home day 3 on antibiotics for cellulitis at the
wound site with follow-up scheduled at six weeks postpartum.
4. Para 0, BMI 18, Non-smoker, booked at 8 weeks gestation for consultant led
care. Medical history of infertility, hypothyroidism and family history of
hypertension. Dichorionic, diamniotic twin pregnancy as a result of IVF with
planned elective caesarean section. Group B Streptococcus isolated
antenatally. Presented in spontaneous labour at 35 weeks gestation.
Emergency caesarean section performed. Two live born female infants
delivered weighing 2.28 and 2.33 kilograms. Both transferred to NICU.
Intraoperative blood loss of 400 millilitres. Subsequent return to theatre for
examination under anaesthesia and uterine balloon insertion for
postpartum haemorrhage secondary to uterine atony. Total blood loss of 2.5
litres. Three units of red cells transfused and one gram of fibrinogen.
Transferred to the high dependency care unit post operatively. Discharged
home well day 6 post-operatively.
5. Nullip, BMI 25, Non-smoker, booked at 14+2 weeks gestation for consultant
led care. No significant medical history. Presented in labour at 39+6 weeks
gestation. Ventouse delivery of live-born female infant weighing 3.21kg,
Apgars 2 at 1, 6 at 5 and 10 at 8.  Baby transferred to NICU
56846 Rotunda Clinical Report 2015 26/10/16 v3_Clinical Rep  26/10/2016  15:50  Page 37
38
for septic work-up.  One litre estimated blood loss at delivery. Subsequent
retained placenta requiring a manual removal of placenta in theatre under
general anaesthetic. Uterine balloon inserted. Total blood loss of 3 litres,
transfused 2 units of red cells and 2 grams fibrinogen. High dependency care
for 24 hours post operatively. Discharged home well on day 4 post operatively.
6. Para 0+1, BMI 22, Non-smoker, booked at 12 weeks gestation for combined
antenatal care. IVF singleton pregnancy. History of hypothyroidism, on
Eltroxin for same. Family history of hypertension. Previous surgery for
removal of ovarian cysts. Presented in labour at 41+2 weeks gestation,
prolonged rupture of membranes. IV antibiotics commenced. Emergency
caesarean section performed for failure to progress and non reassuring
CTG. Female infant weighing 4.24 kgs, Apgars 9@1, 10@5. Intrapartum
haemorrhage with total blood loss of 2.5 litres. Transfused one unit of red
cells.  High dependency unit care for 24 hours. Discharged home well day 4
postnatally.
7. Para 3, unbooked presented to emergency room with shoulder tip pain and
suspected ectopic pregnancy, 7+2 weeks gestation. Three previous
spontaneous term deliveries. Laparoscopy converted to laparotomy due to
ruptured left corneal ectopic. Haemoperitoneum with total blood loss of 2.5
litres. Transfused three units red cells and 2 grams fibrinogen. High
dependency care for 24 hours post operatively. Transferred home well day
4 with follow-up arranged.
8. Para 1+0, unbooked, brought by ambulance to emergency room with severe
abdominal pain and substantial PV bleeding at 14 weeks gestation. One previous
spontaneous term delivery. Intrauterine bleeding noted on ultrasound.
Transferred to high dependency care unit and transfused 2 units of red cells
initially. Ongoing haemorrhage and transfusions. Eight units red cells
transfused in total with >2.5 litre blood loss. Due to deterioration of maternal
status, induction undertaken at 14 weeks gestation under the Protection of Life
Act. High dependency unit care throughout.
9. Para 2. BMI 19. Non-smoker. Two previous terms deliveries. Prior third
degree tear on first delivery, ERPC for retained products 4 weeks postnatally
on last delivery. Booked for combined antenatal care at 16 weeks gestation.
Dichorionic, diamniotic twin pregnancy. Spontaneous onset of labour at 37
weeks gestation. Live born male infant weighing 2.99 kilograms delivered
spontaneously, Apgars 7@1, 8@5. Assisted breech delivery of live born male
infant weighing 2.66 kilograms. Apgars 9@1, 10 @ 5. One litre blood loss
during delivery, further 1.6 litre blood loss after delivery and subsequent
return to theatre for examination under anaesthetic. Retained cotyledon
and vaginal abrasions secondary to assisted delivery noted. Uterine
balloon and vaginal pack inserted. Five units of red cells transfused. Total
blood loss 4.2 litres. Transferred to high dependency unit care for 24 hours.
Antibiotic therapy initiated for ongoing pyrexia. Discharged home well
day 4 postnatally.
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10. Para 2+3, BMI 26, non-smoker, booked for combined antenatal care at 12
weeks gestation. Previous gestational diabetes. Family history of
hypertension. Induced at 40 weeks gestation for macrosomia. Emergency
caesarean section carried out due to non-reassuring CTG. Liveborn male,
weighing 4.26 killograms delivered, Apgars 3 @ 1 and 8 @ 5. Total blood loss
3.5 litres inter-operatively, 4 units red cells and 2 grams fibrinogen
transfused. Admitted to high dependency unit for 2 days. Discharged home
well day 4 postnatally.
11. Para 1. BMI 24, Non-smoker. One previous emergency caesarean section at
41 weeks gestation for failure to progress and non-reassuring CTG. Booked
for combined antenatal care at 13 weeks gestation. Elective caesarean
section undertaken at 39 weeks gestation. Live born male weighing 3.49
kilograms delivered, Apgars 9 @ 1 and 10 @ 5. Estimated intraoperative
blood loss 300 millilitres. Discharged home well day 3 postnatally.
Subsequent pyrexia and secondary postpartum haemorrhage day 10 post
operatively, requiring re-admission. Antibiotics commenced for
endometritis and 4 units of red cells transfused plus 2 grams fibrinogen
over 2 days. Total estimated blood loss 2.3 litres. Re-examination under
anaesthetic carried out day 12 postpartum with evacuation of uterus.
Further 2 units of red cells transfused peri-operatively. High dependency
unit care for 24 hours. Discharged home well day 2 postoperatively.
12. Para 2, two prior preterm vaginal deliveries. DCDA pregnancy. Hospital led
antenatal care. IOL at 37 weeks for IUGR. 2.79 Kgs  female Apgars 9@1, 10@5.
1.7Kgs female Apgars 9@1, 10@5. Postpartum haemorrhage, atonic uterus.
Transferred to OT for EAU. Bakri Balloon inserted 2 Litre blood loss. 2g
Fibrinogen, 1g Tranexamic acid, 2 units RCC transfused. HDU care.
Discharged home well Day 4.
13. Para 0+1. BMI 28, non-smoker. History of abnormal smears and LLETZ
procedure. Infertility. Bipolar Affective Disorder. Laparoscopic
myomectomy in 2013. Admitted at 17 weeks gestation for recurrent
antepartum haemorrhage; short cervix noted. Preterm premature rupture
of membranes at 24+6 weeks gestation. Steroids commenced.
Chorioamnionitis diagnosed at 25 weeks gestation. Induction undertaken.
Live born female delivered weighing 750 grams, transferred to NICU,
estimated blood loss of 1 litre. Retained placenta requiring manual removal
in theatre. Further estimated blood loss of 1.5 litres intraoperatively.
Transfused with 3 units red cells and 2 grams fibrinogen. Admitted to high
dependency unit for 24 hours before transfer to ward. Triple antibiotics
administered for pyrexia. Urinary incontinence post delivery. Discharged
home well day 22 postpartum.
14. Nullip. BMI 32, non-smoker. History of infertility, family history of
hypertension. ICSI pregnancy. Booked at 14+6 weeks gestation for
combined antenatal care. Induced at 41 weeks gestation for post dates and
polyhydamnios. Forceps delivery of a live born female infant, weighing 3.79
kilograms. Apgars 9 @ 1 and 10 @ 5. Placenta delivered, noted to be
incomplete. Estimated blood loss of 2 litres. Examination under anaesthetic 
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undertaken. Retained membranes removed and Rushe baloon inserted.
Transfused 2 units of red cells and 1 gram fibrinogen. Total blood loss 2.5
litres. High dependency unit care for 3 days post operatively. Blood patch
required for post-dural headache day 3 post delivery.  Discharged home well
day 4 postpartum. Subsequent return to emergency room, day 5 postpartum
with severe post dural headache, repeat blood patch performed and patient
discharged.
15. Nullip, BMI 24, non-smoker, booked at 12 weeks gestation for combined
antenatal care. History of urinary tract infections, no other significant
medical or family history.  Presented at 40+4 weeks gestation with
spontaneous rupture of membranes. Spontaneous vaginal delivery of a live
born female infant, weighing 3.83 kgs. Estimated blood loss during delivery
of 1.9 litres. Subsequent retained placenta requiring manual removal in
theatre. Total estimated blood loss 2.5 litres. Two units red cells and 2 grams
fibrinogen transfused intraoperatively.  High dependency Unit care for 24
hours before transfer to postnatal ward. Discharged home well day 4
postnatally.
16. Para 0+3, BMI 22, non-smoker, booked at 14 weeks gestation. Consultant led
antenatal care, no significant medical history. Presented in spontaneous
labour at 37 weeks. Vaginal delivery of live born male infant weighing 3.1
kgs. Apgars 9@1, 10@5. Subsequent retained placenta requiring a manual
removal of placenta and cotyledons in theatre.  Total blood loss 2.8 litres,
transfused 2 units of red cells. High dependency care for 4 days post
operatively. Discharged home well on day 4. Baby transferred to Temple
Street for surgery for duodenal obstruction Day 5 postnatally.
17. Para 3+1. BMI 28,Booked at 12 weeks gestation for combined antenatal care.
Had retained placenta in first pregnancy requiring manual removal of
placenta and high dependency care unit admission. Placenta praevia, acreta
and suspected percreta noted this pregnancy. Elective caesarean section,
caesarean hysterectomy and bilateral salpingectomy performed at the
Mater Hospital at 34 weeks gestation. Live born male infant delivered,
weighing 2.94 kgs, Apgars 8 @ 1, 9 @5 and 9@10. Baby transferred to Rotunda
Hospital NICU. Estimated intraoperative blood loss of 3 litres, 5 units of red
cells transfused. Transferred to the Rotunda day 1 post delivery. High
dependency unit care for 3 days post partum. Discharged home well day 7
postnatally.
18. Para 2+1, unbooked, transferred from Connolly Hospital Emergency
Department with a suspected ectopic pregnancy of unknown gestation. Two
previous term deliveries. Ruptured ectopic confirmed upon review. Midline
laparotomy performed. Right ovarian cyst removed and partial
salpingectomy undertaken. Massive haemorrhage with total blood loss of 3
litres. Transfused four units red cells and four units of octoplas. High
dependency care for 24 hours post operatively. Home well day 5.
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19. Para 1, BMI 21, booked at 11 weeks gestation. Previous emergency caesarean
section at term for prolonged rupture of membranes. Medical history of
anaemia and chronic hepatitis B infection. Family history of hypertension.
Transferred from Naas General Hospital with severe abdominal pain at 33
weeks gestation. Abruption and intrauterine death confirmed by
ultrasound. Caesarean section following correction of maternal
consumptive coagulopathy. Total blood loss of 2.5 litres intraoperatively.
Rusch balloon inserted. Transfused with 600 millilitres from cell salvage
and 2 units red cells. High dependency unit care for 5 days before transfer
to ward for a further 3 days. IV antibiotics administered for intermittent
spikes in temperature. Patient discharged well day 8, on PO antibiotics with
plan for follow-up.
20. Nullip, non-smoker, booked at 13 weeks gestation. Midwife led antenatal
care (Domino), no significant medical history. Family history of
hypertension. Induction of labour at 40 weeks due to prolonged rupture of
membranes. Forceps delivery of live born male infant weighing 4.33kg.
Subsequent retained placenta requiring a manual removal of placenta and
cotyledons in theatre. Vaginal pack. Total blood loss 3.5 litres, transfused 3
units of red cells and 1 grams of Fibrinogen. High dependency care for 24
hours post operatively. Discharged home well on day 3 on antibiotics.
21. Para 0, BMI 21, non-smoker, booked at 12 weeks gestation.  Medical history of
anaemia and family history of hypertension. Midwifery-led care. Induction of
labour at 41+5 for post dates. Triple antibiotics for pyrexia in labour, suspected
chorioamnionitis. Emergency caesarean section undertaken for FTA. Atonic
uterus. 3 litre blood loss. Two units red cells transfused. Live born male infant
weighing 4.78 kilograms Apgars 9@1, 10@5, transferred to NICU for septic
workup for pyrexia.  Mother transferred to high dependency unit for
monitoring. Developed post dural puncture headache, resolved with epidural
blood patch. Discharged home well day 5 postnatally. 
22. Para 1. BMI 27. Non-smoker.  Booked for antenatal care at the Midland
Regional Hospital Mullingar at 13 weeks gestation. Dichorionic, diamniotic
twin pregnancy. Transferred care to the Rotunda Hospital at 23 weeks
gestation. No significant medical or family history. Previous emergency
caesarean section for failed induction. Elective caesarean section
undertaken at 38 weeks gestation. Two live born female infants were
delivered weighing 2.97 and 2.3 kgs. Intraoperative blood loss of 2.75 litres
due to uterine atony. 1 unit of red cells transfused. Transferred to high
dependency unit post operatively. Transferred to ward day 2 post delivery.
Discharged home well day 3 post partum.
23. Para 4+2. Booked at 15 weeks for combined antenatal care. Medical history of
anaemia and thrombocytopenia. Spontaneous vaginal delivery at 41 weeks of a
live born male infant weighing 3.52kg, Apgars 9 @ 1, 10 @ 5. Subsequent atonic
uterus and massive post partum haemorrhage necessitating examination
under anaesthesia and Bakri balloon insertion. Total blood loss of  3.5 litres, 4
units of red cells transfused. High dependency care post operatively. Discharged
home day 3 with arrangements for post natal follow-up at 6 weeks.
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24. Nullip, non-national, booked at 12 weeks gestation with a history of PCRS and
primary infertility.  IVF pregnancy, non-smoker, non-drinker.  Combined
antenatal care.  Spontaneous labour at 40 weeks gestation.  Emergency
caesarean section for non-reassuring CTG in labour, live born female infant
delivered weighing 3.75 kilograms, Apgars 9 at 1 and 10 at 5.  Atonic uterus at
delivery, intra-operative blood loss 2 litres.  Requiring transfusion of 4 units of
packed red cells.  Discharged home well day 5 postnatally.  
25. Nullip. Non-smoker.  Normal BMI.   Background history of PCOS and infertility.
IVF pregnancy.  Twin pregnancy, dichorionic diamniotic twins.  Hospital based
antenatal care with serial growths scans. Cholestasis at 30 weeks gestation.
Admitted at 32 weeks with cholestasis.  Stabilised and arrangements for Day
Care follow-up.  Presented to the Day Care Unit at 35 weeks gestation with a
deceleration auscultated on twin 1.  Admitted for close monitoring.  Induced at
36 weeks gestation.  Assisted vaginal delivery of twin I, female infant, 2.9
kilograms, Apgars 8 at 1 and 9 at 5.  Twin 2, male infant, 2.15 kilograms, Apgars 9
at 1 and 10 at 5.  Transferred to the HDU with a two litre post-operative blood loss
and an episode of desaturation in the Recovery Room.  Transfused with two
units of packed red cells and two units of fibrinogen.  Developed confusion day
2 postnatally, arranged neurology review.  Suspected reversal encephalopathy.
Transferred to the Mater Hospital post partum for follow-up.  Subsequent six
week follow-up, patient had not memory of the first two weeks postnatally.
Frontal lobe changes identified on MRI. 
Uter ine  Rupture  (4 )
1. Para 1+0, previous emergency caesarean section 2013 for non reassuring
CTG at 7cm dilatation.  Live born male infant weighing 3.96kgs.  White coat
hypertension. Late booker, booked at 22 weeks gestation.  Non Smoker.  BMI
26. Counselled in relation to VBAC.  Presented in spontaneous labour at  3cm
dilation at 40 weeks and 4 days.  Emergency caesarean section at 7cm
dilatation, uterine rupture, live born male infant delivered weighing
3.66kgs.  Apgars 6 at 1, 7 at 5.  Discharged home well day 5 postnatally.
2.  Para 1.  Previous emergency caesarean section. Admitted for induction of
labour on a background history of newly diagnosed hyperparathyroidism
and multiple admissions. Developed pre-eclampsia. Following delivery
parathyroid tumour excised 6 months following delivery. Booked at 12
weeks gestation. Hospital based antenatal care. VBAC discussed. Presented
in spontaneous labour at 40 weeks gestation. Suspected uterine rupture
confirmed at 9cm dilation. Live born male infant delivered weighting
3.84kgs.  Apgars 6 at 1, 9 at 5. One litre intra operative blood loss. Discharged
home well day 5 post natal.
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3. Para6+2.  Four previous vaginal deliveries. Two previous sections. Medical
history of a transient ischemic attack.  Peptic ulcer and Hepatitis C. Previous
drug overdose on nine occasions.  Anxiety, back ache, alcohol related
seizures, recurrent urinary tract infections, asthma, bronchitis, liver
cirrhosis.  On Methadone treatment.  Alcoholic, drinking 40 units of alcohol
per day.  BMI 32. Presented by ambulance at 29 weeks with severe pain.
Emergency laparotomy. Suspected uterine rupture.  Confirmed at time of
surgery. Live born male infant delivered weighing 1.035kgs.  Apgars 3 at 1, 4
at 5.  Litre intra operative loss. Neonatal death.  Complicated postnatal
course, sepsis at 5 days following delivery. Poor social circumstances.
Suspected DVT unconfirmed. Discharged home 10 days post operatively.
4.    Para1+2.  One previous emergency caesarean section at 39 weeks gestation.
One previous ectopic and one previous termination of pregnancy in
another jurisdiction.  Pregnancy induced hypertension in her only ongoing
pregnancy.  Known uterine fibroids.  Booked at 17 weeks gestation for
combined antenatal care.  Presented in spontaneous labour at 41 weeks
gestation. Emergency category one caesarean section undertaken for
suspected uterine rupture. Male infant delivered weighing 3.46kgs.  Apgars
9 at 1, 10 at 5.  Uterine rupture confirmed.  Total blood loss 600 mls.  Good
postnatal recovery.  Discharged home day 5.
Per ipar tum Hysterectomy ( 1 )
1. No. 17 above in Major Obstetric haemorrhage.
Eclampsia  ( 1 )
1. Nullip, past history of irritable bowel.  Booked at 12 weeks gestation.
Subsequent hypertension at 38 weeks gestation.  Admitted in labour.
Spontaneous vaginal delivery.  Live born male infant weighing 3.73
kilograms.  Hypertension deteriorated day 1 postnatally necessitating
commencement of magnesium sulphate and transfer to the High
Dependency Unit.  High dependency care, condition stabilised with
magnesium sulphate and labetalol.  Discharged from hospital day 5 
following delivery on medication with arrangements for review. 
Acute  Renal  and  L iver  Dysfunct ion  (7 )  
1. Para 0+1.  Primary infertility.  Donor egg pregnancy.  Past history of
pneumonia and ovarian cystectomy.  Booked at 11 weeks gestation for
hospital based antenatal care. Non-smoker, non-drinker.  HELLP syndrome
at 38 weeks gestation.  Emergency caesarean section.  Live born female
infant delivered weighing 2.8 kilograms.  Apgars 9 at 1 and 10 at 5. Mother
stabilised and transferred to the HDU. 48 hours postoperatively good
recovery and home day 5 postnatal.
2. Nullip, booked at 17 weeks gestation.  Past medical history of migraine. Non-
smoker.  BMI 37.  Presented at 37 weeks gestation with epigastric pain. Abnormal
liver function.  Diagnosis of HELLP syndrome made.   Admitted
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to the HDU for stabilisation with magnesium sulphate, dexamethasone and
emergency caesarean undertaken at 37 weeks gestation.  Live born male infant
delivered weighing 2.78 kilograms.  Apgars 7 at 1 and 9 at 5.  Mother transferred
back to the HDU and discharged home day 6 postnatally. 
3.   Para 2+0.  Two previous term deliveries, induced on the first pregnancy for
pregnancy induced hypertension.  Booked at 15 weeks.  Hypertensive at
booking. Arrangements made for review in the Renal Clinic.  Failed to attend
for the first visit in the Renal Clinic.  Attended for review at 20 weeks
gestation.  Advise for home blood pressure checking.  Subsequent follow-up,
poorly compliant with home blood pressure check.  Subsequently admitted
at 31 weeks gestation with HELLP syndrome, on Labeletol at presentation,
transferred to the HDU.  Dexamethasone administered.  Maternal condition
stabilised.  Subsequent deterioration over the following 48 hours,
necessitating emergency caesarean section at 31+2 weeks gestation.  Live
born female infant weighing 1.64 kilograms delivered.  Apgars 9 at 1 and 9 at
5. Mother stabilised and transferred back to the HDU for three days.
Discharged home day 4 with arrangements for Day Care follow-up. Re-
presented 8 days post caesarean section with hypertension.  Blood pressure
stabilised and discharged with arrangements for follow-up.
4.   Para 0, booked at 13 weeks gestation,  IVF pregnancy, with monochorionic
diamniotic twins.   No significant medical history.   Admitted at 34 weeks
gestation with pre-clampsia, condition deteriorating, stabilised and an
elective caesarean section was done at 34 weeks gestation. Twin I weighed
1.60 kilos, Apgars 8 at 1 and 10 at 5. Twin 2 weight 1.68 kilos, Apgars 8 at 1 and
10 at 5. Maternal care in the HDU secondary to hypertension postoperatively.
Discharged home day 7.
5. Para 2+4.  Two previous term uncomplicated deliveries.  Past history of
depression, recurrent urinary tract infection and Addison's disease.  Booked
at 10 weeks gestation for hospital based antenatal care.  Uncomplicated
antenatal care. Noted to be carrying macrosomic infant at 37 weeks
gestation.  Induction of labour at 39 weeks gestation and a live born female
infant was delivered weighing 4.22 kilograms, Apgars 9 at 1 and 9 at 5.   HDU
care postnatally.  Suspected sepsis on day 2 postnatal.  Klebsiella
bacteraemia identified secondary to a urinary tract infection and
subsequent pyelonephritis.  Discharged home day 4 post delivery.  
6.  Para 1, one previous emergency caesarean section due to renal dysfunction at
35 weeks gestation, live born female infant weighing 1.96 kilograms. Known
lupus nephritis antiphospholipid syndrome.  Transferred from Letterkenny
Hospital at 26 weeks gestation with deterioration in renal function.
Admission to the High Dependency Unit at this time point with significant
proteinuria, anaemia and a raised urea. Stage III chronic kidney disease.
Transferred to the General Ward after two days in HDU.  Six weeks hospital
stay.  Caesarean section and tubal ligation. Discharged home day 6
postnatally well, after delivery of a live born female infant weighing 1.4
kilogram and Apgars 9 at 1 and 9 at 5.
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7.  Nullip.  Booked at 12 weeks gestation. Non smoker.  BMI 22.  Combined
antenatal care.  Presented at 31 weeks gestation with PV bleeding and
diagnosed HELLP syndrome.  Caesarean section under taken at 31 weeks
gestation.  Live born male infant delivered weighing 1.46kgs.  Apgars 5 at 1,
9 at 5. Suspected abruption Good postnatal recovery.  Discharged home day
5 postnatally with arrangements made for haematology follow up.
Acute  Respiratory  Dysfunct ion  (2 )
1. Nullip, transfer from Cavan Hospital at 24 weeks gestation with sever pre-
eclampsia.  Unbooked in this hospital.  24+4 days at transfer.  Steroids
administered. Symmetrical growth restriction noticed in the fetus.  No past
medical history. Non-reassuring CTG at 25 weeks gestation necessitating
stabilisation and delivery.  High dependency care.  Live born female infant
delivered weighing 565g, stabilised and transferred to the Special Care
Baby Unit. Discharged home day 6 on anti-hypertensive with
arrangements for Day Care follow-up and advice in relation to recurrence
risks on any subsequent pregnancy. 
2.  Primip, booked at 11 weeks for combined antenatal care.  Non-smoker.  
Pre-eclampisa at 27 weeks gestation with superimposed sepsis at 28 weeks 
gestation.  Suspected influenza.  Pulmonary oedema identified on chest x-
ray.  Subsequent emergency caesarean section due to deterioration in the
maternal condition at 28 weeks gestation and a live born male infant
weighing 1.14 kilograms delivered, Apgars 8 at 1 and 10 at 5. 
Cardiac  ( 1 )
1. Para 6, admitted for a vaginal hysterectomy and pelvic floor repair cardiac
arrest in the recovery room. Likely secondary to hypovolaemia, stabilised
and transferred to the Mater Hospital. Re-Laparotomy and ligation of the
uterine artery.  Discharged home well.
Status  Epi lept icus  ( 1 )
1. Para 1+ 3, three previous large loop excisions of the transformation zone.
Prior haemorrhoidectomy, panic attacks, epilepsy, renal calculi, asthma.
Poorly compliant with medical care. Transfer of care from America at 19
weeks gestation, ultrasound at presentation correlated with a  gestation of
11 weeks and 2 days.  Cervical cerclage inserted based on prior history of
LLETZ. Presented at 17 weeks with query history of status epilepticus at
home. Had presented originally to Wexford General Hospital with a similar
history and was provided with anti epileptic medication but did not take
the same. Hospitalised for 2 days with arrangements for follow up care. She
was re-admitted subsequently with a similar episode of tonic clonic
seizures. Recurrent pseudo seizures during hospital stay.  Failed to return
for care in the hospital.
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Sept icaemic  Shock  ( 1 1 )
1. Nullip, booked at 11 weeks gestation, non-smoker, non-drinker, BMI of 28.
Past history of recurrent urinary tract infections.  Combined antenatal care.
Admitted at 26 weeks gestation with suspected uro-sepsis.  Septic work-up
and triple antibiotics commenced. Pyelonephritis diagnosed.  72 hours of
high dependency care.  Gradual improvement and discharged home one
week following initial admission. Subsequent uncomplicated antenatal
care. Presented in spontaneous labour at 40 weeks gestation and assisted
vaginal delivery of live born male infant weighing 4.15 kilograms. Apgars 9
at 1 and 10 at 5.
2.  Para 1.  BMI 36.  Previous full term unassisted vaginal delivery in 2011.
Induced on that pregnancy due to pre-eclampsia.  Booked at 14 weeks
gestation on this pregnancy. Hypertensive episodes at term.  Subsequent
induction for the same and a spontaneous vaginal delivery of a female
infant weighing 3.6 kilograms. Discharged home day 2 with subsequent re-
admission with septicaemia. Admitted to the High Dependency Unit.
Commenced on triple antibiotics. Group A streptococcus isolated.
Hypertension review postnatally with meds altered accordingly.
Discharged home day 15 following vaginal delivery.  Apyrexial. 
3.  Para 2, first pregnancy was a term delivery of a female infant weighing 2.24
kilograms noted small for gestation age.  Second pregnancy emergency
section at 32 weeks of a 1.24 kilograms baby with a background history of
abruption.  Past history of pre-eclampsia, epilepsy, mitochondrial disorder
and psychosis.  Late booker. Booked at 21 weeks gestation.  Gestational
diabetes likely secondary to medications. Intra-uterine growth restriction on
this pregnancy.  Admitted at 29 weeks gestation with sepsis of unknown
origin, neutropenia, stabilised and subsequently transferred to the High
Dependency Unit in the Mater Hospital due to sustained hypotension and a
requirement for vasopressors.  Elective section at 37 weeks in fetal interest.
Live born male infant delivered weighing 2.51 kilograms. Apgars 9 at 1 and 10
at 5.  HDU postoperative care due to hypothermia and hypotension.  Five days
hospital stay with arrangements for follow-up in the Mater Hospital
Neurology Service due to persistent headache. 
4.  Para 1. Booked at 12 weeks gestation. Medical history of anaemia and
recurrent urinary tract infections. Emergency admission at 19 weeks
gestation with suspected uro-sepsis.  High dependency care, septic work-up
and triple antibiotics. Gradual improvement with treatment. Discharged
four days following admission. Subsequent uneventful antenatal care.
Spontaneous onset of labour at 40 weeks gestation and delivery of a female
infant weighing 3.36 kilograms, Apgars 9 at 1 and 10 at 5. 
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5.  Para 2+1.  Two previous caesarean sections.  Background history of recurrent
urinary tract infections.  Booked at 15 weeks gestation.  Non-smoker.  BMI 37.
Combined antenatal care.  Numerous episodes of failure to attend for
antenatal care throughout the course of the pregnancy, poorly compliant with
our diabetic screening service.  Presented at 32 weeks with a recurrent episode
of pyelonephritis and suspected septic shock having had one previous episode
of cystitis at 26 weeks in the pregnancy and having failed to attend for follow-
up thereafter.  Transferred to the HDU for septic workup, triple antibiotics.
Spend 48 hours in HDU before transferring to the general ward for completion
of a course of IV antibiotics. Subsequently presented for caesarean section at 38
weeks gestation and a live born male infant was delivered, Apgars 9 at 1 and 10
at 5.  Discharged home day 3 postnatally.
6.  Para 0+1, booked at 13 weeks gestation.  Very little English.  Past medical
history of migraine and asthma. Combined antenatal care.  Presented in
spontaneous labour at 40 weeks gestation. Assisted vaginal delivery for
non-reassuring CTG. Live born male infant delivered weighing 4.61
kilograms. Apgars  at 1 and 10 at 5. Subsequent hypothermia postnatally
with a suspicion of septic shock, necessitating admission to the high
dependency unit. Triple antibiotics, gradual response to treatment.
Treatment complicated by suspected penicillin allergy. Discharged home
well day 4 post delivery.  
7.  Para 0, past history of acute lymphoblastic leukaemia and bone marrow
transplant. Presented with abdominal pain and pyrexia. Suspect
haemtometra, stabilised. Pain controlled and transferred to theatre for
examination under anaesthetic.  Haemtometra drained.  Recurrence of pain
during her hospital stay.  Discharged home with subsequent re attendance
with similar pain with acute sepsis.  Acute bacterial sepsis diagnosed with
vaginitis.  Septic shock.  Stabilised and transferred to our high dependency
unit. Triple antibiotics, suspected toxic shock.  Transferred to the Mater
Hospital for surgical review.
8.  Nullip. No significant medical history.  Booked at 12 weeks gestation for
combined antenatal care. Uneventful pregnancy. Attended the Emergency
Room at 39 weeks, non-reassuring CTG, Category 1 emergency caesarean
section. Hypothermic day one post operatively. Septic shock suspected.
Klebsiella identified on a high vaginal swab. Resistant to gentamicin.
Antibiotics modified.  Discharged home days 6 post section well.
9.  Nullip.  Known cystic fibrosis.  Peg tube in-situ for feeding.  Insulin
dependent diabetic. Booked at 9 weeks gestation for hospital based
antenatal care. Pre-pregnancy lung function approximately 40%.  Know
MRSA and pseudomonas. Hospitalised on occasion over the course of the
pregnancy in Beaumont Hospital with exacerbation of cystic fibrosis and
super imposed infection.  Emergency caesarean section indicated in the
Mater Hospital at 32 weeks gestation.  Delivery of a live born male infant
weighing 1.71 kilograms with Apgars of 9 at 1 and 10 at 5. Baby transferred
back to the Rotunda Hospital.  Maternal care continued in general hospital.
56846 Rotunda Clinical Report 2015 26/10/16 v3_Clinical Rep  26/10/2016  15:50  Page 47
48
10. Para 1+1. One previous Em. LSCS for failure to advance. Med Hx anaemia.
Booked at 12 weeks gestation.  Ultrasound consistent with dates.  Presented to
the ER at 16 weeks gestation with offensive discharge and bulging
membranes and pyrexia.  Transferred to HDU. Second trimester loss with
suspected chorioamnionitis triple antibiotics and blood cultures.  3 day stay in
HDU.  Gradual resolution of symptoms.  Discharged home day 6 post loss.
11.  Para 2, history of menorrhagia and fibriods. Refractory to treatment.
Admitted for TAH. Moderately difficult procedure.  Discharge home day 5
post op. Subsequent re-admission one week post op with nausea, vomiting,
diarrhoea, sepsis. Pelvic collection suspected triple therapy commenced.
Gradual resolution of symptoms. 
ICU  /  CCU Transfer  ( 5 )  
1. See No. 25 in Major Obstetric haemorrhage
2. See No. 3 in Septic Shock
3. See No. 7 in Septic Shock
4. See No. 1 in Cardiac
5. See No. 17 in Major Obstetric haemorrhage
Interventional  at  Radiology  (2 )  
1. See No. 17 in Major Obstetric Haemorrhage
2.  See. No. 1 in Cardiac Arrest
Other  unspec i f ied  ( 13 )
1. Para 2+0, one previous preterm delivery at 36 weeks gestation and a previous full
term assisted delivery.  Past history of depression and migraine, smoker at
booking - approx 10 per day. Booked at 14 weeks.  Presented at 19 weeks gestation
with bilateral lower limb pain and swelling with a family history of thrombosis.
Admitted. Therapeutic Innohep commenced and arrangements made for
doppler imaging.  Doppler reported as negative. Discharged home.  Subsequent
re-presentation at 27 weeks gestation by ambulance with right sided chest pain
radiating into back. Suspected lower respiratory tract infection, commenced on
IV antibiotics. Could not outrule pulmonary embolism.  Therapeutic Innohep re-
commenced. CTPA negative for pulmonary embolism. Solidation and collapse
noted of the right lung.  Persistent tachypneoa.  Transferred to the HDU for
continuous maternal monitoring. Pneumonia diagnosed. One week of IV
antibiotics and multidisciplinary care in HDU. Gradual resolution of symptoms.
Subsequent spontaneous onset of labour at 39 weeks gestation and a live born
female infant delivered weighing 3.83 kilograms, Apgars 9 at 1 and 10 at 5.
Uncomplicated postnatal care. 
2.  Para0+4.  Transferred from Drogheda Hospital.  Threatened pre term labour at
25 weeks gestation and thyrotoxicosis.  Endocrine review and appropriate
treatment commenced.  PV bleeding at 25 weeks gestation. Inpatient care.
Suspected cervical incompetence as presented to the midwifery staff fully
dilated with a breech on the perineum.  Assisted breech delivery of a live born
female infant weighing 0.66kgs.  Baby transferred to the neonatal intensive
care unit.  She subsequently re presented with retained products of
conception necessitating evacuation of retained products.  Orally compliant
with her thyroid medications.  Arrangements for endocrine follow up.
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3. Asian lady, nullip, booked.  History of sub-fertility and Takayasus arthritis.
Booked at 9 weeks gestation with hypertension.  On anti hypertensives.
Anti hypertensives changed to medications more suitable with pregnancy.
Blood pressure poorly controlled necessitating admission at 24 weeks
gestation. Elective caesarean section at 36 weeks gestation. Twelve week
hospital stay. Hypertensive post-operatively necessitating transfer to the
Recovery Room as our high dependency unit was full.  Transferred out to
the HDU when a bed became available. Five days high dependency care due
to the refractory hypertension.  Discharged home day 7 post-operatively.
4.  Para 0, IVF in another unit, presented to the hospital at 4 weeks gestation
with moderate ovarian hyperstimulation necessitating 4 days admission.  A
full recovery with conservative measures. 
5.  Para 0 + 1, transferred from an external IVF unit with ovarian
hyperstimulation at 4 weeks gestation. Four days hospital stay. Good
recovery with expectant management.
6.  Paro 0.  History of primary infertility.  Has Spina Bifida Occulta and ICSI
pregnancy. Presented to the hospital at 4 weeks gestation with moderate
ovarian hyperstimulation. Abdominal drain was sited due to persistent
ascites and patient discomfort.  Fourteen day hospital stay.  Good recovery.
Subsequent term uncomplicated delivery.
7.  Para o. Transferred from a fertility unit with ovarian hyperstimulation at 4
weeks gestation. Five days hospital stay, subsequently discharged but re-
attended with worsening symptoms. Hospitalised for 6 days in total.
8. Para 0,  booked at 11 weeks gestation with a history of Wolff Parkinson
White syndrome since 2003. Atrioventricular block with a pacemaker and
defibrillator in situ. Additional medical history of scarcoidosis and a
penicillin allergy. Multidisciplinary care with cardiology and respiratory
input. Pre-eclampsia developed at 36 weeks gestation. Elective Caesarean
section at 37 weeks gestation. Live born male infant weighing 3.1kg, Apgars
9 at 1 and 10 at 5. HDU care post operatively.  Discharged home well at day 4
postnatal.
9.  Nullip. No significant medical history.  Booked at 8 weeks gestation with
monochorionic monoamniotic twins.  Hospital based antenatal care.
Subsequent admission at 24 weeks gestation for fetal surveillance due to
the risk of cord entanglement.  Caesarean section at 32 weeks gestation.
Twin 1 weighed 1.77 kilograms, Apgars 5 at 1 and 9 at 5.  Twin II weighed 1.54
kilograms, Apgars 5 at 1 and 10 at 5.  Both female infants.  One episode of
symptomatic tachycardia at 25 weeks gestation necessitating high
dependency care during this episode. No further episodes.
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10.  Para 1+1.  One previous elective caesarean section for a growth restricted
infant in 2010.  History of stenosis of the aortic and mitral valves in
conjunction with cervical spine stenosis.  Mucopolysaccharidosis type VI,
and Maroteaux Lamy syndrome.  Booked at 24 weeks gestation, having had
care in Lithuania prior to this.  Combined multidisciplinary cardiac care.
Elective section at 39 weeks gestation.  Live born female infant weighing
3.16 kilograms delivered.  Apgars 9 at 1 and 10 at 5.  High dependency care
post operatively.  Discharged home well day 3 post operatively. 
11. Para 1.  One previous emergency caesarean section for failed induction for
pre-eclampsia, male infant weighing 3.18 kilograms.  History of primary
infertility, Brucellosis in childhood. IVF pregnancy.  Dichorioamniotic
diamniotic twins.  Booked at 7 weeks gestation for hospital based antenatal
care.  Discordant growth of twins noted at 36 weeks gestation.  Admitted for
corticosteroids and fetal monitoring.  Elective caesarean section at 36 weeks
gestation. Twin I weighed 2.63 kilograms, Apgars 9 at 1 and 10 at 5. Twin 2
weighed 2.66 kilograms, Apgars 9 at 1 and 10 at 5. Maternal supraventricular
tachycardia post operatively requiring adenosine. Transferred to the HDU.
Cardiology review.  Three days high dependency care.  
12. See Transfer to Intensive Care above
13. See Septic Shock above.
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C O M P L I C A T E D  P O S T N A T A L  C L I N I C
D r  M a e v e  E o g a n
This clinic offers postnatal review to women who sustain anal sphincter injury
at vaginal delivery. The Royal College of Obstetricians and Gynaecologists, the
HSE and the Institute of Obstetrics and Gynaecology recommend that such
patients are ideally seen in a dedicated Perineal Clinic in order to:  
•  Discuss delivery and associated events in further detail
•  Assess for symptoms of continence compromise
•  Arrange appropriate treatment / referral
•  Advise on future deliveries
Our clinic also reviews women who are pregnant again after a previous anal
sphincter injury in order to discuss options and risks in terms of mode of
delivery. It also provides care for women who have had other postnatal concerns,
including wound infection, perineal pain, dyspareunia and faecal incontinence. 
429 new patients were seen in the clinic in 2015 and the indications for their
attendances are tabulated below:
Indication for Attendance Number of Patients Seen
Postnatal Third Degree Tear 151
Postnatal Fourth Degree Tear 6
Postnatal Perineal Infection / Pain / Dyspareunia 52
Faecal Incontinence 13
Antenatal Assessment (next pregnancy) 180
FGM assessment 6 (3 currently pregnant) 
Other (incl healing issues, history of FGM etc) 21
Total 429
For the first time since this clinic began, the largest group (180 patients)
attending the clinic were pregnant women with a history of previous obstetric
anal sphincter injury (OASI). The next most common reason for attendance was
recent OASI. 167 patients sustained anal sphincter injury in the year 2015, 160 of
whom had third degree tear, while 7 patients sustained fourth degree tear
(extending to involve anal mucosa). 
The modes of delivery of those who sustained anal sphincter injury are
tabulated below:
Mode of Delivery Third Degree Tear Fourth Degree Tear
SVD 91 2
Ventouse 33 1
Ventouse & Forceps 14 1
Forceps 22 3
Born before arrival 0 0
Total 160 7
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Clinic review after anal sphincter injury takes place at 6 weeks postnatal.
However, all patients will have been offered physiotherapy follow-up prior to
that and the clinic works closely with Cinny Cusack and team at the Department
of Physiotherapy.  History is taken, including continence score if there are
symptoms of faecal incontinence. Information regarding perineal healing and
other postnatal symptoms is also obtained. Appropriate treatment or referral is
initiated as required, and the clinic visit also provides an opportunity to answer
questions regarding the index delivery as well as to the potential impact on
future deliveries.
In 2014, the Irish Family Planning Association (IFPA) in with support from the
HSE National Social Inclusion Unit and AkiDwA established Ireland’s first
Specialist Clinical Service for the Treatment of Female Genital Mutilation (FGM).
This clinic refers any women who require surgical treatment to me for
evaluation, and we anticipate that we will be seeing greater numbers of women
in this context over the coming years. 
49 patients who attended the clinic required treatment or ongoing referral (in
addition to physiotherapy, which is offered to all). The specific treatments
required are enumerated below:
Procedure/Referral Number of Patients
Removal of persistent suture material (OPD) 11
Treatment of granulation tissue (OPD) 9
Fenton’s procedure / perineal revision (day case) 14
Reversal of FGM 2
Perineal injection (day case) 4
Referral to colorectal service 9
Total 49
I am very grateful to my colleagues at the Department of Colorectal Surgery,
Mater Misericordiae University Hospital for both clinic and operative support
and also to all the team at the Physiotherapy Department for their holistic and
committed care of our combined patient cohort. 
Audit :
Azura N, Eogan M. Re-audit of Inpatient Follow-up of Patients with Intrapartum
Complications. 
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YEARS 2014 2015
Total number of cases 189 129
Booked 187 126
Unbooked 2 3
Incidence against delivery 2.2% 1.5%
Eclampsia % 0.00% 0.00%
Stillbirths 2 2
Neonatal Deaths 0 0
Multiple pregnancy 13 10
Par ity  of  Pat ients  at  Del ivery
0 126 85
1 38 26
2 10 7
3 10 6
4 plus 55
Total 189 129
Gestat ion  of  Pat ients  at  Del ivery
< 28 weeks 5 2
28 - 29 weeks 3 1
30 - 31 weeks 3 7
32 - 33 weeks 15 10
34 - 35 weeks 15 16
36 weeks plus 148 93
Total 189 129
H Y P E R T E N S I O N  W I T H  P R O T E I N U R I A
T h e  M a s t e r  
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In 2015 there were 2,430 inductions which was a rate of 29%; 1% lower than 2014.
There was no significant difference in the indications or the methods of
inductions performed, compared to the previous year.
INDUCTIONS OVER 5 YEARS
Year Nullip       % Multip      %   Total        % 
2011 1482 57% 1134 43% 2616 29%
2012 1414 57% 1064 43% 2478 28%
2013 1372 54% 1151 46% 2523 29%
2014 1436 55% 1195 45% 2631 30%
2015 1279 53% 1151 47% 2430 29%
INDICATIONS FOR INDUCTIONS 2014
REASONS TOTAL %
Post Dates 630 25.9%
Prolonged SROM 437 18.0%
Reduced Fetal Movements 158 6.5%
Diabetes 123 5.1%
Hypertension 189 7.8%
Heart Disease 3 0.1%
IUD 28 1.2%
Anomaly 17 0.7%
Antibodies 3 0.1%
Diminished Liquor 82 3.4%
IUGR 126 5.2%
Large Baby 60 2.5%
Medical/Social 285 11.7%
Multiple Births 27 1.1%
Other 201 8.3%
Poor Obstetric History 53 2.2%
Decreased Placental Function 6 0.25%
Poor Byphysical Score 2 0.1%
Total 2430 100%
* Anti D detected or Anti E
I N D U C T I O N O F L A B O U R
T h e  M a s t e r
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INDUCTION OF LABOUR
YEARS 2014 2015
Total No. of cases 2631 2430
Incidence against deliveries >500 30% 29%
No. of Caesarean sections for Inductions 614 547
Stillbirths 30 32
Neonatal Deaths 8 5
METHOD OF INDUCTION
YEARS 2014 2015
ARM 215 225
ARM + Synto 559 669
Prostin + ARM + Syntocinon 682 563
Prostin + ARM 375 332
Prostin 299 248
Cytotec 23 19
Prostin + Syntocinon 204 154
Syntocinon 274 220
Total 2631 2430
56846 Rotunda Clinical Report 2015 26/10/16 v3_Clinical Rep  26/10/2016  15:50  Page 55
56
In 2015 the caesarean section rate for the year was 32.2%.  There were 2,696
sections.  Of these 1,364 were elective and 1,332 were emergency.  The section rate
for the year was almost 1% higher than 2014.  Over my seven year tenure as
Master the caesarean section rate has risen from 28.5% to 32.2%.  In terms of the
number of primary caesarean sections was slightly reduced from 1,713 in 2014 to
1,566 in 2015.  The indications were broadly similar; there was a slightly higher
number of placenta praevia cases.  The number of failed instrumental deliveries
was reduced by over half.  There was a slightly higher number of severe IUGR
cases requiring primary section.  In terms of repeat caesarean sections there
were 857 elective repeats and 274 emergency repeats.  Looking at the Robson
criteria for 2015, there were no significant differences in the ten groups.
YEARS 2014 2015
Total number of cases 2753 2696
Incidence against total deliveries > 500g 31.3% 32.2%
Maternal Mortality 2 1
Primary C.S. 62.2% 58.1%
Repeat C.S. 37.8% 41.9%
Classical C.S 2 5
Tubal Ligation at C.S. 132 134
C/S Hysterectomy 1 1
C A E S A R E A N  S E C T I O N
T h e  M a s t e r
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CAESAREAN SECTION ANALYSIS
All Deliveries for 2015 8361
All Caesarean Sections 2696
Section Rate 32.2%
Group 1 - Nullip Single Ceph Term Spont Lab 190/1597
Section Rate 11.9%
Group 2 - Nullip Single Ceph Term Induced 414/1234
Section Rate 33.5%
Group 2a - Nullip Single Ceph Term CS Before Labour 231
Group 3 - Multip Single Ceph Term Spont Labour 36/1963
Section Rate 1.8%
Group 4 - Multip Single Ceph Term Induced 88/1046
Section Rate 8.4%
Group 4a - Multip Single Ceph Term CS before Labour 169
Group 5 - Prev Section Single Ceph Term 965/1220
Section Rate 79.1%
Group 6 - All Nullip Breeches 174/182
Section Rate 95.6%
Group 7 - All Multip Breeches 132/141
Section Rate 93.6%
Group 8 - All Multiple Pregnancies 113/169
Section Rate 66.9%
Group 9 - All Abnormal Lies 18/18
Section Rate 100.0%
Group 10 - All Preterm Single Ceph 167/392
Section Rate 42.6%
Elective Caesarean Section Total 1364
Emergency Caesarean Section Total 1332
Total Multips 4847
Total Primips 3514
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INDICATION FOR PRIMARY SECTIONS 2015
DELIVERY METHOD INDICATION 2014 2015
Fetal Distress {Antepartum & Intrapartum} 555 476
Failure to progress 1st stage 162 157
Failure to progress 2nd stage 31 26
Breech 267 220
Abruption/APH 18 16
P.E.T. 29 29
Transverse Lie/Oblique 17 19
Pyrexia 21 14
Placenta Praevia 28 35
Poor Obstetric History 16 11
Cord Prolapse/Presentation 7 8
Disproportion & Deep Transverse arrest 2 0
Failed Forceps/Ventouse 31 13
Face/Brow Presentation 4 1
Multiple Birth 60 31
Failed Induction 77 84
Prematurity 8 8
Hypertension 18 27
Emergency CS Scheduled for Elective CS 13 13
I.U.G.R. 14 25
Maternal Request 31 38
Medical Disorders 41 44
Poor Biophysical Profile 0 1
Other 181 189
Recurring indications 7 0
Rhesus Antibodies 0 0
Previous 3/4th degree tear 55 64
Malpresentaion in labour 20 17
Total 1713 1566
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INDICATION FOR REPEAT SECTIONS 2015
DELIVERY METHOD INDICATION Elective Emergency 
Failure to progress 1st stage       0 26
Failure to progress 2nd stage       0 4
Fetal distress                      0 70
Disproportion(Malpresentation in Labour) 1 0
Breech                              12 10
Hypertension                        4 4
Placenta praevia                    4 7
P.E.T.                              0 5
Poor obstetric history              4 1
Cord Prolapse/Presentation 0 2
Previous LSCS                       770 85
Previous classical CS               8 0
Multiple birth                      10 2
Abruption / APH 6 0
Failed induction                    0 1
Antepartum fetal distress           0 1
Emergency CS scheduled for elective CS 0 18
Failed forceps/ventouse             0 0
I.U.G.R.                            4 1
Medical disorders                   5 2
Transverse lie / Oblique lie 6 4
Other                               17 25
Recurring Indications 0 2
Maternal request 2 1
Prematurity 0 0
Previous 3/4th Degree tear 3 0
Pyrexia 0 2
Pre-Term Labour 0 1
Rhesus 1 0
TOTAL 857 274
** These reasons are the  First reason for  Caesarean Section 
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CLINIC New Return Total
Attendances Attendances
 Antenatal & Postnatal 10,845 31,991 42,836
Gynaecology 2,323 4,981 7,304
Paediatrics 4,808 3,572 8,380
Endocrinology 2,833 2,285 5,118
Gastroenterology 40 13 53
Haematology 301 309 610
Anaesthetics 607 27 634
Nephrology 232 616 848
Psychiatry 459 467 926
Dove Medical 110 117 227
Allied Health Clinics 5,259 8,001 13,260
Diagnostic Clinics 7,444 20,791 28,235
Total 35,261 73,170 108,431
O U T PA T I E N T  A C T I V I T Y  D A T A  2 0 1 5
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Reports
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OPERATION CATEGORIES
2011 2012 2013 2014 2015
Obstetrical Majors 2745 2604 2717 2821 2757
Obstetrical Minors 1287 1284 1259 1242 1120
Vaginal  Surgery 626 610 609 592 573
Abdominal:Uterus 110 125 93 88 115
Abdominal:Tubes & Ovaries 336 317 311 295 379
Other procedures 2615 2365 2245 2369 2329
D E PA R T M E N T  O F  G Y N A E C O L O G Y
62
THEATRE GYNAECOLOGIC  WORKLOAD 
VAGINAL SURGERY 2014 2015
Vaginal hysterectomy 10 13
Manchester repair 0 2
Pelvic Floor Repair 41 42
Vaginal Hysterectomy & AP Repair 31 49
Sacro Spinous Colpopexy 5 10
Removal of IUCD 146 112
Insertion of IUCD 344 328
Other 15 17
Total 592 573
ABDOMINAL OPERATIONS 
OF THE UTERUS 2014 2015  
Total Abdominal Hysterectomy 14 30
Myomectomy 16 29
TAH & Bilateral Salpingo-oophorectomy 31 34
Sub Total Hysterectomy 27 22
Total  88 115
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OTHER PROCEDURES 2014 2015  
Laparoscopy 259 300
Laparoscopy and Dye 218 173
Hysteroscopy 153 163
D&C/H&C 846 811
UBT 54 68
EUA 65 53
Cystoscopy 15 6
Laparotomy 59 44
Excision Bartholins Cyst 24 47
Fentons 13 9
Diathermy Vulval Warts 0 0
Operative Hysteroscopy 6 29
Endometrial Ablation {Rollerball} 47 50
Laparoscopic division of Adhesions 29 31
Laparoscopic Ablation of Endometriosis/Argan 138 115
Polypectomy 72 68
TVT 1 0
Punch Biopsy of Cervix 4 6
LLETZ 23 7
Other Gynae Surgery 307 294
Other Surgery - fetal/anaesthetic 36 55
Total 2369 2329
GRAND TOTAL
Gynae Grand Total Minors & Majors 3344 3369
THEATRE GYNAECOLOGIC  WORKLOAD 
ABDOMINAL: TUBES AND OVARIES 2014 2015   
Tubal Surgery 1 1
Laparoscopic Sterilisation 28 34
Tubal Ligation at Caesarean Section 92 134
Salpingectomy 68 72
Ovarian Cystectomy 69 90
Oophorectomy 9 16
Ovarian Biopsy 3 7
Salpingo-oophorectomy 25 25
Total 295 379
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MINORS 2014 2015  
SVD 2 6
Delivery Forceps 55 52
Delivery Vacuum 50 36
Episiotomy Resuturing 0 0
Episiotomy Repair 95 63
Evacuation of Uterus (AB) 544 504
Evacuation of Uterus (PPH) 8 10
Placenta  Manual Removal 113 94
Insert Shirodkar suture 31 29
Remove Shirodkar suture 20 10
Suturing 1st/2nd degree Tear 62 46
Suturing 3rd degree Tear 159 160
Suturing 4th degree Tear 5 7
Suturing Vaginal Wall Tear 16 23
Miscellaneous 82 80
Total Minors 1242 1120
GRAND TOTAL
Grand Total  Obstetrics (Majors & Minors) 4063 3877
THEATRE OBSTETRIC WORKLOAD 2014
MAJORS 2014 2015   
Caesarean Hysterectomy 1 1
Classical Caesarean Section 2 5
Ectopic 68 60
Lower Segment Caesarean 2750 2691
Totals 2821 2757
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Consultant Colposcopists DR. PAUL BYRNE (Director Of Colposcopy)
DR. HASSAN RAJAB
DR. TOM WALSH
DR. YAHYA KAMAL
Lead Nurse Coordinator MS. SELINA IGOE
Nurses MS. ROSE THORNE
MS. CAROLE O’ROURKE
MS. JENNIFER O’NEILL
MS. VIRGINIE BOLGER
Health Care Assistants MS. TRISH O’DONOVAN
MS. NICOLA BOYD
Colposcopy Team Leader MS. SUSAN DALY
Administrative Support MS. ÉILIS DALTON
MS. NIAMH O’CARROLL
MS. OLGA PEARSON
MS. MARITA PABERZA
MS RUTH MACKAY
C o l p o s c o p y  S e r v i c e
Service Overview
In 2015, we increased our Service Level Agreement with the National Cancer
Screening Service (NCSS) from 1,500  to 2000 new patients. During the year we
saw 1,902 new patients and there were 3,442 return visits, giving a total of 5,344
patient visits (Table 1). This represents a significant increase in activity
compared to our 2014 figures. Our non-attendees (DNA) rate is 14%, which is
within the NCSS target of 15%. Every effort is made to accommodate patients
who need to reschedule appointments. 
Table 1. Clinic Attendances
2010 2011 2012 2013 2014 2015
New attendances 1664 1908 1563 1569 1503 1902
Return visits 2568 2769 3159 3325 3424 3442
Total 4232 4677 4722 4894 4927 5344
The number of LLETZ treatments decreased significantly in 2015 (Table 2). This
has occurred because of the introduction of the therapeutic modality of Cold
Coagulation. In recent years data has been published showing the LLETZ may be
associated with an increase in the risk of miscarriage and preterm labour.  This
increase in risk is seen particularly in women who require a LLETZ with a depth
of greater than 1cm or in those who require more than one treatment.  Cold
Coagulation is an ablative therapy that does not appear to be associated with
these risks. Furthermore, a recent meta-analysis has shown that this therapy is
as effective as LLETZ for treating all grades of CIN. It is now our policy to offer
Cold Coagulation rather than LLETZ when this is clinically appropriate. 
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Table 2. Biopsies and Treatments
2010 2011 2012 2013 2014 2015
Biopsies 732 991 1014 1013 1114 1469
LLETZ 784 914 752 465 528 380
Cold Coagulation - - - - 42 199
Total 1516 1905 1966 1478 1642 2048
The histological diagnosis in LLETZ and biopsy specimens is shown in Table 3.
There were 5 cases of unexpected invasive disease in women who had a LLETZ
done for what was presumed to be pre-invasive disease. Three cases with clinical
suspicion of  invasive carcinoma were confirmed by colposcopic biopsy.
Table 3. Histology of LLETZ and Colposcopic Biopsies
CIN 1/HPV CIN 2 CIN 3 CGIN/AIS SCC Incl. Negative
Microinvasion
LLETZ 72 83 196 9 5 15
Biopsies 676 325 297 4 3 124
The provision of the colposcopy service in The Rotunda Hospital is based on the
Quality Standards set out by the National Cervical Screening Programme. These
standards cover every aspect of the screening pathway. Some of the key
administrative and clinical targets are shown in Tables 4 and 5. 
The fact that we have exceeded all of the targets in 2015 is a reflection of the hard
work and dedication of all members of the Colposcopy Team. All of this is done in
a facility that is far too small for the clinical workload. Our colposcopy clinic is
currently located in what was once the neonatal unit. We have two small clinical
rooms, with very limited office space. We need to increase our clinical space, both
for patient comfort and so that we can cope with the increased clinical workload.
We gained another clinical room in 2015 as part of the redevelopment of the
existing clinical area. We are optimistic that there will be funding to fully equip
this as a third colposcopy clinical room.
Table 4.
Administrative Standards Rotunda Target
Proportion referred with HSIL seen within 4 weeks 95% >90%
Proportion referred with LSIL seen within 8 weeks 98% >90%
Proportion of appointments that were unattended 14% <15%
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Table 5.
Clinical Standards Rotunda Target
Proportion referred with HSIL1 seen within four weeks 95% >90%
Proportion referred with LSIL2 seen within eight weeks 98% >90%
Proportion of LLETZ3 as outpatients 99% >80%
Proportion of women with CIN4 on histology (LLETZ) 96% >85%
Proportion of women with CIN on histology (Biopsy) 93% >85%
Proportion of women treated at first visit with CIN
on histology         98% >90%
Proportion of women admitted as inpatients
following LLETZ           0% <2%
1  High-grade squamous intraepithelial lesion
2 Low grade squamous intraepithelial lesion
3 Large Loop Excision of the Transformation Zone
4 Cervical intraepithelial neoplasia 
Quality Initiatives in 2015
The compliance with the Guidelines for Quality Assurance in Cervical Screening
is monitored in a variety of ways as outlined below. 
Clinical Audit.
Audits completed in 2015 and certified by The Rotunda Hospital Clinical Audit
Department include:
1.An audit of Cold Coagulation
2.Compliance with National Cancer Screening Service standards 
for Large Loop Exci-sion of the Transformation Zone 
MDT Meetings
Monthly multidisciplinary team (MDT) meetings are held. 
Failsafe Reports
Failsafe reports are run daily and weekly on the Mediscan system. These reports
ensure that the data are captured correctly for each visit. This data are returned
to the NCSS on a regular basis.
Monthly Reports
A report on key performance indicators is returned to the NCSS each month. 
NCSS Report
The NCSS Performance Evaluation Unit compares and evaluates key
performance indicators across the 15 colposcopy clinics in Ireland. In a recent
assessment, the Rotunda Hospital colposcopy clinic compared very favourably
with the other clinics across a wide variety of standards. 
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SERVICE DEVELOPMENTS IN 2015
Cold Coagulation
Cold coagulation, which allows treatment of CIN without the risk of pregnancy
complications was introduced in September 2014. Our clinical audit of the first
100 cases has confirmed that this treatment is effective as Large Loop Excision of
the Transformation Zone (LLETZ) which is considered to be the gold standard. 
Nurse-led Clinics
Our nurseled colposcopy clinics, introduced in 2014, continue to gathered
momentum over the last year. Three of the nurses are now trained to work
independently as diagnostic colposcopists and run their own weekly clinics. In
2015 we increased the number of nurse-led clinics from two to three each week.
In 2015, 401 new patients were seen in these clinics. This has had a significant
beneficial effect on the throughput to clinics, as it allows more women with
high-grade disease to be seen in the consultant clinics. 
Management of Low-grade Disease
The introduction of reflex HPV testing of low grade smears by the NCSS is one of
the main reasons for the increase demand for colposcopy, hence the need to
increase our referrals from 1500 to 2000.  This increase in demand has been offset
to some extent by other changes introduced by the NCSS whereby women who
have been treated (LLETZ or cold co-agulation) now have only one test of cure (TOC)
in our clinic. Until recently, such women had two TOCs before being discharged.  
Track & Trace
The Track and Trace System was introduced in the Colposcopy Clinic in April
2015.  It is used to track all Reusable Invasive Medical Devices (RIMDs) through
their cleaning and de-contamination processes and to trace their usage on
patients. The system helps lessen contamination risk, ensure compliance with
required standards and assures quality. It maintains better quality
decontamination records and enables ready access to the records. The system is
highly automated using scanning technology and GS1/MS1 coding.
PRIORITIES FOR 2016.
1. Dealing with increased referrals
To increase the number of new patients from 1500 to 2000 per year will make
significant demands on our resources at every level. An extra weekly consultant
clinic will be required to service this increase in referrals. 
2. Cold Coagulation
We aim to increase the use of Cold Coagulation for women who are suitable for
this type of treatment. As the numbers of treatments increase a second
treatment unit will be required. 
3. Develop a 3rd Treatment Room
As part of the redevelopment of the Mortuary, we have gained one extra room in
the colposcopy clinic. The aim is to have this room fully equipped as a third
treatment room.  
4. Upgrading of Clinical and IT Equipment
Our colposcopes and IT equipment are reaching the end of their lifespan and
will need to be replaced in the coming year.
56846 Rotunda Clinical Report 2015 26/10/16 v3_Clinical Rep  26/10/2016  15:50  Page 68
69
DR. D. CORCORAN , PROF. A. EL KHUFFASH (DEPT. HEAD) 
DR. A. FORAN, DR B. HAYES, PROF. N. MCCALLION, 
PROF. M. D. KING (NEUROLOGY),DR J. FRANTA (TRANSPORT MEDICINE)
ADMISSIONS TABLES (1.1-1.10) 
In 2015 the number of admissions to the NICU reduced slightly compared with 2014 1,311
vs 1,439). The average occupancy was 78.15% peaking in July at 86.77%. We continued to
look after over 800 babies on the postnatal wards. We continue to have difficulty with
neonatal nurse staffing and maintaining a nurse to patient ratio that is consistent with
international recommendations. Ideally we require a minimum of 13 nurses per shift to
reach any kind of minimum safe standard, and we still lack a dedicated resuscitation
nurse for emergencies. At times close to 20 babies were being treated in the high
dependency unit which has a maximum capacity of 13 beds. It is a credit to all our staff
especially frontline nursing staff that we managed to maintain acceptable survival and
morbidity results, but this cannot be sustained. 
This is the third year we are in a position to present more detailed data on babies
admitted with birth weights >1500g. We wish to thank the IT midwives and especially
Kathy Conway for their hard work in compiling this data. Going forward this will help
us develop a new model of care and identify those babies that can be nursed safely in
a transitional care unit.
Vermont Oxford Network (Section 2 Tables 2.1-2.5) 
Neonatal Mortality (< 28 days)(Tables 3.2 and 3.3) 
Congenital Malformations (3.2)
Deaths of Normally formed infants receiving intensive care (3.3) 
Neonatal Encephalopathy (Table 3.1) 
Follow-up of babies <1500g
Neonatal Encephalopathy
In 2015, 27 babies (16 inborn) delivered at ≥ 35 weeks gestational age were
admitted with signs of hypoxic ischaemic encephalopathy (HIE). Encephalopathy
was graded as severe in 4 newborns (1 inborn), moderate in 12 (6 inborn) and mild
in 11 (9 outborn) newborns.  In total 17 babies were treated with therapeutic
hypothermia including all 16 babies with moderate/ severe encephalopathy.
Cooling was continued in another baby despite a history consistent with only
mild encephalopathy given limitation of examination on arrival due to sedation.
Cooling was initiated within the critical 6 hour time period in all cases. In one 
D E PA R T M E N T  O F  P A E D I A T R I C S
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baby therapeutic cooling was discontinued early in view of a large subdural
which required neurosurgical drainage. The trend for improved outcomes in
babies with moderate encephalopathy treated with therapeutic hypothermia
has again continued and all babies in this group with neurodevelopmental
surveillance in the Rotunda have had normal developmental progress to date.
Developmental surveillance of this group is ongoing. We are delighted that all
babies admitted with significant encephalopathy will now be invited back to the
Rotunda for formal neurodevelopmental assessments at 2 years. Unfortunately,
outcome remains extremely poor for newborns with severe encephalopathy. In
this cohort, all four babies died in the initial neonatal period. One baby (inborn)
failed to respond to intensive care measures with refractory pulmonary
hypertension and systemic hypotension. Post-mortem confirmed group B sepsis
in addition to severe hypoxia ischaemic brain injury. In the remaining 3 babies
(outborn) intensive care measures were withdrawn given severity of
encephalopathy and no improvement in clinical exam and
electroencephalogram (EEG) at greater than 48 hours after birth. 
Comments
Paediatric outpatients’ attendances remained high at 8,380 which is a slight
decrease from 2014 but significantly lower than previous years when over 12,000
attendances were recorded. 366 babies were reviewed in the emergency room. 59
attended our specialist neurology clinic and 48 our neurodevelopmental follow
up clinic. 217 attended our rainbow clinic for specialist follow up of those infants
at high risk for infectious diseases. The overall DNA rate was low at 9%
The Dublin North East neonatal network (encompassing the Rotunda, Drogheda
and Cavan) continues to evolve. There were 5 transfers from Cavan and 6 from
Drogheda to the rotunda ex utero, contributing to 217 NICU bed days in the
Rotunda respectively. There were 19 Mothers from Cavan and Drogheda in-utero
with 88 bed days. 
The appointment of a neonatal dietician last year has drastically improved our
nutrition services and provision of total parenteral nutrition. Onsite
physiotherapy in the NICU is improving the developmental care of our sick
infants. In addition, we had a neonatal pharmacist on a temporary basis and this
has significantly decreased the number of drug errors in the unit. Now that we
have social work, physiotherapy and dietetics streamlined we hope to expand
with permanent neonatal pharmacy, speech and language therapy and
permanent psychology services.
The neonatal transport has been running on a 24/7 basis for two years now. Dr
Jan Franta continues his excellent work as the consultant leading the service and
continues to have a huge impact on training of NCHDs and nurses, allowing more
formal training especially with respect to air retrieval. The total number of
infants transported by the NNTP in 2015 was 611. The Rotunda received 57 (9.3%)
of these: 46 (7.5%) were national referrals for neonatal management, this figure
represents 33% of the total number (139) of NNTP transports referred for neonatal
management to the three Dublin maternity Hospitals in 2015; 3 from adult
hospitals (booked in RH); 43 from non-tertiary neonatal centres [including 11
within NE network, 6 from Cavan and 5 Drogheda]; 11 (1.8%) were own hospital
returns from Dublin paediatric hospitals, post-surgical / cardiology / neonatal 
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interventions. The Rotunda Hospital also used the NNTP service to transfer out
72 infants: This represents 11.8% of all NNTP transports in 2015. Of these:  54
(8.8%) were referrals to Dublin paediatric hospitals for surgical and cardiac
management; 18 (2.2%) were returns to original hospitals, 17 outside Dublin and;
1 within Dublin. The NNTP team from the Rotunda conducted 32% (196) of the
total number (611) NNTP transports in 2015, 107 (55%) of which were outside the
greater Dublin area.
The neonatal unit continues its active role in research, and during 2015 there
were a total of four higher degree candidates in the Department of Paediatrics:
Drs Adam James, Colm Breatnach, Raga Malika, and Elaine Neary. The Rotunda
Hospital continues to lead and actively participate in Randomised Control trials.
While consultants were invited speakers and projects were presented at many
local and national meetings, we have presented only publications and
presentations at larger international meetings. 
The Rotunda Hospital continues to support the role of advanced neonatal nurse
practitioners with a third candidate undertaking the program in 2015. The
Neonatal Unit will then have three Advanced Nurse Practitioners in
Neonatology, which further expands the ANP role within the unit. Three staff are
due to undertake the postgraduate Diploma in neonatal nursing in the RCSI,
with two staff due to complete the program this year. Throughout the year staff
were also supported to attend national and international neonatal nursing
conferences. 
The neonatal unit continues to identify quality improvement plans to enhance
our philosophy of a family centred care approach. The need for a neonatal
lactation specialist and developmental care (NIDCAP) specialist, have been
highlighted in previous parent satisfaction surveys. Providing lactation
consultant support for our most vulnerable babies is essential and approval was
given in May 2015 to provide 15hrs per month to increase support in this area,
which will further improve support for all mothers to provide breast milk for
their babies. A member of the neonatal nursing team is currently undertaking
the lactation course. It is envisaged that this role/post will be provided in
addition to our current whole time equivalent in the near future.
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TABLE 1.1 
ADMISSION & DISCHARGE TO THE NEONATAL UNIT
 ADMISSIONS 1,311
DISCHARGES 1,273
INFANTS > 1.5Kg 1,145
INFANTS TREATED ON WARD 752
*Including readmissions
TABLE 1.2 
ADMISSION WEIGHT TO THE NEONATAL UNIT
500 - 1000grms 46
1001 - 1500grms 82
1501 - 2000grms 143
2001 - 2500grms 175
Over 2500grms 827
TOTAL INFANTS DISCHARGED 1,273
* Based on Infants Discharged from NICU
SECTION 1
TABLE 1.3 
MAIN INDICATIONS FOR ADMISSION TO THE NEONATAL UNIT
RESPIRATORY SYMPTOMATOLOGY 523
PREMATURITY < 37 WEEKS 357
JAUNDICE 360
LOW BIRTH WEIGHT < 2.5Kg 446
HYPOGLYCAEMIA 241
CONGENITAL ABNORMALITIES 240
SUSPECTED SEPSIS 40
NEONATAL ABSTINENCE SYNDROME 28
SEIZURES 8
HIE 29
GASTRO-INTESTINAL SYMPTOMS 15
SOCIAL 5
DEHYDRATION 16
*Some Infants are assigned more than one reason for admission
TABLE 1.4 
TERM BABY CAUSES OF RESPIRATORY MORBIDITY (>37 WEEKS)
TRANSIENT TACHYPNOEA OF THE NEWBORN 239
MECONIUM ASPIRATION SYNDROME 5
PERSISTENT PULMONARY HYPERTENSION OF THE NEWBORN 22
RESPIRATORY DISTRESS SYNDROME 26
STRIDOR 12
CONGENITAL PNEUMONIA 11
LEAK 0
CONGENITAL DIAPHRAGMATIC HERNIA 6
LARYNGOMALACIA 1
TRACHEO-OESPHAGEAL FISTULA 1
CONGENITAL CYSTIC ADENOMATOID MALFORMATION 1
PULMONARY HYPOPLASIA 2
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TABLE 1.5
CONGENITAL HEART DISEASE
PATENT DUCTUS ARTERIOSUS 70
DYSRHYTHMIA 63
PERSISTENT PULMONARY HYPERTENSION OF THE NEWBORN 36
VENTRICULAR SEPTAL DEFECT 25
ATRIAL SEPTAL DEFECT 8
ATRIOVENTRICULAR SEPTAL DEFECT 3
HYPOPLASTIC LEFT HEART SYNDROME 5
TRANSPOSITION OF THE GREAT ARTERIES 6
TETRALOGY OF FALLOT 3
TABLE 1.6
GASTROINTESTINAL ANOMALIES
GASTRO-OESOPHAGEAL REFLUX 6
INGUINAL HERNIA 12
CLEFT PALATE ONLY 7
OMPHALOCOELE 3
CLEFT LIP 3
GASTROSCHISIS 3
SPONTANEOUS PERFORATION 2
IMPERFORATE ANUS 2
BOWEL ATERESIA 0
TRACHEO-OESPHAGEAL FISTULA 1
PYLORIC STENOSIS 0
TABLE 1.7
CENTRAL NERVOUS SYSTEM ABNORMALITIES
NEONATAL ABSTINENCE SYNDROME 28
SEIZURES NOT HIE 8
MEINGITIS 3
HYDROCEPHALUS 2
ERB'S PALSY 0
MICROCEPHALY 2
SCHIZENCEPHALY 3
SUBDURAL HAEMORRHAGE 0
TABLE 1.8
METABOLIC / ENDOCRINE /HAEMATOLOGICAL ABNORMALITIES
HYPOGLYCAEMIA 241
ANAEMIA OF PREMATURITY 93
THROMBOCYTOPENIA 47
DISSEMINATED INTRAVASCULAR COAGULOPATHY 19
HYPERGLYCAEMIA 19
POLYCYTHAEMIA 39
ANAEMIA(NOT INCL OF PREMATURITY) 8
HYPOTHYROIDISM 3
SIADH 6
HYPERINSULINISM 2
GALACTOSAEMIA 1
HAEMOLYTIC DISEASE OF NEWBORN 21
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Gestational  Inborn Survival % Outborn Survival % Total %
Age Infants to Infants to Survival
(completed) Discharge Discharge Discharge to 
weeks
21 1 0 (0%) 0 0 0 (0%)
22 1 0 (0%) 0 0 0 (0%)
23 6 0 (0%) 1 0 (0%) 0 (0%)
24 6 5 (83%) 0 0 5 (83%)
25 7 7 (100%) 3 3 (100%) 10 (100%)
26 10 9 (90%) 0 0 9 (90%)
27 6 6 (100%) 2 1 (50%) 7 (88%)
28 25 23 (92%) 2 2 (100%) 25 (93%)
29 19 18 (95%) 2 2 (100%) 20 (95%)
30 9 9 (100%) 3 3 (100%) 12 (100%)
31 12 10 (83%) 3 3 (100%) 13 (87%)
32 4 2 (50%) 0 0 (0%) 2 (50%)
> 32 7 6 (86%) 0 0 (0%) 6 (86%)
Total 113 95 84% 16 14 (88%) 109 (84%)
Delivery room deaths 2015
< 24 weeks gestation 4
severe congenital abnormalites 3
Other 1
Total 9
SECTION 2    -    VLBW INFANTS
TABLE 2.1
NUMBER OF CASES REPORTED TO VON 2015
All Cases Excluding Congenital 
Anomalies
Infants < 401g but ≥22 wks gestation 1 0
Infants 401-500g 2 0
Infants 501-1500g 122 16
Infants > 1500g but ≤29 wks gestation 5 0
Total 129 16
TABLE 2.2
GESTATIONAL AGE BREAKDOWN AND SURVIVAL TO DISCHARGE OF ALL
INFANTS REPORTED TO VON (INCLUDING THOSE WITH CONGENITAL
ANOMALIES) 2015 (N=129)
TABLE 1.9
DYSMORPHIC SYNDROMES
TRISOMY 21 *19
DYSMORPHIC FEATURES (NO FINAL DIAGNOSIS) 7
TRISOMY 18 (EDWARDS) 0
TRISOMY 13 (PATAU) 0
* 19 Infants born with T21, 14 admitted to NICU
TABLE 1.10
JAUNDICE IN TERM BABIES > 37 WEEKS
NON-HAEMOLYTIC 132
HAEMOLYTIC
ABO 17
RH 2
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TABLE 2.3
BIRTH WEIGHT AND SURVIVAL TO DISCHARGE OF ALL INFANTS REPORTED TO
VON (INCLUDING THOSE WITH CONGENITAL ANOMALIES) 2015 (N=129)
Birth  Inborn Survival % Outborn Survival % Total %
Weight Infants to Infants to Survival
(grams) Discharge Discharge Discharge to 
<500 2 0 (0%) 0 0 0 (0%)
501-600 11 6 (55%) 0 0 - 6 (55%)
601-700 6 4 (67%) 1 0 (0%) 4 (57%)
701-800 9 7 (78%) 2 2 (100%) 9 (82%)
801-900 8 8 (100%) 2 1 (50%) 9 (90%)
901-1000 2 2 (100%) 1 1 (100%) 3 (100%)
1001-1100 12 9 (75%) 1 1 (100%) 10 (77%)
1101-1200 12 10 (83%) 1 1 (100%) 11 (85%)
1201-1300 18 18 (100%) 3 3 (100%) 21 (100%)
1301-1400 10 9 (90%) 2 2 (100%) 11 (92%)
>1400 23 22 (96%) 3 3 (100%) 25 (96%)
Total 113 95 (84%) 16 14 (88%) 109 (84%)
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TABLE 2.4
MORBIDITY FIGURES FOR INFANTS 501-1500G BORN (CONGENITAL
ANOMALIES INCLUDED) COMPARED TO THE VERMONT OXFORD NETWORK
N Rotunda (n=129 ) VON n=62082
Inborn  129 113  (88%) 88%
Male 129 75 (58%) 51%
Antenatal Steroids (partial or complete) 129 108 (84%) 81%
C/S 129 90   (70%) 72%
Antenatal Magnesium Sulphate 129 75  (58%) 55%
Multiple Gestation 129 57 (44%) 27%
Any major birth defect 129 16 (12%) 5%
Small for gestational age 129 28  (22%) 24%
Conventional Ventilation 120 72 (60%) 56%
High Frequency Ventilation 120 12 (10%) 21%
Any Ventilation 120 73 (61%) 59%
High Flow Nasal Cannula 120 55 (46%) 53%
Nasal CPAP 120 105 (87%) 75%
Nasal CPAP before ETT Ventilation 107 36 (34%) 59%
Ventilation after Early CPAP 36 13 (36%) 37%
Surfactant at any time 129 87 (67%) 57%
Steroids for CLD  119 10 (8%) 10%
Inhaled Nitric Oxide 120 11 (9%) 5%
RDS 120 109  (91%) 73%
Pneumothorax 120 12 (10%) 4%
Chronic Lung Disease (at 36 wks) 104 21   (20%) 24%
"Chronic Lung Disease, Infants <33 wks" 98 21 (21%) 25%
Early Bacterial Infection 119 2 ( 2%) 3%
Late Bacterial Infection  116 7 (6 %) 9%
Coagulase Negative staph infection 116 15 (13 %) 6%
Nosocomial Bacterial Infection 116 20 ( 17 %) 12%
Fungal Infection 116 0  0( %) 1%
Any Late Infection (Bacterial or Fungal) 116 20 (17 %) 12%
NEC/bowel perforation Surgery 120 2 (2%) 3%
PDA ligation 120 4 (3%) 4%
Surgery for ROP 120 11 (9%) 2%
Any Grade of IVH (Grade 1-4) 114 44 (39%) 25%
Severe IVH (Grade3-4)  114 13  (11%) 8%
Cystic PVL 118 3 (2%) 3%
Retinopathy of Prematurity 99 18 (18%) 31%
Severe ROP (Stage 3 or more) 99 9 (9%) 6%
NEC  119 11  (9%) 5%
PDA 120 45 (37%) 28%
Ibuprofen for PDA 120 22 (18%) 7%
Probiotics 120 102 (85%) 14%
Mortality 129 20 (15%) 15%
Mortality excluding Early Deaths 119 10 (8%) 10%
Survival 129 109 (85%) 85%
Survival without Specified Morbidities 129 64 (50%) 57%
56846 Rotunda Clinical Report 2015 26/10/16 v3_Clinical Rep  26/10/2016  15:50  Page 75
76
Measure N SMR SMR 95% SMR 95% N SMR SMR 95% SMR 95%
Lower Upper Lower Upper 
Mortality 121 1.1 0.7 1.6 378 1.3 1 1.6
Mortality Excl Early Deaths 113 1 0.5 1.5 355 1.2 0.9 1.6
Death or Morbidity 121 1.1 0.9 1.4 378 1.1 0.9 1.2
Chronic Lung Disease 100 1 0.6 1.4 295 0.9 0.7 1.1
"CLD, Infants < 33 Weeks " 94 1 0.6 1.4 271 0.9 0.7 1.1
"NEC, Any Location " 114 1.5 0.9 2.4 359 1.8 1.3 2.4
Late Bact Infection 111 0.8 0.4 1.3 345 0.7 0.4 1
Coag Neg Staph 111 2 1.1 3.1 345 1.7 1.1 2.3
Nosocomial Infection 111 1.3 0.8 1.9 345 1.1 0.8 1.4
Fungal Infection 111 0.2 0 1.4 345 0.1 0 0.7
Any Late Infection 111 1.3 0.8 1.8 345 1.1 0.8 1.4
Any IVH 109 1.5 1.1 1.9 342 1.5 1.2 1.7
Severe IVH 109 1.3 0.8 1.9 342 1.4 1 1.8
Pneumothorax 115 1.5 0.9 2.2 360 1.6 1.1 2.1
Cystic PVL 115 1 0.3 1.9 349 0.9 0.5 1.5
Any ROP 94 0.7 0.5 1.1 284 0.6 0.4 0.8
Severe ROP 94 1.6 0.9 2.7 284 1.3 0.8 2
TABLE 2.5 
SHRUNKEN STANDARDISED 
MORTALITY AND MORBIDITY (SMR) 
RATES 2015
SHRUNKEN STANDARDISED 
MORTALITY AND MORBIDITY (SMR) 
RATES 2013- 2015 INCLUSIVE
SECTION 3  - HYPOXIC ISCHAEMIC ENCEPHALOPATHY AND MORTALITY TABLES
TABLE 3.1  -  HYPOXIC ISCHAEMIC ENCEPHALOPATHY (HIE)
Inborn Outborn
TOTAL 15 11
Mild HIE (Grade 1) 9 2*
Moderate HIE (Grade 2) 6 6
Severe HIE (Grade 3) 1 3
Therapeutic Hypothermia 7 10
*Therapeutic Hypothermia continued on 1 outborn baby with mild encephalopathy
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Grade Place of Gestation Mode of    Arterial      Venous 1 Minute 5 Minute Therapeutic Seizures Brain ND Age
HIE Delivery delivery   Cord Gas Cord Gas Apgar Apgar Hypothermia MRI Progress at
pH BE pH BE Assessment
2 inborn 40+5 Inst 6.9 -17 7.1 -14 5 6 Yes No Normal Normal 11
2 inborn 40+2 SVD 7.2 -4.1 7.1 -6.4 0 5 Yes No Normal Normal 5
2 inborn 39+5 Inst nd nd 4 7 Yes No Brightness Normal 8
deep white 
matter 
bilaterally
2 inborn 40 Inst 7.3 -3.9 7.3 -3 2 6 Yes No Arnold chiari Spina Bifida 
malformation F/uin TSCUH
2 inborn 39 EMCS 6.9- 17 6.9 -17 7 8 Yes No Normal Normal 5
2 inborn 41+1 Inst 6.9 -14 7 -11 2 6 Yes Yes Right Cerebral Normal at 3
Contusion; months;
associated large Followed in
cerebral Children’s 
haematoma Hospital 
requiring 
drainage
2 outborn 40+6 EMCS nd nd 3 7 Yes No Normal Normal 12
2 outborn 37+5 SVD 7-15 7 -16 5 5 Yes Yes Abnormal Followed
restricted locally
diffusion 
corpus callosum 
and right optic 
radiation; Deep 
white matter 
brighter than 
expected 
2 outborn 40+2 EMCS 7.2 -6.1 7.2 -6.3 1 3 Yes No Normal Normal 4
2 outborn 41 EMCS 6.6 -23 6.6 -23 2 4 Yes Yes Echogenicity Followed
basal ganglia, Locally
thalami and  
perirolandic
fissure
2 outborn 36 EMCS nd nd 8 9 No Yes Cerebral oedema: Followed
small foci deep Locally
white matter 
restricted 
diffusion 
left cerebral 
hemisphere
3 inborn 40 EMCS 6.5- 35 nd 0 0 yes No No Neonatal Death Day 1*
3 outborn 39+6 EMCS nd nd 0 0 yes No No Neonatal Death Day 2
3 outborn 41+2 EMCS 6.6 -26 6.7 -25 0 5 Yes Yes No Neonatal Death Day 3
3 outborn 36+5 EMCS nd nd 0 2 yes No No Neonatal Death Day 2
EMCS= Emergency Caesarean Section; Inst= Instrumental SVD= Spontaneous Vaginal Delivery; nd= Not Documented;
¥ Optic Atrophy on ophthalmological examination felt to be unrelated to perinatal events
*Associated group B sepsis on post-mortem
TABLE 3.1a CLINICAL DETAILS OF NEWBORNS WITH SIGNS OF MODERATE TO
SEVERE HIE
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Birth Wt (g) Gestation Sex Delivery Apgars Age Principle Cause of Death
1.16kg 28+1 F EmLSCS 01,15,110,115, 020 <1 day Twin to twin tranfusion syndrome, 
growth discordance, pleural and 
pericaridal effusions, cardiomegaly, 
chronic hypoxia.
2.62kg 38+4 M SVD 91, 105" 6 days Normal neonatal care. Normal newborn
examination. Passed away Day 6 at 
home. Awaiting State Pathologist report.
0.51kg 24+0 F SVD 31,65,810 4 days Extreme prematurity, severe 
intraventricular and intraparenchymal 
haemorrhage (Grade III and Grade IV), 
maternal chorioamnionitis,hypotension.
1.025kg 26+0 F EmLSCS 21,85,1010 4 days Extreme prematurity, Pulmonary 
Haemorrhage, necrotising enterocolitis, 
bilateral intraventricular haemorrhage 
(Grade III and Grade IV).
0.8kg 23+3 M SVD 61,55,810 2 days Extreme prematurity, Twin 2, Large 
bilateral Grade IV intraventricular 
haemorrhage
0.64kg 28+4 M EmLSCS 41,75,810 4 days Uteroplacental insufficiency, Severe 
respiratory distress syndrome, 
pulmonary hypertension, prematurity, 
IUGR,  acute tubular necrosis, hypoxic 
ischaemic encephalopathy.
3.38kg 40+0 F EmLSCS 01,05,010, 015 1 day Invasive group B streptococcal disease. 
Full resuscitation. First heart rate at 28 
minutes after delivery. Severe 
encephalopathy. Redirection to comfort 
care.
1.035kg 29+2 M EmLSCS 11,35,410,515 2 days Uterine rupture at 29 weeks, prolonged 
resuscitation, severe encephalopathy, 
seizures, significant ischaemia on 
cranial ultrasound.
0.66kg 23+1 M SVD 31,75 2 days Extreme prematurity, severe respiratory
distress syndrome, recurrent 
pneumothoraces, large grade IV IVH 
with midline shift.
0.54kg 22+2 M SVD Not applicable <1 day Extreme prematurity <23 weeks.
1.42kg 32+4 M SVD 31,25,045 <1 day In utero vascular accident, 
arthrogryphosis.
0.75kg 23+5 M Assisted 61,45,150 <1 day Twin to twin transfusion syndrome 
breech (other twin 390g), extreme prematurity.
TABLE 3.3  -  INBORN /OUTBORN INFANTS NORMALLY FORMED  > 500G
Birth Wt (g) Gestation Sex Delivery Apgars Age Principle Cause of Death
2.34kg 40+0 M SVD 71,75 4 days Trisomy 13, Holoprosencephaly
2.77kg 38+6 F SVD 51,65 2 days Turner's Syndrome, Hypoplastic left heart
2.42kg 40+6 M LSCS 11,45 <1 day Osteogenesis imperfecta
2.0kg 31+0 M EmLSCS 11,05 <1 day Large omphalocoele, cord avulsion, 
multiple contractures, pulmonary 
hypoplasia
1.9kg 37+0 F SVD breech 9,10 <1 day Renal agenesis
2.49kg 38+4 F ELSCS 41,45 <1 day Right congenital diaphragmatic 
hernia, pulmonary hypoplasia
3.48kg 39+6 M SVD 01,25 <1 day Pulmonary hypoplasia, severe skeletal 
anomalies, eventeration diaphragam, 
dysmorphic features,antenpartum 
haemorrhage
1.36kg 34+0 M SVD 55,55 <1 day Bladder outlet obstruction, Potter's 
Syndrome
3.38kg 38+5 F forceps 51,85 3 days Diaphragmatic eventeration, 
pulmonary hypoplasia
1.75kg 40+0 M SVD not available <1 day Lumbosacral myelomeningocoele, renal 
agenesis, Arnold-Chiari malformation, 
anhydramnios
2.54kg 35+6 M SVD 41,25 <1 day Thanatophoric dwarfism
2.87kg 42+2 M ELSCS 9,10 1 day Anencephaly
1.1kg 31+4 F SVD 41,25 <1 day Congenital diaphragmatic hernia, 
Cornelia de Lange
1.07kg 32+0 M SVD not available <1 day Trisomy 18
1.83kg 41+1 F SVD 11,05 <1 day Trisomy 18
TABLE 3.2  - INBORN /OUTBORN INFANTS WITH CONGENITAL ANOMALIES (18)
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D E PA R T M E N T  O F  A N A E S T H E S I A
DR. MARY BOWEN (CHAIRMAN) , DR. NIAMH HAYES, DR. JOHN  LOUGHREY
DR. CONÁN MC CAUL, DR. RÓISIN NÍ MHUIRCHEARTHAIGH, 
DR. PATRICK THORNTON.
The Department continues to participate in high risk cardiac obstetric cases and
multidisciplinary six weekly meetings with Dr. Kevin Walsh, Consultant
Cardiologist, Mater Misericordiae University Hospital, Dr. Fionnuala NíAinle,
Consultant Haematologist (Adult) and Dr. Peter McKenna, Consultant
Obstetrician Gynaecologist.
This year an additional Pre-Operative Assessment Clinic for gynaecological
patients has been introduced and is being lead by Dr. Patrick Thornton.  We are
fortunate to have two Specialist Midwives: Sinead Corbett and Linda Chiles who
were appointed to support the running of the clinic.  
Dr. Thornton continues in his role as Clinical Tutor.
The RHOET courses run successfully and provide training in obstetrical
emergencies.
The Department maintained an active involvement in the RCSI student teaching
programme.
The Department is currently applying for two new consultant positions to
incorporate sessions with James Connolly Memorial Hospital.  We also hope to
gain approval for a consultant position shared with Beaumont Hospital.
We run a very comprehensive teaching programme, providing formal teaching
sessions at least twice a week for the NCHDs.  Training in Echocardiology and
Difficult Airway Skill Programme is included in this.
Non-Consultant Hospital Doctors:
We would like to congratulate Dr. Rania Haydar and Dr. Shane O’Sullivan who both
passed their Membership examinations in anaesthesia.
Dr.  Anne Doherty was our first NCHD appointed as a special interest year in
obstetrical anaesthesia.  She was also appointed as lead NCHD from July 2015 until
January 2016.  This is the first time a lead NCHD has been chosen from the
Department of Anaesthesia. Dr. Doherty received the ABBVIE Scholarship from the
College of Anaesthetists.  She has also been involved in the HANDLE study.
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DELIVERY  SUITE  ACTIVITY
DELIVERIES UNDER EPIDURAL
The number of women requesting epidural analgesia remains high, a similar
rate to 2014. Patients receiving epidurals continue to receive patient controlled
epidural infusions (PCEA) with a background infusion.
Labour Analgesia is also provided by Entonox, TENS and Remifentanil PCA.
A Remifentanil PCA is offered to patients in whom epidurals are contraindicated
or who want an alternative to epidural analgesia and 33 patients availed of this.
Mode of Delivery for Parturients who select Epidural Analgesia.
Epidural  Workload 2015
Deliveries Under Epidural 2014 % 2015 %
Nulliparous {% of Primips less C/S 2331 70% 2198 72%
before labour {2014-3311}   {2015-3039}
Multiparous {% of Multips less C/S 1696 45% 1700 47%
before labour {2014-3800} {2015-3610}
TOTAL 4027 3898
Mode of Delivery after Epidural Analgesia
NULLIPAROUS
Mode of Delivery 2014 % 2015 %
Normal 711 30.5 759 34.5%
Forceps 254 10.9 230 10.5%
Vacuum (Vacuum & 
Vacuum/Forceps) 757 32.5 706 32.1%
L.S.C.S 606 26.0 500 22.7%
Breech 3 0.1 3 0.1%
Total 2331 2198
MULTIPAROUS
Mode of Delivery 2014 % 2015 %
Normal 1281 75.5 1284 75.5%
Forceps 51 3.0 40 2.4%
Vacuum (Vacuum & 
Vacuum/Forceps) 213 12.6 211 12.4%
L.S.C.S 149 8.8 161 9.5%
Breech 2 0.1 4 0.2%
Total 1696 1700
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Neuraxial Analgesia Techniques
Epidural % CSE %
Nulliparous 2083 57.7% 159 45.2%
Multiparous 1530 42.3% 193 54.8%
TOTAL 3613 352
Some patients had CSE + Epidural so combined totals different
CAESAREAN SECTION RATE 2014- 2015
2015
Mode of Anaesthesia Elective % Emergency %
Spinal 1329 96.8 629 44
G.A. 13 0.9 106 7.4
Epidural 4 0.3 621 43.5
CSE 27 2.0 73 5.7
Total 1373 1429
2014
Mode of Anaesthesia Elective % Emergency %
Spinal 1281 96.0 630 40.1
G.A. 13 1.0 139 8.8
Epidural 5 0.4 718 45.7
CSE 36 2.7 84 5.3
Total 1335 1571
OPERATING THEATRE ACTIVITY
GYNAECOLOGICAL REPORT
Operation Categories 2011 2012 2013 2014 2015
Obstetrical Majors 2745 2604 2717 2821 2757
Obstetrical Minors 1287 1284 1259 1242 1120
Vaginal  Surgery 626 610 609 592 573
Abdominal:Uterus 110 125 93 88 115
Abdominal:Tubes & Ovaries 336 317 311 295 379
Other procedures 2615 2365 2245 2369 2329
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ANAESTHESIA OUTPATIENT CLINIC
The Pre-Anaesthesia Assessment (Obstetric) Clinic lead by Dr. McCaul continues
on a weekly basis with 526 attendees this year.  
A Pre-Operative Assessment Clinic (Gynaecology) lead by Dr. Thornton, was
commenced in August of this year and by the end of year had reviewed 87
patients.  
The Cardiac Anaesthetic Clinic runs on a monthly basis also lead by Dr. Thornton
and reviewed 104 patients this year.
POST DURAL-PUNCTURE HEADACHE (PDPH)
There were 3,613 epidurals performed with 1,333 obstetric spinal anaesthetics
and 27 Combined Spinal Epidurals CSEs.  There were 82 documented Post Dural
Puncture Headaches (1.7%) of whom 31 required epidural blood patch treatment
(0.6%).  A repeat blood patch was required by 4 patients to achieve resolution of
the headache.
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H I G H  D E P E N D E N C Y  U N I T
DR. MARY BOWEN  CONSULTANT ANAESTHETIST
Total   Admissions 217
Obstetrical  198
Gynaecological 19
Obstetric Category Number % Overall % Obstetric Admissions
Haemorrhage (APH/PPH)   87 40 43.9
PET / Eclampsia/ HELLP 42 19.8 21.2
Sepsis   33 15.2 16.6
Cardiac 11 0.50 0.55
Miscellaneous 40 0.18 0.20
Ovarian Hyperstimulation 
Syndrome 4 0.018 0.02
TOTAL 198 91.2
Gynaecology Number % Overall % Gynaecological
Admissions
Pain Control 2 0. 9 0.10
Sepsis 4 1.8 0.21
Bleeding 3 13 0.16
Miscellaneous 10 4 0.52
TOTAL 19 8
Transfers 
To: Mater Misericordiae University Hospital (MMUH) 5
From: Mater Misericordiae University Hospital 1
From: St. Vincent’s University 1
From: Our Lady of Lourdes Hospital, Drogheda 1
TOTAL 8
Transfers To MMUH 5 1. A Parturient delivered twins with a 
PPH and estimated blood loss of 2 
litres. She was transfused with 2RCC, 2
Fibrinogen. Patient became confused 
in HDU. Had CT brain at MMUH and 
diagnosed with Post reversible 
encephalopathy syndrome
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2. Patient one week post abdominal 
hysterectomy. Admitted with sepsis 
and pelvic collection. 
3. Gravida 3 Para 2 @ 29/40 with sepsis. 
Known mitochondrial disorder, 
epilepsy, hearing deficit, psychosis and 
gestational Diabetes. Presented with 
hypotension requiring a noradrenalin 
infusion. Transferred to MMUH. 
4. A gynaecological patient developed 
sepsis of unknown origin. History of 
Acute lymphatic leukaemia at age 
17 years. Had Bone marrow transplant 
and full body radiation.  Transferred 
for imaging.
5. Case of Vaginal hysterectomy and 
anterior repair. Collapse on ward 4hrs 
post surgery due to haemorrhage. Had
embolisation of iliac vessels at MMUH
From Mater Misericordiae
University Hospital 1 D1 post LSCS and hysterectomy under 
GA at MMUH for placenta accreta. 
Transfused 5 RCC. Had interventional 
radiology assistance.
From St. Vincent’s 
University Hospital. 1 Known epileptic. 22/40 presented to 
SVUH with seizures. Referred to 
Rotunda hospital. Had been diagnosed
with Pseudo seizures. Transferred back
to SVUH
From: Our Lady of Lourdes 
Hospital, Drogheda 1 39yr old 24/40 with bad obstetric 
history and IVF pregnancy presented 
to Drogheda with APH. Noted to be 
thyrotoxic, Started on Carbimazole.
Cardiac Admissions:
1 Patient presented with supraventricular tachycardia (SVT) at 220 b/min. 
Given adenosine 6mg IV. Reverted to sinus rhythm. 
2 Admitted post Elective LSCS had history of SVT with loss of consciousness.
3 Admitted post Elective LSCS under combined spinal epidural (CSE) Patient
had corrective surgery in childhood for Tetralogy of Fallot.
4 Known case of Wolf Parkinson White (WPW) Syndrome with ICD in situ.  
Patient was hypertensive during the   pregnancy. Admitted post Elective 
LSCS under Spinal anaesthesia. 
5 Known case of Maroteaux-Lamy Syndrome. Patient had 
mucopolysaccharidosis with Aortic and Mitral regurgitation. Admitted for
monitoring after Elective LSCS under CSE
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6 Known case of corrected Tetralogy of Fallot with residual pulmonary 
incompetence and moderate right ventricular dilatation. Patient had 
lumbar scoliosis requiring multiple operations and had Harrington rods in
situ. Admitted post elective LSCS under CSE. 
7 Patient admitted post EL LSCS under spinal. Patient had a history of 
Coarctation of the Aorta.  She had WPW and was on beta blockers.
8 Admitted post EL LSCS under CSE.  Known case of Transposition of Great 
arteries with Ebstein's anomaly with an ICD implant in situ. 
9 Patient with Transposition of great arteries, VSD and Pulmonary atresia. 
She had corrective surgery as a child. She had developed a ventricular 
aneurysm. She had a history of 2 CVAs and was on long term 
anticoagulation. She also had scoliosis and corrective surgery with 
Harrington rods and a spinal fusion. She was admitted post  elective  LSCS
under CSE
10 Patient 36/40 with twins who developed atrial flutter. Given adenosine. 
Elective LSCS the day following onset of atrial flutter. She had recurrent 
episodes of atrial flutter post operatively requiring adenosine.
11 Patient with a history of VSD repair and Tricuspid and Mitral valve 
replacements.
She developed PET in pregnancy and had a semi elective LSCS.
Miscellaneous  Admissions: 
The miscellaneous group of patients admitted to the HDU included 5
gynaecological patients 2 of which were CPAP dependent.  One obstetric patient
with a high BMI was also admitted post delivery.
There were 2 cases of anaphylaxis post caesarean section. One had anaphylaxis
to benzylpenicillin and one to morphine.
One IDDM obstetrical patient was admitted following a hypoglycaemic episode.
Two patients were admitted due to poorly controlled epilepsy and one of these
was subsequently diagnosed with pseudoseizures.
The majority of gynaecological patients admitted were admitted for post
operative analgesic requirements.
Additional/Invasive Monitoring:
Arterial   Lines   40
CVP Lines 3
Caesarean Hysterectomies: 1
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D O V E  C L I N I C
DR MAEVE EOGAN, Consultant Obstetrician and Gynaecologist
DR JACK LAMBERT, Consultant in Infectious Diseases
DR WENDY FERGUSON, Infectious Diseases Associate Specialist Paediatrician 
DR BARRY KELLEHER, Consultant in GI/Hepatology
DR RICHARD DREW, Consultant Microbiologist 
MS MAIREAD LAWLESS, ID Liaison Midwife
MR JUSTIN GLEESON, Drug Liaison Midwife 
MS RUTH POWER, Medical Social Worker
DR VALERIE JACKSON, Clinical Audit & Surveillance Scientist
INTRODUCTION
The DOVE clinic was set up to look after the specific needs of women who have
or are at risk of blood and sexually transmitted bacterial and viral infections.
This could be through drug use, unprotected sex, or any contact with infected
blood or body fluid.  
DOVE BOOKINGS IN 2015
During 2015, 203 women booked into the DOVE clinic for their antenatal care. Of
these,
• 65 (32% of bookings) women were positive for Hepatitis B surface antigen, 
representing a increase of 49% compared to 2014 (Fig 1). 
• 55 (27%) women were positive for Hepatitis C antibody, an increase of 4% 
compared to 2014.
• 24 (12%) were positive for HIV infection, a decrease of 8% compared to 2014.
• 18 (9%) women had positive Treponemal serology, a decrease of 5% 
compared to 2014.
• 52 (26%) women were known to be on prescribed methadone programs, the
same number as booked in 2014.
• In addition, 67 women attended for treatment for Chlamydia Trachomatis 
infection in 2015.
Fig 1: DOVE Bookings by Year
86
56846 Rotunda Clinical Report 2015 26/10/16 v3_Clinical Rep  26/10/2016  15:50  Page 86
87
DOVE DELIVERIES 2015
Deliveries to HIV Positive Mothers 2015
Total Mothers Delivered <500g (incl miscarriage) 1
Total Mothers Delivered >500g 24
Live Infants 25 (incl.1 set of twins)
Miscarriage 1
Stillbirths 0
Infants <37 weeks gestation 2
Infants ≥37 weeks gestation 23
Infants delivered by Caesarean Section 11
HIV Positive Infants 0
Maternal Data (n=25)
Median Age 34
Newly Diagnosed at ANS 2
*Final serology not yet available for all infants.
Deliveries to HCV Positive Mothers 2015
Total Mothers Delivered <500g (incl miscarriage) 2
Total Mothers Delivered >500g 48
Live Infants 50 (incl. 2 sets of twins)
Miscarriage 3 (incl.1 set of twins)
Stillbirths 0
Infants <37 weeks gestation 7
Infants ≥37 weeks gestation 43
Infants delivered by Caesarean Section 20
HCV Positive Infants 0*
Maternal Data (n=50)
Median Age 31
Newly Diagnosed at ANS 8
Final serology not yet available for all infants
Deliveries to HBV Positive Mothers 2015
Total Mothers Delivered <500g (incl miscarriage) 3
Total Mothers Delivered >500g 40
Live Infants 40 (incl.1 set twins &1 baby of a set of twins)
Miscarriage 3 
Stillbirths 2 (incl.1 baby of a set of twins)
Infants <37 weeks gestation 3
Infants ≥37 weeks gestation 37
Infants delivered by Caesarean Section 14
HBV Positive Infants 0*
Maternal Data (n=43)
Median Age 30
Newly Diagnosed at ANS 8
*3 delivered elsewhere/ 2 sets of twins **Final serology not yet available for all infants
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Deliveries to Syphilis Positive Mothers 2015
Total Mothers Delivered <500g (incl miscarriage) 1
Total Mothers Delivered >500g 15
Live Infants 15
Miscarriage 1
Stillbirths 0
Infants <37 weeks gestation 4
Infants ≥37 weeks gestation 11
Infants delivered by Caesarean Section 2
Syphilis Positive Infants 0
Maternal Data (n=16)
Median Age 33.5
Newly Diagnosed at ANS 4
Deliveries to Mothers under DLM* service 2015
Total Mothers Delivered <500g (incl miscarriage) 7
Total Mothers Delivered >500g 62
Live Infants 63 (incl. 1 set of twins)
Miscarriage 7
Stillbirths 0
Infants <37 weeks gestation 11
Infants ≥37 weeks gestation 52
Infants delivered by Caesarean Section 24
NICU admissions for NAS 15
*DLM: Drug Liaison Midwife
In 2015, 217 infants attended the Rotunda Paediatric Infectious disease clinic (The
Rainbow clinic) for follow up. The clinic is delivered solely by a paediatric specialist
(Dr Ferguson).
EDUCATION AND TRAINING 
Members of the DOVE team continue to be actively involved in undergraduate,
postgraduate and hospital education programmes. 
The ID Liaison Midwife, Mairead Lawless continues to provide monthly in-
service education sessions for all clinical staff. In addition Mairead also gives a
lecture on Infectious Diseases in Pregnancy to the TCD postgraduate midwifery
students on an annual basis.
The British Association for Sexual Health and HIV (BASHH) accredited Sexually
Transmitted Infection Foundation (STIF) Course continues to be held Dublin,
with Dr Lambert acting as course director, and Dr Eogan providing teaching on
management of rape and sexual assault. The course took place in February and
September 2015 and provided multidisciplinary training in the attitudes, skills,
and knowledge required for the prevention and management of STIs. Further
courses are planned for 2016. 
Dr Wendy Ferguson was a member of the writing committee for the revision of
the national guidelines on Preventing Perinatal Transmission, launched in
August 2015. This document gives a comprehensive and practical overview of
care pathways for antenatal, perinatal and postnatal management of HIV, HBV,
HCV, Syphilis and Herpes Simplex Virus. 
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Dr Ferguson also continues her role as chair and project coordinator for the Irish
Congenital CMV Working Group (ICCWG), established in 2015 to address the ongoing
issue of late diagnosis of congenital cytomegalovirus (CMV) in asymptomatic infants
with sensorineural hearing loss. CMV screening of infants who fail the newborn
hearing test will commence in January 2017, for a period of 2 years. This pilot will run
in the three Dublin Maternity hospitals and Cavan General. If successful and cost
effective, the initiative will be rolled out nationally to all maternity units.
The hepatitis B working group was set up in January 2016 to direct the Antenatal
Hepatitis B Screening and Perinatal Hepatitis B Prevention Programme in Ireland.
This is a HSE national project and Dr Ferguson is the appointed paediatric ID
representative on the group. The management of hepatitis B women and the follow-
up of their infants by the DOVE team at the Rotunda Hospital has been identified by
the working group as the gold standard model for the project. The aim is to establish
this standard in in all maternity units with minimum costs incurred. The project is
due to commence in January 2017.
RESEARCH ACTIVITIES OF THE DOVE CLINIC
There are several research projects ongoing, many in collaboration with other
disciplines within the Rotunda Hospital and also with the ID and Hepatology teams
at the Mater Misericordiae University Hospital. Areas of interest include the
emergence of drug resistance and the pharmacokinetics of HAART during pregnancy.  
PUBLICATIONS AND PRESENTATIONS
1. Syphilis serology in pregnancy: an eight-year study (2005-2012) in a large teaching
maternity hospital in Dublin, Ireland. McGettrick P, Ferguson W, Jackson V, Eogan
M, Lawless M, Ciprike V, Varughese A, Coulter-Smith S, Lambert JS. Int J STD AIDS.
2016 Mar;27(3):226-30. Epub Mar 2015 
2. Lamivudine treatment and outcome in pregnant women with high hepatitis B
viral loads. Jackson V, Ferguson W, Kelleher TB, Lawless M, Eogan M, Nusgen U,
Coughlan S, Connell J, Lambert JS. Eur J Clin Microbiol Infect Dis. 2015 Mar;
34(3):619-23. 
3. Impaired glucose metabolism in HIV-infected pregnant women: a retrospective
analysis. Moore R, Adler H, Jackson V, Lawless M, Byrne M, Eogan M, Lambert JS.
Int J STD AIDS. 2016 Jun;27(7):581-5. Epub May 2015 
4. The effect of initiation of antiretroviral therapy on monocyte, endothelial and
platelet function in HIV-1 infection. O'Halloran JA, Dunne E, Gurwith M, Lambert
JS, Sheehan GJ, Feeney ER, Pozniak A, Reiss P, Kenny D, Mallon P. HIV Med. 2015
Nov;16(10):608-19. Epub Jun 2015
5. Pregnancy Outcomes of Mothers with Detectable CMV-Specific IgM Antibodies: A
Three-Year Review in a Large Irish Tertiary Referral Maternity Hospital. Drew RJ,
Stapleton P, Abu H, Healy E, Ferguson W, De Gascun C, O'Gorman J, Eogan M. Infect
Dis Obstet Gynecol. 2015
6. A Retrospective Audit of Clinically Significant Maternal Bacteraemia in a Specialist
Maternity Hospital from 2001 to 2014. Drew RJ, Fonseca-Kelly Z, Eogan M. Infect
Dis Obstet Gynecol. 2015 
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STEPHANIE RYAN  FFR RCSI 
NEIL HICKEY FFR RCSI
AILBHE TARRANT FFR RCSI
The radiology department in the Rotunda Hospital performed 6,534 exams in
2015 representing a slight reduction in activity when compared to 2014. Our
department images both adults and children. 94% of these were paediatric
examinations and 6% were adult examinations.
We continue to train radiographers in ultrasonography and in particular in hip
sonography and continue to provide a neonatal hip screening programme.  We
continue to have quarterly meetings in quality improvement and audit.
In August 2015 the Rotunda hospital joined multiple other hospitals in adopting
the National Integrated Medical Imaging System (NIMIS) as our radiology image
management system. NIMIS was initiated in August 2007 and since then has
been installed in over 40 hospitals. It delivers a filmless solution for radiology
and cardiology imaging in all these hospitals. It provides a paperlite or paperless
solution for test requesting and test reporting. All hospitals with NIMIS are
integrated, facilitating the controlled, rapid and secure movement of patient
image data through the health service.  The system went live on the 24th August
2015. With the aid of the Mc Kesson installation team and the tireless input of
Lorraine Hanley and Meave Hayes in our department, the transition from our pre
existing system to NIMIS went smoothly. Nearing the end of our first year with
NIMIS, Rotunda patients have benefited from the secure transfer of their images
to all other participating hospitals, including Our Lady’s Hospital for Sick
Children, Crumlin and The Mater Hospital. The system facilitates the
participation of the Rotunda radiology department in national quality
improvement programmes. As part of NIMIS  in the Rotunda hospital we use
Peervue, a software application which records quality activities such as
prospective and retrospective peer review, notification of unexpected findings
and of critical and urgent findings to clinicians and recording of
acknowledgments of receipt of same.
ADULT RADIOLOGY 
The adult radiology service in the Rotunda Hospital is provided by Dr. Neil
Hickey. In 2015 a total of 474 adult radiological examinations were performed of
which 166 (35%) were hysterosalpingograms, performed as part of the fertility
clinic work up. Other examinations also include other fluoroscopic procedures
such as cystograms, non-obstetrical ultrasound (general abdominal, renal,
pelvic, head and neck, vascular and soft tissue) and plain films.
R A D I O L O G Y /
P A E D I A T R I C  U L T R A S O U N D
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PAEDIATRIC RADIOLOGY 
Paediatric imaging accounts for 94% of the workload in the Department of
Paediatric Radiology. In 2015, a total of 6,060 paediatric studies were performed.
Of these, just over half (3,157) were paediatric ultrasound examinations. 
1,865 hip ultrasounds are performed as part of a targeted screening programme
for developmental dysplasia of the hip. As the hip screening service is well
established now, there has been no significant change in the number of hip
ultrasound scans performed since 2014. 
We continue to perform fluoroscopic studies, for investigation of the upper and
lower GI tract, often as an emergency out of hours study. There continue to be
modified feeding studies performed in Rotunda hospital but many of these still
need to be referred to TSH where facilities for feeding the baby upright are
available and where the advice of the Speech and Language therapists can be
sought.
The MRI unit at the Children’s University Hospital, Temple Street, which has
state of the art neonatal monitoring equipment, scanned a total of 116 Rotunda
babies from both NICU and POPD.  This is particularly valuable in the evaluation
of the newborn with neonatal encephalopathy and adds very useful additional
information to the bedside cranial ultrasound examination.  MRI scanning was
also used for the evaluation of babies with brain and spine malformations as
well as metabolic and other diseases.  15 paediatric patients were referred to
Temple Street for CT scanning.  26 fetal MRIs were performed in Temple Street for
Rotunda obstetric patients. Many of these Rotunda babies are discussed at
multidisciplinary meetings in Temple Street Children’s University Hospital
attended by Rotunda neonatologists and radiologists and where the input of
paediatric neurology and paediatric neurosurgery teams is valuable.  
Both Dr Ryan and Dr Tarrant are actively involved in training at several levels
and in paediatric radiology research. Several audits have been performed. There
were several publications from our department as well as presentations and
lectures at national meetings. 2015 was the 4th year of a cranial ultrasound
course, organised by the paediatric MD registrar and the department of
radiology. This course is a practical course for paediatric trainees designed to give
participants an introduction to cranial ultrasound and provide practical hands
on experience for neonatal/paediatric trainees. Again, this was well attended
and it is foreseen that it will continue on an annual basis.
TABLE 1: STAFF COMPLIMENT 2015
WTE
Diagnostic radiographers / ultrasonographers 2.5
Secretary 0.5
Consultant paediatric radiologist 0.76
Consultant adult radiologist 0.20
Senior medical physicist As needed
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PUBLICATIONS AND PRESENTATIONS STEPHANIE RYAN 2015
Publications
1. Boyle M, Shim R, Gnanasekaran R, Tarrant A, Ryan S, Foran A, and McCallion
N. Inclusion of extremes of prematurity in ventricular centile charts. J 
Perinatology 2015 35(6): 439-443 
2. Post natal MRI Brain in infants treated for Twin to twin transfusion 
Syndrome. Boyle M, Lyons A, Ryan S, Malone F and  Foran A Ir Med J. 2015 
Sep;108(8):240-3.
3. Hayes BC, Ryan S, Mc Garvey C et al. Brain magnetic resonance imaging and
outcome after hypoxic ischaemic encephalopathy. J Matern Fetal Neonatal 
Med Published on line 4 Sep 2015
Presentations
1. Iterative reconstruction – a dose saving paradigm in paediatric computed 
tomography imaging. Saidlear C, Bonner M, Donoghue V, Ryan S, Twomey E,
Robinson I, Laffan E.  Scientific exhibit C-188 European Congress of 
Radiology, Vienna, 2015
Invited Lectures
1. Skeletal Injury – Role of Imaging in making a diagnosis of Non Accidental 
Injury.  As part of NAI - A collarbaritve Approach.  Multidisciplinary 
conference UCD 24 Jan 15
2. Topical Topics in Neonatal Brain Imaging at Paediatric  Imaging 
Symposium, Dublin. 11 Sep 2015
3. Imaging of Congenital Chest Abnormalities. Radiological Soiety of North 
America Annual Meeting. Chicago Dec 15
Publications on Eurorad: the electronic teaching database of the European
Society of Radiology
1. Case 12451 A Case of a Primitive Neuroectodermal Tumour in a 2 year old
KA Lee, S Ryan. 9 Feb 2015. URL: http://www.eurorad.org/case.php?id=12449
2. Case 12449 A Case of a Medullary Glioma in a 12 year old. KA Lee, S Ryan 29 
Jan 2015. URL: http://www.eurorad.org/case.php?id=12449
3. Case 12728 Thyroid Dyshormonogenesis Auyushi Rai, S Ryan 30 Jun 2015. 
URL:http://www.eurorad.org/case.php?id=12729.DOI: 
10.1594/EURORAD/CASE.1272892
TABLE 2: ACTIVITY LEVELS 2015
TOTAL ACTIVITY 6,534
TOTAL ADULT EXAMS 474
HSG 166
TOTAL PAEDS   (X-ray & US) 6,060
TOTAL PAEDS US 3,157
HIP US 1,865
NEONATAL FLUOROSCOPY 59
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MS. MARGARET PHILBIN, DIRECTOR OF MIDWIFERY/NURSING
Midwives and Nurses work with skill and dedication both within the hospital
and in the community to provide high quality care for women, babies and
families. The ongoing commitment of staff to the hospital and to those who
attend for care is truly appreciated. 
STAFFING
Ms. M. Philbin Director of Midwifery/Nursing
Ms. P. Williamson Assistant Director of Midwifery/Nursing
Ms. F. Hanrahan Assistant Director of Midwifery/Nursing
Ms. M. Keane Assistant Director of Midwifery/Nursing
Ms. C. Halloran Assistant Director of Midwifery/Nursing (from 24/03/14)
Ms. M. O’Reilly            Practice Development Co-ordinator
Ms. A. O’Byrne Practice Development Co-ordinator
Ms. M. Brennan Assistant Director of Midwifery/Nursing-Infection Control
Ms. J. MacFarlane Night Superintendent
Ms. A. Keenan Acting Night Superintendent
Ms. M. Whelan Clinical Audit Facilitator
STAFF IN POST AT 31ST DECEMBER 2015
POST WTE in Post
Director of Midwifery/Nursing 1
Midwifery/Nursing Administration 7.76
Practice Development Co-ordinator 1.60
Advanced Nurse Practitioner (Neonatology) 2
CMM/CNM 3 6
Clinical Skills Co-ordinator 1.80
Clinical Placement Co-ordinator (BSc Midwifery) 2.90
Allocations Officer (BSc Midwifery) 0.50
PGDM Clinical Co-ordinator 1
Neonatal Discharge Co-ordinator 1
Colposcopy Nurse Co-ordinator 2
CMM/CNM 2 42.52
CMS/CNS 9.88
CMM/CNM 1 22.65
Staff Midwife 154.90
Staff Nurse 66.58
Student Midwife 18.5
Maternity Care Assistant 29.6
Total 371.69
D E PA R T M E N T  O F
M I D W I F E R Y / N U R S I N G
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APPOINTMENTS WTE RESIGNATIONS WTE
Midwives/Nurses/Midwifery Students  Midwives/Nurses/Midwifery Students
TOTAL:   38.50 TOTAL: 26.91
Active recruitment initiatives resulted in a net gain in the number of Midwives
and Nurses employed at the end of the year. Despite this we continue to
experience difficulty attracting staff to specialised areas of Neonatal Intensive
Care and Theatre.
RETIREMENTS
There were no retirements from the Midwifery and Nursing staff in 2015. 
HOSPITAL BASED MIDWIFERY AND NURSING SERVICES
Staff in the Adult Outpatient Department facilitated a total of 42,742 attendances
of pregnant women during 2015 representing a slight increase on the previous
year. An additional 9,000 attendances to specialist clinics were recorded.  A further
3,512 women attended the Early Pregnancy Unit which represented a reduction of
over 400 since 2014. Although some elements of the outpatient service
experienced a reduction in attendances the increasing complexity of the attendees
continued to be a significant factor in the provision of care.
The Midwifery Inpatient Antenatal Service incorporating Day Care, Fetal
Assessment, Ultrasound and Fetal Medicine is provided by a team of dedicated
Midwives and Sonographers. There were a total of 24,723 attendances at
Ultrasound, Fetal Assessment and Prenatal Diagnosis Clinics during the year,
which represents a significant increase on the 2014 figures. A total of 4,043
attendances were recorded to the expanded Day Assessment Unit during the year
with a significant number of women attending on more than one occasion. The
Unit continues to facilitate the ongoing assessment and management of women
with a variety of conditions. The service has seen a significant increase in the
number of women attending with hypertension and for blood sugar series. The
most common indications for attendance are represented in Table 1.
Table 1: Attendance at Day Care 
Attendance Reason Number
Antenatal and Postnatal Hypertension 1441
Cardiotcograph Monitoring 1292
Obstetric Cholestasis 321
Intrauterine Growth Retardation 158
Blood Sugar Series 289
Preterm Pre-labour Rupture of Membranes 56
Hyperemesis 64
IVIG 1
IV Antibiotic Administration 25
Admission 316
Prolutin Administration 442
Dexamethazone Administration 184
Insulin Education 111
Iron Infusion 21
94
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The Nurses and Midwives in the Neonatal Intensive Care Unit experienced a small
decline in activity with a total of 1,302 babies being admitted to the Unit. Sixty-four
of these babies were transferred into the Unit from other hospitals situated within
and outside of the RCSI Hospitals Group. The Paediatric Outpatients Department
facilitated 8,376 neonatal reviews, a slight decline on the 2014 figures. 
Ongoing education for all staff in the Neonatal Unit continued throughout 2015.
Two more staff successfully completed the Postgraduate Diploma in Neonatal
Nursing with the RCSI and a further four staff members were sponsored to
undertake the programme, which commenced in September 2015. Three new staff
members participated in the ’Principles of Neonatal Care’ Level 1 Programme with
five staff undertaking it at Level 2. Throughout the year Nursing staff were also
supported to attend National and International Neonatal Nursing Conferences. A
Neonatal Palliative Care Group was established in 2015 the aim of which is to
enhance and improve care given to neonates with life limiting and life threatening
conditions. This initiative was led by two Neonatal Staff Nurses who went on to
organise a National Neonatal Palliative Care Study Day in October 2015. The first of
its kind in Ireland, this study day was extremely well attended by both Rotunda
staff and delegates from Neonatal Units around the country.
Staff in the Delivery Suite provided care to a total of 8,361 women who delivered
8,538 babies. Despite the slight reduction in the number of births in 2015 women
are presenting with more complex care requirements which are consistently
provided for in a competent professional manner. A total of 22,270 attendances to
the Emergency and Assessment Unit (which falls under the remit of the Delivery
Suite) were recorded, the majority with pregnancy related problems. 
The Theatre Nursing and Midwifery Team continued to experience high levels of
activity. The team assisted with a total of 1,131 day cases and 725 elective and non
elective Gynaecological Surgical Operations. In addition, a total of 2,696 Caesarean
Sections were performed, 1,332 of which were categorised as emergency
operations. 
Staff in the Gynaecological Department faced a challenging year with 401 elective
and 350 non-elective gynaecological admissions to the department. Care was also
provided to a range of antenatal, postnatal and high dependency admissions.
Bereaved couples were also predominantly cared for by the Gynaecological team.
This diverse casemix results in a complex and hugely demanding work
environment for the staff in this area.
Maternity Care Assistants continue to play a pivotal role in assisting in the
provision of patient care throughout the hospital. Their contribution to the
services provided by the hospital throughout the year is enormous and is very
much appreciated.
56846 Rotunda Clinical Report 2015 26/10/16 v3_Clinical Rep  26/10/2016  15:50  Page 95
96
COMMUNITY MIDWIFERY SERVICES
2015 was a busy year for the Community Midwifery Team. It was also the year
that the Hospital marked the 10 year anniversary of this service. An afternoon of
celebration was organised in December attended by the Lord Mayor, members of
the Board of Governors, staff and most importantly mothers, babies and families
who had availed of the service over the years.
A 9th Antenatal Community Clinic was established during 2015. Entitled ‘Next
Birth after Caesarean Section’, this clinic offers Midwife provided antenatal care
to women with a previous Caesarean Section and no underlying medical
condition. Currently ten to fifteen women are seen at each clinic session. The
pathway of care includes a scheduled visit to see a Consultant Obstetrician at 28
and 38 weeks gestation respectively with women reverting to midwifery
provided care following same. Also incorporated in this pathway of care is a
dedicated home support visit at 24 weeks gestation to review medical notes
from previous pregnancies. 
Hypnobirthing classes and an antenatal breast feeding class were initiated by
the Community Team in 2015 to further provide women centred care with the
numbers attending steadily increasing throughout the year.
In 2015, a total of 1,687 women booked for antenatal care with the Community
Midwifery Team which represents a significant increase on the previous year.
Women are booked directly (home booking visits with the Community Midwife)
and indirectly (referrals from the Adult Outpatients Department). The team
continue to provide all aspects of antenatal care including booking visits and
subsequent home visits where appropriate in addition to facilitating a number
of clinics in local health centres.
A total of 354 women left the scheme at varying stages of their pregnancies. This
is an increase on the figure for 2014. These women were deemed unsuitable to
continue under the care of the Community Midwifery Team for varying medical
reasons and were referred back to the hospital for obstetric care by the attending
Midwives at the outlying antenatal clinics as referenced in Table 2 below. A
marked growth in the number of women with abnormal glucose tolerance tests
was noted, rising from 25 in 2014 to 54 in 2015.
Table 2: Indications for referral from the Community Midwifery Service for
Obstetric Review and Ongoing Care
Referrals Numbers
Small for Dates/ Oligohydramnios 34
Large for Dates / Polyhydramnios 20
Breech Presentation 5
Abnormal Glucose Tolerance Test 54
Ante Partum Haemorrhage / NSAPH 8
Hypertension 11
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Outcomes for women attending the Community Midwifery Services are
reflected in Table 3 below. Of note, from a total of 1,310 deliveries, 69% (N=901) of
women had a spontaneous vertex delivery. The Emergency Caesarean Section
rate within this cohort was 13% (N=166) and the Elective Caesarean Section rate
was 4% (N=58) one percentage higher than in 2014. One woman attending the
service unfortunately experienced an intra-uterine death at term+3. The mother
delivered a male infant with a birth weight of 4.3kg. The likely cause of death
was an acute event consistent with an umbilical cord accident. We offer our
sincere condolences to the family on their tragic loss.
Table 3: Outcomes of Care
Total Deliveries 1,310 100%
Spontaneous Vertex 901 69%
Ventouse 129 10%
M/C Forceps 42 3%
Ventouse/Forceps 10 1%
Emergency Caesarean Section 166 13%
Elective Caesarean Section 58 4%
Born Before Arrival 3 0.2%
Stillborn 1 0.07%
The team also offer postnatal visits to women who are living in the Greater
Dublin Area.  A total of 3,432 women availed of the service in 2015 representing a
slight increase from the previous year. The Community Midwives carried out
10,296 postnatal visits over the year providing on average of three postnatal
visits at home.  
LACTATION SERVICES
The Rotunda Hospital remains the only Dublin Maternity Hospital to have
achieved the National Baby Friendly Accreditation Award. The hospital also
continues to hold the Baby Friendly Health Initiative ‘Breastfeeding Supportive
Workplace’ Silver Award. 
Our Lactation Specialists continue to work with staff of all disciplines to protect,
promote and support breastfeeding as the optimal way for a mother to feed her
baby.  Acknowledging that breast milk offers important health benefits for both
mother and child we strive to assist as many women as possible to initiate
breastfeeding. The initiation rate increased to 71.49% in 2015. 
Supports available for breastfeeding mothers and babies in the hospital include:
• The provision of breastfeeding information in the Antenatal Clinic with
referral to the Lactation Specialist if required.
• Inclusion of information on the benefits and management of 
breastfeeding at parent education sessions. 
• Provision of a breastfeeding workshop every Tuesday and Thursday 
evening.
• Hospital policies include mother friendly labour and birthing practices.
56846 Rotunda Clinical Report 2015 26/10/16 v3_Clinical Rep  26/10/2016  15:50  Page 97
98
• Skin to Skin contact is policy for all mothers and babies including those
following a Caesarean Section. Contact is encouraged for at least 60 
minutes post delivery and babies are offered the first breastfeed at this 
time.
• Individual assistance and support with early breastfeeding problems is 
provided. 
• The Lactation Specialist attends the ward when more specialised care 
and advice is necessary.
• Postnatal breastfeeding information sessions are held at ward level.
• An outpatient service is available for mothers with breastfeeding issues
from Monday to Friday.
• A phone counselling and advice service is available Monday to Friday.
• A breastfeeding support group is held every Thursday between 11.30hrs 
and 12.30hrs.
• Community links with Public Health Nurses, General Practitioners and 
Voluntary support groups are an important resource outside of the 
hospital setting. Mothers are advised to link in with these services.
Breastfeeding Committee Meetings  
This multidisciplinary committee which also includes members from the
voluntary breastfeeding support groups continued to meet during 2015. There
were 4 meetings held during the year. 
Breastfeeding Education
Joint breastfeeding training continued to be facilitated by the three Dublin
Maternity Hospitals for Nurses and Midwives comprising of four 20 hour
training sessions and three refresher courses. Breastfeeding lectures were
included in orientation programmes for all new staff, Medical and Midwifery
students.
National Breastfeeding Week
To celebrate this important week which ran from the 1st to the 7th October all
babies delivered during that time were presented with a gift of a knitted hat and
cardigan or blanket and hat kindly donated by the Friends of the Rotunda and
the Rotunda Knitters Group. Ms. Maura Lavery represented the hospital at Áras
an Uachtaráin where an event to celebrate Breastfeeding Week was hosted by
Mrs. Sabina Higgins, wife of the President of Ireland.  
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PERINATAL MENTAL HEALTH SERVICE
The Midwifery Perinatal Mental Health Team working in close collaboration with
the Consultant Psychiatrist continued to play a very active role in the provision of
this specialised service in 2015. A total of 1,599 women reported a mental health
history at their booking visit during the year. All of these women were given the
opportunity to contact the services antenatally following which individual
meetings were organised to continue to support them during their pregnancy and
to facilitate brief intervention following delivery. 
The Midwifery Team provided 335 new and 251 follow-up consultations for women
in the Health Promotion Clinic.  These women are seen individually for up to an
hour each. The sessions include an individual assessment; talk therapy, support
and relaxation techniques which are provided in both the antenatal and postnatal
periods. Women can avail of this service for up to four months post delivery. 
A further 1,676 women with a mental health history were reviewed at ward level
for brief intervention, including health promotion, mental health management
and follow up service advice. In addition, the Mental Health Support Midwives
support the practice of offering every woman in the Rotunda the opportunity to
complete the Edinburgh Postnatal Depression Score before discharge. 
There is a steady demand for the Mental Health Support Team to present to
Midwifery Students in TCD. Public Health Nurse Colleagues also attended for
training on assessment, treatment and referral of women with a mental health
history. 
BEREAVEMENT SUPPORT AND CHAPLAINCY SERVICES
The Rotunda Hospital acknowledges that the loss of a baby during pregnancy or
following delivery is a one of the most painful experiences imaginable in any
parent’s life and we offer a range of services provided through the Bereavement,
Recurrent Pregnancy Loss, and Prenatal Diagnosis Clinics to afford bereaved
parents the necessary support to meet their individual needs. The Bereavement
Team continued to provide sensitive, compassionate and individualised care to
these families in 2015. 
Education sessions were provided by the team during the year, including full
study days for Undergraduate and Postgraduate Midwifery Students, and
Midwives and Nurses in conjunction with the Centre for Midwifery Education.
Training sessions for Non Consultant Hospital Doctors and other disciplines of
staff were also delivered. 
The work of the hospital is greatly assisted by the Chaplains and Ministers who
are available to offer support to patients and staff alike. Their dedication and
attention to women, their babies, families and staff is very much appreciated.
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ANNUAL SERVICE OF REMEMBRANCE
The Annual Service of Remembrance was held in the Pro-Cathedral in November
2015. We are again very grateful for the continued support of The Very Reverend,
Cannon Damian O’Reilly for facilitating this extremely important event where
we gather to remember and honour the precious short lives of babies who died
during 2015 and in previous years. The number of families attending this
remarkable service continues to increase. The service was also attended by
Chaplains from the main Churches, members of the Board of Governors, the
Executive Management Team and many staff members. The occasion was
enhanced by the music provided by soloist, Mary Flynn and harpist, Denise Kelly.
We extend our gratitude to the numerous staff members who volunteered to
assist on the day. Following the Service many families joined the Governors and
staff in the Gresham Hotel for light refreshments. 
BOOKS OF REMEMBRANCE
The Books of Remembrance which are a key feature of the Remembrance Service
are reserved in the Hospital Mortuary Chapel. Babies’ names are entered by the
Hospital Chaplain at the request of parents.
PARENT EDUCATION
The Parent Education Midwife working in close liaison with the Physiotherapy
Department continued to provide an extensive range of education sessions to both
Inpatients and Outpatients during 2015. Demand for this service remained high and
additional first classes were facilitated to meet the requirements. Parent education
sessions aim to convey positive messages to parents regarding their role in the
development of healthy children and their lifestyles.  This is achieved by woman
focused sessions with the role of the father emphasised throughout.  Education is
provided to expectant women and their birth partners on issues relating to
pregnancy, labour and the immediate postnatal period with feeding choices, baby
care and the future demands of parenthood also discussed.  Information is also
provided to inform parents where to source support and resources when they go
home with their new baby. Special education sessions were organised for groups
with specific identified needs including:
• Those with hearing disabilities
• Parents with sight disabilities
• Those with language difficulties
MIDWIFERY EDUCATION / PRACTICE DEVELOPMENT UNIT 
Throughout 2015 the Practice Development Team maintained a strong commitment
to supporting the 94 Undergraduate and Postgraduate Midwifery Students in clinical
placement from the University of Dublin, Trinity College. In addition to the
Midwifery Students, the team supported almost 200 other students, including Public
Health, General and Integrated Nursing Students from various hospitals and
Universities on short term placements. 
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Ongoing education of our Midwifery and Care Assistant Staff is an extremely
important element of the team’s role within a leading teaching hospital and a
wide variety of education sessions to support continuous professional
development were facilitated throughout the year. The Practice Development
Team played a key role in the implementation of the National Early Warning
Observation Chart for non-pregnant women.
Staff were released to attend more than 800 study days in recognition of the
positive impact of professional development on the quality of care of women,
babies and families. Midwives were supported to attend the ‘Newborn Discharge’
and ‘Lactation Consultant’ education programmes.  A number of staff were also
supported to undertake education programmes at Degree and Masters Level and
participated in National Programmes including Nurse/Midwife Prescribing. Two
staff members continued their preparation for progression to positions as
Advanced Nurse (NICU) and Midwife (Emergency) Practitioners.
CLINICAL AUDIT
The Clinical Audit Facilitator continued to promote and support all disciplines of
staff to undertake clinical audit throughout the year. In 2015 from a total of 57
clinical audits, 11 were undertaken by the Midwifery/Nursing Staff.  Outcomes
from all audits were presented at the monthly Quality and Safety Committee,
Departmental Patient Safety and at the Quarterly and Biannual Audit Results
meetings. All audits requiring immediate action were reported to the Executive
Management Team for progressing.
HEALTH PROMOTING HOSPITALS
‘Healthy Ireland’ is a Government Framework for action to improve health and
wellbeing for future generations. This initiative has been developed in response to
rising levels of chronic illness, lifestyle trends that threaten health and persistent
health inequalities. The Rotunda is a committed member of Healthy Ireland with a
focus on supporting a reduction in obesity and diabetes, improving mental health
and increasing breastfeeding rates.
November 2015 marked the second anniversary of the Rotunda Hospital becoming a
‘Tobacco Free Campus’. The Smoking Cessation Service jointly facilitated by the
Smoking Cessation Officer and the Occupational Health Department continues to
offer support to the patients and staff who wish to reduce and/or quit smoking.
Patient referrals to the Smoking Cessation Service come primarily from the Midwives
and Doctors in the Outpatient Department with the highest number of referrals
following the first booking visit. Self referrals are invited from members of staff
either through the Smoking Cessation Service or the Occupational Health
Department. Motivational interviewing techniques are used to help individuals
address the issues around their smoking with intensive follow up support offered to
those who quit. Training in these interview skills is included in the ‘Brief
Intervention in Smoking Cessation’ training (BISC) for staff, assisting them with the
management and support of patients and colleagues who are trying to stop
smoking. A total of 148 new clients availed of the service in 2015 which represented a
reduction of 16 on the 2014 figure. However, the improved ‘quit rate’ of 15% is
heartening taking cognisance of the difficult challenges facing individuals trying to
stop smoking.
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OCCUPATIONAL HEALTH DEPARTMENT
The Department of Occupational Medicine endeavours to promote and maintain
the highest degree of physical and mental health of all employees by preventing
departures from good health, controlling risks and adapting work to people and
people to their jobs as much as possible. The Department provides an
independent and confidential service for all employees hosting a clinic for staff
on one morning per week.
Throughout 2015 the team continued a rigorous campaign to promote and
administer the flu vaccine to all staff. The annual vaccination clinic was held in
the Front Hall over a 12 hour period to facilitate staff on duty. Thereafter, the
Occupational Health Nurse Manager held regular vaccination clinics in the
Department of Occupational Medicine and the N.I.C.U Department. We have
seen a rise in the uptake of this vaccination throughout the many disciplines
working in the Rotunda which is very positive for the health and wellbeing not
alone of our staff but also the women and babies we care for.
CONCLUSION
I would like to take this opportunity to thank the Chairman, Ms. Hilary Prentice
and the members of the Board of Governors for the support they have continued
to provide to Midwifery and Nursing during 2015. I would like to extend my
sincere thanks to the Master, Dr. Sam Coulter Smith and Secretary/Group
General Manager, Ms. Pauline Treanor, for their support and advice throughout
the year. I would like to extend my appreciation to Medical, Allied Health and
Administration Support staff colleagues for their continued assistance. I wish to
acknowledge and thank all of the external Agencies that have continued to
support Midwifery and Nursing Education and Practice during 2015 in particular
staff in the Nursing and Midwifery Planning and Development Dublin North
East, colleagues involved in Midwifery Programmes, Trinity College and the
collaboration with staff in the Centre for Midwifery Education. 
The hospital could not run as effectively or efficiently without the dedicated
Midwifery and Nursing staff who continue to provide such high quality care
despite the many challenges they face. I am indebted to them for their continued
commitment to work in the Rotunda Hospital for and with women, babies and
families. I would like to add a special word of thanks to the Assistant Directors of
Midwifery/Nursing and to Carol, Ger and Mags for their loyal support and
endless patience. They continue to meet the ever increasing demands on their
time and talents with cheerful enthusiasm.
Ms Margaret Philbin
Director of Midwifery/Nursing 
2015
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1. DEPARTMENT STAFF
PROFESSOR AND HEAD OF DEPARTMENT
Fergal D Malone MD, FACOG, FRCOG, FRCPI
HONORARY CLINICAL PROFESSORS 
Sam Coulter Smith MB, BCH, LCRPI & SI, FRCOG
Michael Geary, MD, FRCOG, FRCPI, DCH
SENIOR LECTURERS
Fionnuala Breathnach MD, MRCOG FRCPI DCH DipGU Med
Paul Byrne MD, FRCOG, FRCPI
Bridgette Byrne, MD, FRCOG, FRCPI
Ronan Gleeson MA MD, FRCOG FRCPI
Carmen Regan, MD, FRCOG, FRCPI
HONORARY CONSULTANT SENIOR LECTURERS
Carole Barry MD, FRCOG   
Edgar Mocanu MD, DM, FRCOG, DMMD, Dip Ethics.
MATERNAL FETAL MEDICINE SUBSPECIALTY FELLOWS
Etaoin Kent MD, MRCPI, MRCOG (Jan – July)
Jennifer Walsh, MD, MRCPI, MRCOG (July – Dec)
SPECIALIST REGISTRAR LECTURERS/TUTORS
Siobhan Corcoran MB BCh BAO MRCPI MRCOG
Hugh O’Connor MRCPI
Cathy Monteith MB BCh BAO MRCPI
Siglinde Muellers MRCPI (Jan – July)
Ann McHugh MB BCh BAO MRCPI MRCOG  (July – Dec)
RESEARCH FELLOW PHD MIDWIFE SONOGRAPHERS 
Siglinde Muellers MRCPI Claire O’Rourke
Ann Fleming 
RESEARCH NURSE RESEARCH STAFF
Grainne Mc Sorley Elizabeth Tully (Research Manager) PhD
Patrick Dicker PhD (Epidemiologist/Statistician) 
Robin George (Lab Technician) 
Jessica Colby-Milley MSc (Research Coordinator)
Lisa McSweeney MSc (Research Coordinator)
Fiona Cody MSc (Research Sonographer)
ADMINISTRATION
Suzanne Kehoe Paula Carty
Michelle Creaven Sinead Buckley (Maternity Cover) 
Suzanne King 
ROYAL COLLEGE OF SURGEONS IN IRELAND
DEPT. OF  OBSTETRICS & GYNAECOLOGY
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1.  PATIENT SERVICES
The RCSI Fetal Medicine Centre continues to provide advanced fetal medicine
services for patients of the Rotunda Hospital, as well as those referred from
throughout Ireland. During the current academic year a total of 3,394 fetal
ultrasound examinations were performed at the Centre. This included a total of 416
first trimester assessments for fetal aneuploidy, based on combined nuchal
translucency and serum screening, as well as 653 non-invasive prenatal testing
(NIPT) cases using free fetal DNA. The RCSI Fetal Medicine Centre operates a one-
stop clinic for assessment of risk of fetal aneuploidy, using the Brahms Kryptor
biochemistry platform and also NIPT.  Management of multiple gestations
contributed a significant workload to the Centre, with 36 twin pregnancies and 5
triplet pregnancies managed through our unit. 
2.  TEACHING SERVICES
One hundred and ninety six students participated in the RCSI Obstetrics &
Gynaecology clinical rotations. The RCSI Department of Obstetrics and
Gynaecology has a leadership role in providing teaching and assessment for
undergraduates at the Rotunda Hospital, National Maternity Hospital, Our Lady
of Lourdes Hospital Drogheda, Midland Regional Hospital Mullingar, St. Luke’s
Hospital Kilkenny, and Waterford Regional Hospital. 
These students participated as sub-interns on the hospital wards and in clinics,
contributing significantly to the mission and function of the hospital, while
providing increasingly positive feedback on their learning experiences.
Continuing Medical Education Courses Taught:
• Advanced Course in Ultrasound and Fetal Medicine, 352 Academy, Belfast,
Northern Ireland, October 2015
• Institute of Obstetricians and Gynaecologists, Annual Study Day, Dublin, 
Ireland, September 2015
• 3rd Irish Congress of Obstetrics, Gynaecology and Perinatal Medicine – 
Dublin, Ireland, May 2015
3. RESEARCH OUTPUT
a) Research Grants and Awards:
• Health Research Board, Ireland
- HRB Ireland Perinatal Clinical Trials Network
- F. Malone, MD Principal Investigator
- Total support €2,500,000
- 2014 – 2019
• Health Research Board, Ireland
- Knowledge Exchange and Dissemination Scheme
- Healthy Pregnancy in Ireland 
- F. Malone, MD Principal Investigator
- Total support €60,000
- 2015 – 2016
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b) Perinatal Ireland
Perinatal Ireland is a multi-centre, all-Ireland research consortium focussed on
carrying out research into women's and children's health. The consortium which
was the first HRB-funded network in the country, links the 7 major academic
obstetric hospitals across the island of Ireland (Rotunda Hospital Dublin,
Coombe Women and Infants University Hospital Dublin, National Maternity
Hospital Dublin, Cork University Maternity Hospital, University College Hospital
Galway, Mid-Western Regional Maternity Hospital Limerick, and Royal Jubilee
Maternity Hospital Belfast), as well as representatives of all 7 medical schools on
the island of Ireland (UCD, TCD, RCSI, UCC, NUIG, University of Limerick, and
Queens University Belfast). 
The network is headquartered at the RCSI Department of Obstetrics &
Gynaecology at the Rotunda Hospital and is an international leader in obstetric
and paediatric research. In addition to its clinical research activities, Perinatal
Ireland is active in other educational activities and methods of advancing clinical
care including: 
• Hosting of annual teaching conferences for practitioners in critical areas of
obstetric and paediatric health
• Development of national clinical guidelines to optimise the management of
important obstetric conditions 
• Contribution to international guidelines
• Development of new information technology systems to underpin obstetric
ultrasound equipment based on data developed from our studies
2015 saw completion of the recruitment phase of both the GENESIS and TEST
studies. The GENESIS study aimed to prospectively assess the use of Fetal Head
Circumference in the late third trimester, as a predictive tool for labour dystocia
and intrapartum caesarean section. GENESIS recruited over 2500 nulliparous
women nationally and primary findings were accepted for presentation at both
the Society for Maternal Fetal Medicine (SMFM) Pregnancy Meeting and the
British Maternal Fetal Medicine Society (BMFMS) Meeting in early 2016. 
The main aim of the TEST study was to examine the benefit of routinely
prescribing low dose aspirin to low risk women in their first pregnancy compared
with test indicated aspirin on the basis of a positive early pregnancy screening test
for pre-eclampsia and fetal growth restriction. The TEST study is the first national
drug trial in pregnancy recruiting over 550 women across two sites (the National
Maternity Hospital and the Rotunda Hospital) and data from the pilot phase of this
randomised controlled trial (RCT) will be used to inform a larger definitive study.
c) HRB Mother and Baby Clinical Trial Network Ireland
In late December 2014, RCSI was joint recipient (together with University College
Cork) of a HRB Clinical Trials Network Grant of ¤2.5 million to fund a five year
programme of clinical trials in the perinatal space. The HRB Mother and Baby
Clinical Trials Network Ireland (HRB MB-CTNI) is a new, exciting and unique
partnership between these two successful perinatal research entities, Perinatal
Ireland and the SFI funded INFANT centre in Cork and further solidifies the
existing collaboration and partnership between the seven largest academic
obstetrics units on the island.
56846 Rotunda Clinical Report 2015 26/10/16 v3_Clinical Rep  26/10/2016  15:50  Page 105
The HRB Mother and Baby CTNI have a well-established record in collaborative
research and in conducting large-scale, multicentre, randomised controlled trials.
The network builds on the complimentary world class expertise and strengths of
both INFANT and Perinatal Ireland with a core focus on conduct of clinical trials of
novel interventions and diagnostics in pregnancy and neonates. 
The initial work programme for the HRB Mother and Baby CTNI involves the
implementation of the PARROT RCT as the main network definitive intervention
clinical trial, as well as a suite of other pilot and feasibility studies including; TEST,
MINT and IRELAND. The CTNI will also launch a research programme in the area of
Clinical Trials Methodology and will launch a nationwide follow up programme for
the children who participate in these trials. The HRB Mother and Baby Clinical Trial
Network Ireland brings together leading Irish obstetric and neonatal researchers,
with an international reputation to address problems in women and children’s
health that will have a global impact. 
The overall vision of the networks is the following;
• To establish a world-class centre of excellence in perinatal medicine research
• To build an all-Ireland dedicated research capacity to conduct high-quality, 
patient-oriented clinical research
• To translate research findings into clinical practice to improve the health of 
women and children
• To develop collaborative, cross-disciplinary programmes to generate a self-
sustaining national and international research infrastructure
Current portfolio of network trials
PARROT - PARROT is a multi-centre stepped wedge RCT of a point of care (POC)
device to measure plasma PIGF (Placenta Growth Factor) in women who present
with suspected pre-eclampsia prior to 37 weeks gestation. 
TEST –  TEST is a pilot study to assess the effectiveness of routine prescription of Low
Dose Aspirin to low risk women in their first pregnancy versus women who were
prescribed aspirin on the basis of a positive early pregnancy screening test for pre-
eclampsia and fetal growth restriction
MINT – MINT is a pilot study to assess the feasibility of performing a pivotal trial to
obtain preliminary data to calculate a sample size for definitive multicentre trial of
milrinone therapy in new-borns with persistent pulmonary hypertension (PPHN).
IRELAND – IRELAND is a pilot study investigating the role of Aspirin in the
pregnancy outcome of women with pre-gestational diabetes.
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4.  RESEARCH PUBLICATIONS
A) Papers in Peer-Reviewed Journals:
• Corcoran S, Breathnach F, Burke G, McAuliffe F, Geary M, Daly S, Higgins J,
Hunter A, Morrison JJ, Higgins S, Mahony R, Dicker P, Tully E, Malone FD.
“Dichorionic Twin Ultrasound Surveillance: Sonography Every 4 Weeks
Significantly Underperforms Sonography Every 2 Weeks – Results of the
Prospective Multicenter ESPRiT Study.” American Journal of Obstetrics and
Gynecology 213:551.e1-5, 2015. 
• Boyle M, Lyons A, Ryan S, Malone F, Foran A. “Postnatal MRI in Infants Treated for
Twin-Twin Transfusion Syndrome.” Irish Medical Journal 108:240-243, 2015.
• Mullers SM, McAuliffe FM, Kent E, Carroll S, Mone F, Breslin N, Dalrymple J,
Mulcahy C, O’Donoghue K, Martin A, Malone FD. “Outcome Following Selective
Fetoscopic Laser Ablation for Twin to Twin Transfusion Syndrome: An 8 Year
National Collaborative Experience.” European Journal of Obstetrics
Gynecology and Reproductive Biology 191:125-129, 2015.
• Dempsey MA, Flood K, Burke N, Murray A, Cotter B, Mullers S, Dicker P, Fletcher P,
Geary M, Kenny D, Malone FD. “Platelet Function in Patients with a History of
Unexplained Recurrent Miscarriage who Subsequently Miscarry Again.” European
Journal of Obstetrics Gynecology and Reproductive Biology 188:61-65, 2015.
• Hirtz DG, Weiner SJ, Bulas D, DiPietro M, Seibert J, Rouse DJ, Mercer BM, Varner
MW, Reddy UM, Iams JD, Wapner RJ, Sorokin Y, Thorp JM, Ramin SM, Malone
FD, Carpenter MW, O’Sullivan MJ, Peaceman AM, Hankins GD, Dudley D, Caritis
SN. “Antenatal Magnesium and Cerebral Palsy in Preterm Infants.” Journal of
Pediatrics 167:834-839, 2015.
• Dempsey MA, Flood K, Burke N, Fletcher P, Kirkham C, Geary MP, Malone FD.
“Perinatal Outcomes of Women with a Prior History of Unexplained Recurrent
Miscarriage.” Journal of Maternal Fetal and Neonatal Medicine, 28:522-525, 2015.
• Hehir MP, Dalrymple J, Malone FD. “Decision-Support Guide and Use of
Prenatal Genetic Testing.” JAMA – Journal of the American Medical
Association 13:313, 2015. 
• Peaceman AM, Lai Y, Rouse DJ, Spong CY, Mercer BM, Varner MW, Thorp JM,
Ramin SM, Malone FD, O’Sullivan MJ, Hankins GD. “Length of Latency with
Preterm Premature Rupture of Membranes before 32 Weeks’ Gestation.”
American Journal of Perinatology 32:57-62, 2015.
• Unterscheider J, Dicker P, Malone FD. “The PORTO Study and the Importance of
the Cerebroplacental Ratio in Fetal Growth Restriction.” American Journal of
Obstetrics and Gynecology, 212:552, 2015.
• Horton AL, Lai Y, Rouse DJ, Spong CY, Leveno KJ, Varner MW, Mercer BM, Iams
JD, Wapner RJ, Sorokin Y, Thorp SM, Ramin SM, Malone FD, O’Sullivan MJ,
Hankins GD, Caritis SN. “Effect of Magnesium Sulfate Administration for
Neuroprotection on Latency in Women with Preterm Premature Rupture of
Membranes.” American Journal of Perinatology, 32:387-392, 2015.
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• Unterscheider J, O’Donoghue K, Malone FD. “Guidelines on Fetal Growth
Restriction: A Comparison of Recent National Publications.” American Journal
of Perinatology, 32:307-316, 2015.
• Haddow JE, Neveux LM, Palomaki GE, Lambert-Messerlian G, Malone FD,
D’Alton ME. “An Inverse Relationship Between Weight and Free Thyroxine
During Early Gestation Among Women Treated for Hypothyroidism. Thyroid
25:949-953, 2015.
• Varner MW, Marshall NE, Rouse DJ, Jablonski KA, Leveno KJ, Reddy UM, Mercer
BM, Iams JD, Wapner RJ, Sorokin Y, Thorp JM, Malone FD, Carpenter M,
O’Sullivan MJ, Peaceman AM, Hankins GD, Dudley DJ, Caritis SN. “The
Association of Cord Serum Cytokines with Neurodevelopmental Outcomes.”
American Journal of Perinatology, 30:115-122, 2015.
• Olson G, Weiner SJ, Rouse DJ, Reddy UM, Mercer BM, Varner MW, Leveno KJ,
Iams JD, Wapner RJ, Ramin SM, Malone FD, Carpenter MW, O’Sullivan MJ,
Dinsmoor MJ, Hankins GD, Caritis SN. “Relation Between Birth Weight and
Weight and Height at the Age of Two in Children Born Preterm.” American
Journal of Perinatology, 32:591-598, 2015.
• Murphy NC, Diviney MM, Donnelly JC, Cooley SM, Kirkham CH, Foran AM,
Breathnach FM, Malone FD, Geary MP. “The Effect of Maternal Subclinical
Hypothyroidism on IQ in 7 to 8 Year Old Children: A Case Control Review.”
Australia and New Zealand Journal of Obstetrics and Gynaecology, 55:459-463,
2015.
• Palatnik A, Mele L, Landon MB, Reddy UM, Ramin SM, Carpenter MW, et al.
“Timing of Treatment Initiation for Mild Gestational Diabetes Mellitus and
Perinatal Outcomes.” American Journal of Obstetrics and Gynecology
213:560.e1-8, 2015. 
• Borowski KS, Clark EA, Lai Y, Wapner RJ, Sorokin Y, Peaceman AM, et al.
“Neonatal Genetic Variation in Steroid Metabolism and Key Respiratory
Function Genes and Perinatal Outcomes in Single and Multiple Courses of
Corticosteroids.” American Journal of Perinatology 32:1126-1132, 2015.
• Stuebe AM, Landon MB, Lai Y, Klebanoff M, Ramin SM, Wapner RJ, et al. “Is
There a Threshold Oral Glucose Tolerance Test Value for Predicting Adverse
Pregnancy Outcome?” American Journal of Perinatology 32:833-838, 2015.
• Halling C, Malone FD, Breathnach FM, Stewart M, McAuliffe F, Morrison JJ,
Dicker P, Manning F, Corcoran JD. Neurodevelopmental outcome of a large
cohort of growth discordant twins. Eur J Pediatr (Accepted Sept 2015)
• Corcoran S, Breathnach FM. The early bird catches the worm: Predicting the
onset of gestational diabetes in the first trimester. J Matern Fetal Neonatal
Med 2014 Jul 11:1-2. PMID: 24920284 IF:1.311
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B) Abstracts in Peer-Reviewed Journals:
• Corcoran S, Breathnach F, Burke G, McAuliffe F, Geary M, Daly S, Higgins J,
Hunter A, Morrison J, Mahony R, Dicker P, Tully E, Malone F. “Dichorionic Twin
Ultrasound Surveillance – Four Weekly Significantly Underperforms Two
Weekly Ultrasound: Results of the Prospective Multicenter ESPRiT Study.”
American Journal of Obstetrics and Gynecology 212, S34-S35, 2015.
• Muellers S, Burke N, Cowman J, Kearney M, Flood K, O’Connor H, Dicker P, Tully E,
Geary M, Kenny D, Malone F. “Platelet Function in Intrauterine Growth Restriction:
Altered Platelet Behaviour as a Cause or a Consequence of Utero-Placental Disease.”
American Journal of Obstetrics and Gynecology 212, S125-S126, 2015.
• Corcoran S, Briggs K, O’Connor H, Muellers S, Monteith C, Donnelly J, Dicker P,
Franklin O, Malone F, Breathnach F. “Prenatal Detection of Congenital Heart
Disease.” American Journal of Obstetrics and Gynecology 212, S126, 2015.
• Corcoran S, Unterscheider J, Daly S, Geary M, Kennelly M, McAuliffe F,
O’Donoghue K, Hunter A, Morrison J, Burke G, Dicker P, Tully E, Malone F. “Fetal
Growth Restriction Co-existing with Gestational Diabetes – Impact on
Perinatal Outcome: Results of the Multicenter PORTO Study.” American Journal
of Obstetrics and Gynecology 212, S126-S127, 2015.
• Anglim B, Walsh J, Daly S, Unterscheider J, Geary M, O’Donoghue K, Kennelly
M, McAuliffe F, Hunter A, Morrison J, Burke G, Dicker P, Tully E, Malone F.
“Cardiovascular Doppler Assessments in IUGR: Are They Associated with
Adverse Perinatal Outcome? Results from the Multicenter Prospective PORTO
Trial.” American Journal of Obstetrics and Gynecology 212, S83, 2015.
• Kent E, Breathnach F, Burke G, McAuliffe F, Geary M, Daly S, Higgins J, Hunter A,
Morrison J, Higgins S, Mahony R, Dicker P, Manning F, Tully E, Malone F. “Perinatal
Outcome in Twins Discordant for Umbilical Arterial Doppler Abnormalities.”
American Journal of Obstetrics and Gynecology 212, S170-S171, 2015. 
• O’Connor H, Unterscheider J, Daly S, Geary M, Kennelly M, McAuliffe F,
O’Donoghue K, Hunter A, Morrison J, Burke G, Dicker P, Tully E, Malone F.
“Comparison of Asymmetric Versus Symmetric IUGR – Results from a National
Prospective Trial.” American Journal of Obstetrics and Gynecology 212, S173-
S174, 2015.
• Regan C, Unterscheider J, Daly S, Geary M, Kennelly M, McAuliffe F,
O’Donoghue K, Hunter A, Morrison J, Burke G, Dicker P, Tully E, Malone F. “The
Effect of Maternal Cigarette Smoking on Pregnancy Outcome in FGR.”
American Journal of Obstetrics and Gynecology 212, S377, 2015.
• Monteith C, Mullers S, Unterscheider J, Flood K, Breathnach F, Daly S, Geary M,
Kennelly M, McAuliffe F, O’Donoghue K, Hunter A, Morrison J, Burke G, Dicker
P, Tully E, Malone F. “Is a Normalizing Cerebro-Placental Ratio (CPR) a Potential
Predictor for Adverse Outcome in Intrauterine Growth Restriction: Results of
the Multicenter PORTO Study.” American Journal of Obstetrics and Gynecology
212, S308, 2015.
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• Hehir M, Breathnach F, McAuliffe F, Geary M, Daly S, Higgins J, Dornan  J,
Morrison J, Burke G, Higgins S, Dicker P, Mahony R, Malone F. “Gestational
Hypertensive Disease in Twin Pregnancy: Influence on Outcomes in a Large
National Prospective Cohort.” American Journal of Obstetrics and Gynecology
212, S257-S258, 2015.
• Hehir M, Unterscheider J, Daly S, Geary M, O’Donoghue K, Kennelly M,
McAuliffe F, Hunter A, Morrison J, Burke G, Dicker P, Tully E, Malone F. “The
Influence of Growth Restriction on Mode of Delivery: Results from a Multi-
Center Prospective Cohort.” American Journal of Obstetrics and Gynecology
212, S210-S211, 2015.
• Roche A, Mullers S, Monteith C, Kent E, Corcoran S, O’Connor HD, Flood K,
Cooley SM, Donnelly J, Dicker P, Foran A, McCallion N, Malone FD, Breathnach
F. “Customised Centiles for Trisomy 21: Presenting Prenatal Growth References
for Down Syndrome.” American Journal of Obstetrics and Gynecology 212,
S225-S226, 2015.
5. INVITED LECTURES
Prof. Fergal Malone
“HRB Perinatal Clinical Trial Network Ireland” – HRB Clinical Research Coordination
Ireland and Dublin Centre for Clinical Research, Joint Scientific Meeting, Dublin,
Ireland, November 2015 
Clinical Trials in the Perinatal Space - National Clinical Research Infrastructure
Showcase, Dublin, Ireland, November 2015
“Fetal Surgery for Twin-to-Twin Transfusion Syndrome” – King Hamad University
Hospital, Bahrain, November 2015
“Fetal Growth Restriction Management” – Advanced Course in Ultrasound and
Fetal Medicine, 352 Academy, Belfast, Northern Ireland, October 2015
“Fetoscopic Laser Ablation for Twin to Twin Transfusion Syndrome” – Institute of
Obstetricians and Gynaecologists, Annual Study Day, Dublin, Ireland, September
2015
“Doppler Ultrasound in the Management of Fetal Growth Restriction” – MDI
Ultrasound Annual Study Meeting, Straffan, Ireland, June 2015
“What Have We Learned from Perinatal Ireland” – 3rd Irish Congress of Obstetrics,
Gynaecology and Perinatal Medicine, Dublin, Ireland, May 2015
“Fetal Growth Restriction – Evidence from the PORTO Study” – National Institute of
Child Health and Human Development, Society for Maternal Fetal Medicine, and
American Congress of Obstetrics and Gynecology, Fetal Imaging Workshop –
Fetal Growth Restriction, Washington, DC, USA, April 2015
“Perinatal Ireland – Establishing a Clinical Research Network” – Health Research
Board of Ireland Grantholders Conference, Limerick, Ireland, February 2015
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DR FIONNUALA NÍ ÁINLE (DIRECTOR)
MR JOHN O’LOUGHLIN (LABORATORY MANAGER)
INTRODUCTION
The Department of Laboratory Medicine is staffed by dedicated and highly educated
professionals who are committed to providing a service of the highest quality that is
pro-active and responsive to the needs of the users of the service. Quality is of
paramount importance. These high standards are reflected in continuing
accreditation to International Organisation for Standardisation (ISO):15189
requirements across all departments. Individual departments continuously seek
opportunities to improve the care that we provide to our patients, responding to new
challenges and developments particularly in high-risk areas. 
During 2015, major initiatives were launched that will greatly benefit both our
patients and users. The microbiology department repatriated key serological tests
from the National Virus Reference Laboratory and commenced testing using of a
state of the art piece of equipment, “GeneXpert”, to enable rapid diagnosis of
Influenza and other dangerous microorganisms. The haematology/transfusion
department initiated capillary electrophoresis (replacing HPLC) for
haemoglobinopathy testing, the biochemistry department introduced testing for
the AMH hormone and introduced a new blood gas analyser to the neonatal
intensive care unit and the histopathology department commenced a new service in
Connolly Hospital, Blanchardstown.
Key awards and achievements included the recognition of an innovative initiative
led by haemovigilance officer, Ms Siobhan Ryan-Enright along with the neonatology
multidisciplinary team. Ms Enright represented the Rotunda Hospital at the HMI
leadership awards, presenting data from this project.
Finally, we are delighted to have been the first public medical testing laboratory in
Ireland to have gained accreditation for Flexible Scope (INAB)
The overall laboratory workload is reflected in Tables 1 and 2.
*Histology work is numbered by case. Each case can include multiple specimens
and blocks, requiring ≥1 stains of various complexity
D E PA R T M E N T  O F  L A B O R A T O R Y
M E D I C I N E
TABLE 1: TESTS PERFORMED IN-HOUSE IN 2015
Department Specimens/ Cases*
% Change
over 2013
Tests
/ Blocks*
% Change
over 2013
Haematology 57,889 -3.4 79,291 -0.6
Blood Group Serology 24,983 5.8 32,362 -9.1
Transfusion 8,891 -3 8,891 -3
Microbiology 42,334 -3.5 78,775 -3.6
Virology / Serology 14,071 2.49 57,651 73.9
Biochemistry 58,653 1.6 264,682 2
Histopathology 6,631 14 16,554 9
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TABLE 2: TESTS REFERRED TO OUTSIDE LABORATORIES IN 2015
Specimens % Changeover 2013 Tests
% Change
over 2013
Haematology 1,537 -3.4 1,537 -3.4
Biochemistry* 1,501 18.6 1,501 -18.6
Microbiology 1,656 -27 7,457 -5
Rubella/VZ/Syphilis 9,528 -2.25 9,889 -2.4
* Serology Confirmation and other specialized tests 
VZ: Varicella Zoster
QUALITY MANAGEMENT SYSTEM IN THE 
DEPARTMENT OF LABORATORY MEDICINE: 
Quality Manager: Ms Susan Luke
Deputy Quality Officer Ms Emily Forde*
Training Officer Mr. Ciaran Mooney* 
Health and Safety Officer Ms Aiveen O’Malley*
POCT Co-ordinator Ms Lorna Pentony*
LIMS Officer Ms Jane Halligan 
(*duties carried out in addition to departmental position)
The department of laboratory medicine maintained accreditation in 2015 across
all disciplines ensuring all processes are compliant with the required standards
and that these standards are continually maintained. The lab is accredited to ISO
15189 AND ISO 22870.
In 2015 the Rotunda laboratory became one of the first medical testing
laboratories to achieve accreditation for flexible scope, this allows the laboratory
to report tests as accredited without having to have an onsite assessment. This
can be utilised for some processes. This in turn provides a cost saving to the
laboratory as extra assessment can be financial burden on the budget.
The maintenance of the laboratory quality management system requires a
continuous active program to ensure achievement and compliance with the
required standards and quality of service the laboratory wishes to maintain.
This is achieved through documented procedures both testing, managerial and
day to day running of the laboratory being systematically reviewed. An audit
calendar is drawn up at the beginning of each year. In 2015 the laboratory
performed 90 audits (fig 1).
Figure 1
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The laboratory submitted an Annual Report for Blood Transfusion to the Health
protection Regulatory Agency (HPRA) formally the Irish Medicines Board (IMB).
This report documents the activity for the previous year and reports blood usage
and wastage, status of accreditation and informs of any planned future changes.
The report has been submitted for 2015. 
The QMS is embedded across the laboratory services and is dependent on all
those working in the laboratory. 
In 2015 the laboratory has endeavoured to reduce the paper trail and increase the
use of Q-pulse to manage the QMS. This is turn allows a robust tracking of
documentation to alert review dates, on-going tracking and trending of non-
conformances. 
In addition the use of Q-pulse to record and hold accurate and easily accessible
records of our suppliers, training records, contracts and SLA’s both historic and
live information. 
The laboratory has implemented a Risk Management System. The risk
Management System scores actual and potential risks to the department using
the HSE Risk Management Matrix. This utilizes Impact and Likelihood scores to
quantify risks that may affect the department. 
Risks are identified through a variety of methods but the most commonly used
method in the department is risks identified and quantified using process flow
analysis.  Each department maps each of its processes and documents the
processes using a Process Flow Diagram. Each critical process is identified and a
Failure Mode Effect Analysis (FMEA) is carried out to identify risks that may
result in a failure in the process. Each process is first discussed amongst staff in
the department and any potential failure modes are discussed and investigated.
This is essentially a brain storming session talking through any issues that may
pose a risk to the system. Also any actions that may alleviate the risk are
discussed and documented.  Each step is then scored using the Impact by
Likelihood scoring tool. We also add an additional score Detectability which
allows us to score and rank risks based on their risk Priority Number (RPN). The
RPN is calculated by multiplying Impact by Likelihood by Detectability (IxLxD).
This allows us to priorities risk and manage accordingly.
We are committed to providing a service of the highest quality and shall be
aware and take consideration of the needs and requirements of the users which
is reflected in our quality policy.
56846 Rotunda Clinical Report 2015 26/10/16 v3_Clinical Rep  26/10/2016  15:50  Page 113
HAEMATOLOGY and BLOOD TRANSFUSION:
Consultant: Dr Fionnuala Ní Áinle (Adult Haematology)
Dr Melanie Cotter (Paediatric Haematology)
Chief Medical Scientist: Ms. Deirdre Murphy 
Senior Medical Scientists: Mr Ciaran Mooney, 
Ms Deirdre O’Neill
Ms Emily Forde
Medical Scientists: Ms Liliana Rasidovic
Ms Edel Cussen (commenced a 3 year career 
break December 2013)
Ms Noreen Brady (commenced year career 
break in August 2015) 
Ms Aileen Carr (commenced maternity leave in 
March 2015), 
Ms Michelle Burns, 
Ms Deirdre Corcoran 
Ms Elaine O Leary (locum post; commenced 
June 2015) 
Ms Christine Clifford (Locum post commenced 
Sept 2015)
Laboratory Aide: Ms. Karen Fennelly
1. General Overview, and developments during 2015
The laboratory submits an Annual Report for Blood Transfusion to the Health
Products Regulatory Authority formally the Irish Medicines Board (IMB). This report
documents the activity for the previous year and reports blood usage and wastage,
status of accreditation and informs of any planned future changes. The report has
been submitted for 2015. The annual report for Blood Transfusion for 2014 was
submitted to the Irish Medicines Board (IMB). This was satisfactory and no visit was
deemed necessary
The Haematology laboratory validated and introduced a capillary electrophoresis
method for the diagnosis of Haemoglobinopathies in adult and newborn patients.
This new technology was awarded INAB accreditation in October 2015
2. Training and development initiatives
Since 2012 the department in conjunction with Dublin Institute of Technology,
Kevin Street, has provided third year in-service training for Medical laboratory
Science Degree students. Blood Transfusion laboratory in service training was
again provided in 2015. 
The department provides training of non routine staff for the on call service. The
department of laboratory medicine has introduced monthly multi disciplinary
case review where interesting cases from each department are reviewed.    
114
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3. In-house workload (Table 3)
A recent review of Rotunda Hospital guidelines for investigation of acquired and
inherited Thrombophilia has resulted in testing being performed in line with
international guidelines and best practice. Numbers are consistent with
previous year 2014 when the new guidelines were implemented 
Table 3: Haematology in-house workload
Test Name 2014 Change 2013
Full blood count 42,468 -3.0 43,779
Manual differential 1,811 -4.0 1,886
Manual Platelet count 9 N/A 12
Reticulocyte count 456 N/A 460
Coag Profile 
(PT, APTT, Fibrinogen) 2,662 -12.5 3,043
Lupus anticoagulant 175 +6.7 164
Kleihauer1 457 -6.0 488
Haemoglobinopathy 3,143 +10.0 2,847
Malaria 16 N/A 15
Thrombophilia 53 10.4 48
Total tests 57,889 -3.4 59,909
1 Kleihauer tests performed on post-delivery patient samples for confirmation of
flow cytometry results are not included.
Table 4: Variations in testing in 2015 compared with 2014.
(NOTE: Some tests with small numbers have been removed as these differences
are not statistically significant)
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TABLE 5: COMMON HAEMATOLOGY REFERRED TESTS
% CHANGE
TEST TESTS OVER 2014
Anti Cardiolipin/  2 Glycoprotein 279 1
Thrombophilia (referred component) 152 5
Haemoglobinopathy confirmation 121 -15
Lymphocyte subsets 108 -0.9
Factor Assays 24 -23
Cytogenetics 415 -16.16
Molecular Genetics/Microarray 108 20
YDNA 39 -19
Genetic Antenatal screening 154 15
ESR 30 N/A
D-Dimer 19 N/A
Anti-Xa assay 10 N/A
Factor V Leiden 9 N/A
Anti-D  quantitation 69 -33
Total Referred tests 1537 -3.4
TABLE 6: BLOOD GROUP SEROLOGY WORKLOAD  
Test Name 2015 % Change 2013
(Most Common Tests)
ABO Group 24,233 -9 26,630
Rhesus (Rh) Group 24,233 -9 26.63
Antibody Screen 17,876 -1.9 18,218
Direct Coomb’s Test 3,607 -16.8 4,335
Antibody Identification panel 605 13.7 532
Phenotype 831 70.6 487
Rh D antibody screen 1,518 -1.7 1,545
Antibody Titre 96 -6.8 103
Antibody Elution 48 -21.3 61
Weak/Partial RhD Typing 44 -30.2 63
Flow Cytometry 701 -10.6 784
Total tests 32,362 -9.1 35,582
4. Referred workload (Table 5 )
CG: cytogenetics; PCR: polymerase chain reaction; ESR: Erythrocyte
sedimentation rate
5. Blood Group Serology (Tables 6 and 7)
A decrease in Blood Grouping was observed as consequence of a fall in activity
during 2015. The introduction of the two sample rule in 2013 is now embedded for
issue of group specific blood products for both adult and paediatric patients..The
increase in phenotyping is a combination of patient phenotyping as part of
antibody investigation /exclusions and increase in blood stock typing in an
effort to reduce the phenotyped blood stock ordered from the IBTS.  
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TABLE 7: DETAILS OF RED BLOOD CELL ALLOANTIBODIES DETECTED 
Antibody Number Antibody Number
D 2 Anti-H ( Bombay) 1
E 8 Fya 2
C + D 4 M 22
Cw 3 M+E 1
c +/- E 6 M+ Undefined specificity 1
D+C+ Auto 1 N + Chido Rodgers 1
Fya + E 1 S 3
e+/-C 2 s 2
K 3 Anti-S + Jkb 1
Undefined specificity 10 Anti-Lua 1
Le a+b 3 Anti-Lea +C 1
Lea 10 Lua 1
Leb 2 Cr1 related 1
antibody
Auto Anti-E + undefined 
specificity 1 Autoagglutinin 2
Total: 97
6. Blood transfusion
There continues to be modest decrease in the number of patients transfused
overall. Another increase in the cross-match to transfusion ratio was observed in
2015 (Table 8), reflecting perhaps the complexity of the patient population and a
change in the grading of placenta praevia. The MBOS is due for review in the
coming year and with the introduction of new clinical guidelines for
crossmatching in this patient cohort we hope to reduce the crossmatch
transfusion ratio. Blood wastage remains low, but the shortage of an O RhD
negative blood supply in the IBTS on a couple occasions did impact on this. It is
hoped that a reduction in the C:T ratio will aid in reducing this as well. 
Novo seven was used for one paediatric patient transferred from another
hospital for a case of Neonatal Haemochromatosis.
Blood was imported from the UK for one adult patient of the Oh Bombay blood
group, as no suitable blood was available in the Irish donor population. This
blood was not required for the patient and was later returned to the IBTS where
it can be utilized in the investigation of antibodies to high incidence antigens
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TABLE 8: BLOOD TRANSFUSION WORKLOAD  
Test 2015 Change 2014
Group and save 7691 1.6 7573
Crossmatch 1200 -24.9 1599
Patients crossmatched 512 -9.3 565
Red Cell Units transfused 424 -38 684
Patients Transfused 191 -43.8 340
Crossmatch: transfusion ratio 2.7:1 1.7:1
IUT (red cell units) 9 N/A 15
Pedipack units transfused 118 N/A 119
Transfused Components 2015 Change 2014
Plasma (adult) 67 66
Plasma (paediatric) 21 25
Platelets (adult) 7 18
Platelets (paediatric) 38 39
Fibrinogen (adult) 70 18.6 57
Fibrinogen (paediatric) 19 -51.3 39
Novoseven 3* 1 patient 0
Anti-D 2901 2729
Wastage: 2015 Change 2014
Red cell (concentrated) 4.50% 2.60%
Platelets 6.45% 0%
Plasma 16.50% 18.50%
7. Haemovigilance 
The haemovigilance officer (HVO) continues to provide extensive education on
the process of blood transfusion to clinical staff. During 2015, 230 Nurses,
Midwives and Student Midwives and 84 non-consultant hospital doctors
attended Haemovigilance Education.
Once again, a very high standard was maintained in haemovigilance, with 100%
traceability of all blood components issued.
In 2015 1.7% of mother who delivered babies > 500g required a blood transfusion,
the most common indication for blood transfusion in the Obstetric setting
remains post-partum haemorrhage.  In 2014 there was an initiative to reduce
administration of 2 units of red Cells to 1 unit where appropriate this led to a 20%
reduction for 2015( Post-natal Transfusions- 80% received 2 units , 20% 1 unit) we
hope this trend continues.
There has been an overall reduction in neonatal transfusion – this has mainly
been achieved through the work of multi-disciplinary team. The most
significant changes have been in reduction of donor exposure of babies <1000g
from a mean of 2 donors to a mean of 1 donor. The incidence of transfusion for
babies > 1500g has decreased by 50% over the last 5 years.
The Rotunda Hospital Haemovigilance Department maintains close links with
the National Haemovigilance Office (NHO) with the continuing aim of
maintaining quality of care through regular audit and education.
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The HVO reports serious adverse events (SAE) and Serious Adverse Reactions to
the NHO. Three SAEs and One SAR were reported to the NHO during 2015, there
were no adverse outcomes for patients. SAE’s pertained to delayed and missed
administration of Anti-D immunoglobulin. The recently revised clinical pathway
managing patients who require Anti-D for prevention of RhD sensitization
continues to be under review, and specific SAE numbers related to this process
remain low as a consequence, compared with previous years.
Implementation of a programme of RAADP administration to RhD negative
women was launched in July 2013. Audit and evaluation of the system is ongoing
through the Rotunda Hospital multidisciplinary RAADP committee.
In 2015 a total of 1124patients received RAADP - average 21 patients are receiving
Anti-D per week. 
CLINICAL MICROBIOLOGY
Consultant: Microbiologist Dr. Richard Drew   
Specialist Registrar: N/A
Associate Paediatric Specialist in
Infectious Diseases: Dr Wendy Ferguson
Chief Medical Scientist: Mr David Le Blanc 
Senior Medical Scientists: Ms Niamh Cahill
Mr Haydn Hammerton 
Medical Scientists: Ms Ita Cahill (0.5)
Ms Patricia Baynes
Ms Ann Lamont (0.5)
Ms Bernadette Lennon (0.5)
Ms Ellen Lennon (0.5)
Ms Gemma Tyrrell.
Laboratory Aides: Ms Grainne McDonald
Mr Tom Murphy 
Assistant Director of 
Midwifery/Nursing in
Infection Prevention and Control: Ms Marian Brennan
Infection Prevention and 
Control Midwife: Ms Alva Fitzgibbon
Infectious Diseases Liaison Midwife: Ms Mairead Lawless
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TABLE 9: OVERALL MICROBIOLOGY WORKLOAD IN 2015 COMPARED WITH 2014
2015 % Change
Tests Specimens Tests Specimens
Testing in-house
General Microbiology 78775 42334 -3.62 -3.45
Virology/Serology 57651 14071 73.91 2.49
Total tested in-house 136426 56405 18.75 -2.03
Referred
Syphilis Screening 9889 9528 -2.25 -2.43
Confirmation and other 
specialist tests referred 
externally 7457 1656 -4.82 -27.08
Total Referred 18340 12539 -53.47 -48.59
GENERAL MICROBIOLOGY WORKLOAD
The activity and complexity of the Microbiology workload and that of the Neonatal
Unit, contributed significantly to continuing high workload (summarised in Table
9 and detailed in Table 19). 
Overall, the workload was slightly down (4%) on 2014, which can be reflected in the
reduction of admissions and general reduction in hospital activity. The total swab
numbers were down by 2.78% with screens down by a total of 5.81%. Total urine
samples for culture and sensitivity were also down by 7%. Pregnancy testing
continues to decline in the laboratory as this procedure is generally tested at the
patient bedside. The laboratory continues to supply, control and maintain the
pregnancy sticks supplied to the wards. CSF numbers were down significantly by
33% on 2014 and blood culture numbers also dropped by 6% on 2014. Sample
numbers from the Mortuary increased in 2015 and continue to rise as the
department expands. Specimens for testing for Chlamydia trachomatis PCR were
up (7%), with a similar rise in testing for Neisseria gonorrhoea. New PCR testing was
introduced on the GeneXpert for C. difficile, Influenza and MRSA/SA on positive
blood cultures. In total 274 tests were performed on the GeneXpert, which although
may cost the department financially, it is the wards that benefit from the rapid (2
hour) turnaround time for these tests. 
The department continues to enjoy full accreditation (ISO: 15189) in Serology,
Andrology and General Bacteriology and was again inspected in 2015, with all non-
conformities raised cleared within the 1 month time frame. As a result of continued
quality control within the department IQA samples were slightly up by 7.64% on 2014. 
SURVEILLANCE SCREENING
In line with best practice and in the interests of patient safety, screening for multi-
drug resistant organisms (MDROs) including MRSA, VRE, ESBLs and CRE in
identifiable ‘at risk’ groups in adults and neonates continued in 2015.
2015 saw continued surveillance screening for the entire hospital and improved
reporting of figures to hospital committees. This included figures for adult &
paediatric blood cultures and screening of the NICU for resistant Coliforms, VRE,
pseudomonas and MRSA. All these figures are presented at the NICU and infection
control meetings, which take place quarterly.
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Also presented at these meetings are any infection clusters (Influenza, Norovirus or
C. difficile), EARSS data and resistance patterns on various antibiotics.
Surveillance of the adult blood cultures saw a continuation of contamination
among the positive blood cultures (2.89%), which is down on 2014 and most
significantly is <3%. This is the first time since rates have been measured that it fell
below 3%. Contamination rates among the neonatal patients continues to be <3%.
Data sharing between the other two Dublin maternity hospitals continued in 2015
and has proved very useful when collating data.
The Laboratory works as part of a multi-disciplinary team and provides the
surveillance data to the Neonatal Infection Prevention and Control group, which
helped to enable the group to identify changes and practices, which were required
in order to reduce the incidence of contaminated samples and healthcare
associated infection (HCAI). 
During 2015 the rectal screening of the NICU yielded 4 Gentamicin resistant
Coliforms, 24 AmpC producing Coliforms, 4 ESBL producing Coliforms and 7
Pseudomonas spp. There were no CRE isolates in 2015. These figures are consistent
with 2014.
Screening for MRSA continued, yielding a total of 20 positive patient results in 2015,
2 of which were in the NICU. These results are similar to previous years and the
Rotunda continues to enjoy low rates of MRSA among patients due to its policy of
‘seek and destroy’. 
Quarterly reporting of EARS organisms continued in 2015 and results were as
follows. 20 E. coli, 1 Ent. feacalis, 1 S. aureus (MRSA), 1 Kleb. Pneumonia, 0 Ps.
Aeruginosa, 1 Group A streptococcus and no Ent. feacium or S. pneumoniae. There
was no case of invasive infection with multiple antimicrobial resistant Gram-
negative bacilli in the Neonatal Unit throughout 2014 and this continued in 2015.
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TABLE 10: CLINICAL MICROBIOLOGY WORKLOAD IN 2015 COMPARED WITH 2014
SPECIMEN TYPES AND TEST NUMBERS
Specimens 2015 % Difference over 2014
Urine 19571 -7.09
Swabs 9134 -2.78
CSF 157 -33.19
Blood Cultures 2786 -6.32
GeneXpert Total 274 Not tested in 2014
Mortuary 211 21.97
Semen 2220 14.97
Pregnancy Tests 64 -47.11
Screening 4264 -5.81
Chlamydia trachomatis/
N. gonorrhoea PCR 2765 7.30
IQA 888 7.64
Total specimens 42334 -3.45
Tests
Urines 31217 -8.31
Swabs 18268 -2.78
CSF 490 -35.19
Blood Cultures 2786 -6.32
Mortuary 211 21.97
MRSA Screen 4090 -2.94
Rectal Screen 6657 -8.31
Semen 5319 14.04
Antimicrobial Cards 2597 -4.28
Pregnancy Tests 64 -47.11
Chlamydia trachomatis 2765 7.3
Neisseria gonorrhoea 2765 7.34
GeneXpertMRSA/BA 196 Not tested in 2014
GeneXpertC. diff 132 Not tested in 2014
GeneXpertInfluenza 330 Not tested in 2014
IQA 888 7.64
Total Tests 78775 -3.62
VIROLOGY/SEROLOGY WORKLOAD
The virology/serology for the Rotunda IVF Clinic continues to be performed in the
virology/serology section of the Microbiology laboratory and is down by roughly
10%. Under the EU Tissue Directive, it is a legal requirement that this testing can be
only performed in a laboratory that is fully accredited to ISO. The laboratory was
again inspected by INAB in 2015, and continues to enjoy ISO: 15189 Accreditation. 
The number of antenatal booking bloods tested is similar with the number for
2014; however the overall in-house virology testing has increased dramatically on
2014. Overall virology testing is up by 74% for virology tests and 2.49% for virology
samples. This is mainly due to the fact that the Serology department is now
performing virology tests for Med-Lab pathology, generating valuable revenue for 
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the laboratory. Also, the department repatriated both VZV IgG and Rubella IgG
testing from the NVRL, which was cost neutral. CMV IgG testing is down by 10.19%,
which reflects a drop in Rotunda IVF blood testing. The number of specimens
referred for testing at outside laboratories is down (49%) and tests are down by
54%, reflecting the increase in on-site testing. 
Validation began in late 2015 for Syphilis (TPE) testing on the Abbott Architect and
has been fully operational since January 2016. Syphilis screening is expected to be
assessed for ISO:15189 accreditation in April of 2016. Money was sourced from the
HSE to perform these tests and so there is no cost to the hospital. In addition,
Biomerieux provided a free upgrade of the mini-vidas analyser in order to carry out
confirmatory testing for Rubella IgG, VZ IgG and Hep B core. This allows the
department to report all tests in a timely manner and prevents unnecessary and
time-consuming dispatch of confirmatory testing.  The addition of all these tests
in-house is of great benefit to the Hospital and more importantly the patient.  A full
detail of Virology/Serology testing is represented in Tables 11 &12
TABLE 11: VIROLOGY/SEROLOGY WORKLOAD (TESTS), 2015
Tested in-house 2015 % Change over 2014
HIV 12637 5.34
HbsAg 12707 6.21
Hepatitis B Core 3432 33.18
HepC Antibody 6312 22.4
CMV IgG 1304 -10.19
Rubella IgG 10353 -1.29 (Performed in NVRL)
VZV IgG 9324 -1.48 (Performed in NVRL)
Rubella IgG - vidas 776 Performed in NVRL
Hep B core - vidas 175 Performed in NVRL
VZ IgG - vidas 631 Performed in NVRL
Total 57651 73.91
Specimens Referred 
Syphilis Screening SJH
TPE 9528 -2.43
RPR 147 0.68
TPEM 68 15.25
TPPA 146 -0.68
Sub Total 9889 -2.25
NVRL & others
Confirmation and other specialist 
tests referred externally (MA) -34.39 994
Other Referred tests (ME) 7457 -4.82
Total referred 18340 -53.47
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ACCREDITATION WORKLOAD
Work involved in continuation of the ISO: 15189 2012 standards continue to be both
challenging and time consuming. Batch acceptance (Internal Quality Assurance) of
all reagents, media, antibiotics and kits continues to be an important part of the
weekly management of the department. It is an essential part of providing a
quality service and Internal Quality Assessment increased in 2015; however this
does not capture all the work involved. A lot of IQA performed, in particular on
analysers, is not captured on the LIMS but is stored on either hard copy or soft copy. 
Accreditation also involves updating standard operating procedures (SOPs) on a
continual basis, keeping a close eye on what is international best practice. Methods
and procedures are forever evolving, requiring validation or verification of new test
methods. New media and/or reagents/kits come on-stream from time to time and
again require validation or verification before they can be employed.
Continual training for non-microbiology on-call staff and either new staff
members or returning staff members form long-term leave is always a
challenge. Proficiency testing and competency testing is an important part of a
scientist training log. The Microbiology department continues to strive towards
international excellence and to this end has ISO: 15189 for nearly 100% of its
repertoire of tests.
ANDROLOGY WORKLOAD
Semen analysis for Infertility tests and Post vasectomy testing continued into 2015
and was fully accredited to ISO: 15189 in late 2015. The SQA-V Gold instrument for
analysing Semen was replaced with more up-to-date and user friendly software.
This computer assisted semen analysis (CASA) has reduced the cost of performing
semen for infertility significantly making it cost neutral. Semen analysis for
infertility is by appointment only on the days Monday through Wednesday from
9am to 1pm and a maximum of 10 appointments are made for each morning and
as a medical scientist is specifically assigned to carry out the duties; this adds
pressure to the rest of the department. Sample numbers for infertility were up
significantly in 2015 (11%), with overall numbers for semen analysis up by 15%,
reflecting an increase in samples for post vasectomy testing. These samples are
less time consuming and do not require immediate testing and therefore can be
batched together allowing better use of the scientist time. All Andrology testing
provides valuable income for the laboratory and it is hoped that in 2016 the
repertoire of tests can be increased and the service expanded. It is vital that a
room be found within the hospital to allow patients to produce samples on-site as
Semen for infertility should ideally be tested within 1 hour of been produced.
CHANGES IN LABORATORY EQUIPMENT AND TESTING PROCEDURES
Computer Assisted Semen Analysis (CASA)
Replacement of the SQA-V Gold instrument, for the analysis of semen for
infertility with a new, state-of-the-art software package. The sperminator uses a
combination of video clips from a mounted camera on a microscope to track
sperm for motility and perform a sperm count, allowing for an accurate analysis
of the patients sample.
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VITEK MS
VITEK MS is a bacterial and fungal identification system, which uses the matrix-
assisted laser desorption/ionisation (MALDI) mass spectrometry. It is a rapid
method for microorganism identification from clinical cultures. The VITEK MS
analyses material from microbial cultures to provide organism identification. The
VITEK MS was purchased for the department by the HSE in December 2015 and
won’t be fully operational until early 2016. It will revolutionise the way in which
the department currently identifies microorganisms. At present it takes at least 24
hours to identify many bacteria and yeast, which can be costly. The VITEK MS, will
identify bacteria and yeast in a matter of minutes at a fraction of the cost and so
ultimately will reduce laboratory costs and have significant impact on patient
management. The VITEK MS has huge potential for research and development and
it is envisaged to purchase the research module for the instrument in 2016.
VITEK MS comes with software (MYLA) allowing all the Biomerieux analyzers to be
connected to this one high tech software package. The VITEK MS, VITEK 2 Compact
and BacTAlert 3D instruments can all be interfaced through this software package,
reducing the high costs of analyser interfacing. MYLA can be accessed remotely,
allowing easy access to patient results and releasing to the LIMS in a timely manner.
GeneXpert
The GeneXpert was fully operational in 2015 and was also fully accredited to ISO:
15189, for Influenza, C. difficile and MRSA/SA (Positive Blood Cultures). These tests
are now offered 24 hours a day, 7 days a week and significantly improve the
management of patients and particularly that of turnaround times. The
GeneXpert is a valuable asset to the department and it is hoped to expand the
repertoire of tests in 2016, particularly in the area of Group B streptococcus in
patients with PPROM.  Currently the Rotunda offer C. difficile testing to the
Children’s University Hospital Temple Street and in return they analyse our stool
samples for routine culture and sensitivity. 
Mini-Vidas
An audit was performed on repeat testing for VZV IgG and Rubella IgG on the
mini-vidas and the number of repeat tests has dropped significantly allowing for
prompt patient results and significant reduction in cost.
Liaison
The liaison was interfaced in 2015 with the LIMS reducing the time spent
entering results manually onto the APEX computer system. This has eliminated
the likelihood of transcription errors and significantly improved the scientist’s
workload, allowing for better time spent elsewhere. Also, the work performed on
the Liaison was streamlined making it more efficient and cost productive. 
Clusters of unusual infection and investigation of these outbreaks
MRSA
There were no clusters of MRSA in 2015
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Figure 2:
Influenza & Norovirus
Influenza and Norovirus continue to be a challenge for hospital staff and patients
throughout the country. Luckily there were no major clusters of either within the
Rotunda. There were no reported cases of Norovirus for Rotunda patients in 2015.
There was a total of 13 Positive Influenza A (3 of which were H1N1) and 13
Influenza B in 2015. Quarter 1 and Quarter 4 remain the busiest times for
influenza, when national numbers are at their peak. 
Clostridium difficile
There were no cases of C. difficile for Rotunda patients in 2015.
Pseudomonas aeruginosa
There was 7 Pseudomonas aeruginosa isolated from the NICU in 2015. This was a
slight increase from 2014. Screening continues using the latest Chromogenic ID
agar to help in the identification of Pseudomonas aeruginosa & improve TAT.
The laboratory remains vigilant to identify any isolates in clinical specimens
from the NICU and the situation is being kept under review.
Resistant Gram Negative Bacilli
Figure 3
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TABLE 12:  SEROLOGY TESTING
2015 Tests 2014 Tests Difference Nos % Change 
VZV IgG 9324 9464 -140 -1.48
VZVR 631 3 628
Total VZ IgG 9955 9467 488 5.15
Rubella IgG 10353 10488 -135 -1.29
RUBGVR 776 0 776
Rubella IgG 11129 10488 641 6.11
Confirmatory & misc tests 994 1515 -521 -34.39
Total NVRL tests (MA) 994 21467 -20473 -95.37
TPE 9528 9765 -237 -2.43
RPR 147 146 1 0.68
TPPA 146 147 -1 -0.68
TPEM 68 59 9 15.25
Total TP (SJH) 9889 10117 -228 -2.25
Tested In-House
HIV 12637 11996 641 5.34
Hep B 12707 11964 743 6.21
Hep B core 3432 2577 855 33.18
Hep C 6312 5157 1155 22.4
CMV 1304 1452 -148 -10.19
HBCVR 175 1 174
Total  36567 33147 3420 10.32
Total Serology In-House 57651 33150 24501 73.91
Total Samples In-House 14071 13729 342 2.49
Total Tests on MA samples 68534 64734 3800 5.87
Referred Tests (ME) 7457 7835 -378 -4.82
Referred Specimens (ME) 1656 2271 -615 -27.08
Total Referred Tests 18340 39419 -21079 -53.47
Total Referred Specimens 12539 24391 -11852 -48.59
Total Tests 75991 72569 3422 4.72
Total Specimens 26610 38120 -11510 -30.19
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TABLE 13: MICROBIOLOGY TESTING
2015                           2014                     Difference               % 
numbers Change
Tests Specimens Tests Specimens Tests Specimens Tests Specimens
MSU
Microscopy’s 11413 12749 -1336 -10.48
MSU Culture 11450 12793 -1343 -10.5
Total MSU 22863 11450 25542 12793 -2679 -1343 -10.49 -10.5
First visit 8354 8121 8504 8271 -150 -150 -1.76 -1.81
Total Urine 31217 19571 34046 21064 -2829 -1493 -8.31 -7.09
Pregnancy 
Tests 64 64 121 121 -57 -57 -47.11 -47.11
Blood 
Culture (sets) 2786 2786 2974 2974 -188 -188 -6.32 -6.32
Mortuary 
samples 211 211 173 173 38 38 21.97 21.97
GeneXpert 
Influenza 330 110 3 1 327 109
GeneXpert 
C. diff 132 66 2 1 130 65
GeneXpert 
MRSA/SA 196 98 44 22 152 76
Total 
GeneXpert 658 274 49 24 609 250
CSF Culture 157 235
CSF Gram 153 230
CSF Cell 
Count 152 233
CSF Diff 28 58
Total CSF 490 157 756 235 -266 -78 -35.19 -33.19
Semen 
Volume 2220 1931 289 14.97
Semen 
Count 2207 1928 279 14.47
Semen 
Motility 876 789 87 11.03
Semen 
Morphology 16 16 0 100
Total Semen 5319 2220 4664 1931 655 289 14.04 14.97
CT PCR 2765 2577 188 7.3
NG PCR 2765 2576 189 7.34
Total PCR 5530 2765 5153 2577 377 188 7.32 7.3
IQA 888 888 825 825 63 63 7.64 7.64
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2015                           2014                     Difference               % 
numbers Change
Tests Specimens Tests Specimens Tests Specimens Tests Specimens
MRSA 4090 2045 4214 2107 -124 -62 -2.94 -2.94
Rectal 6657 2219 7260 2420 -603 -201 -8.31 -8.31
Total Screens 10747 4264 11474 4527 -727 -263 -6.34 -5.81
Swabs 18268 9134 18790 9395 -522 -261 -2.78 -2.78
Antimicrobial
Susceptibilities 2597 2713 -116 -4.28
Total 78775 42334 81738 43846 -2963 -1512 -3.62 -3.45
PUBLICATIONS:
• RJ Drew, P Stapleton, H Abu, E Healy, W Ferguson, C DeGascun, J O’Gorman,
M Eogan. Pregnancy Outcomes of mothers with detectable CMV-specific 
IgM antibodies: A three year review in a large Irish Tertiary Referral 
Maternity Hospital. Infectious Diseases in Obstetrics and Gynecology
2015: 218080
• M Meehan, M Cafferkey, S Corcoran, A Foran, N Hapnes, D LeBlanc, C 
McGuinness, U Nusgen, N O’Sullivan, R Cunney, RJ Drew. Real-time 
polymerase chain reaction and culture in the diagnosis of invasive group 
B Streptococcal disease in infants: a retrospective study. European Journal
of Clinical Microbiology and Infectious Diseases 2015; 34: 2413-2420.
• RJ Drew, Z Fonseca-Kelly, M Eogan. A retrospective audit of clinically 
significant maternal bacteraemia in a specialist maternity hospital from 
2001 to 2014. Infectious Diseases in Obstetrics and Gynecology 2015: 518562
• AD Irwin, RJ Drew, P Marshall, K Nguyen, E Hoyle, KA MacFarlane, 
HF Wong, E Mekonnen, M Hicks, T Steele, C Gerrard, F Hardiman, 
PS McNamara, PJ Diggle, ED Carrol. Etiology of childhood bacteraemia and
timely antibiotics administration in the Emergency Department. 
Pediatrics2015; 135(4): 635-642.
• RJ Drew, TS Cole, W Newman. How to use... eye swabs. Archives of Diseases
of Childhood Education and Practice 2015; 100(3): 155-161.
• RJ Drew, EE Ormandy, K Ball, SE Lambert, S Paulus, NJ Williams, 
NA Cunliffe. Antimicrobial susceptibility patterns among Extended 
spectrum beta-lactamase producing Enterobacteriaceae in a large 
paediatric hospital in United Kingdom. Journal of the Pediatric Infectious 
Diseases Society 2015 4(4): 147-150.
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BIOCHEMISTRY:
Consultant: Prof Philip D Mayne
Chief Medical Scientist: Ms Gráinne Kelleher
Senior Medical Scientist: Ms Sharon Campbell
Medical Scientists: Ms Lorna Pentony
Ms Miriam Blesa
Clinical Scientist: Ms Aiveen O’Malley
Laboratory Assistants: Mr Paul Reilly
1. General Overview, and developments during 2015
During 2015, the Biochemistry department continued to provide an extensive
repertoire of investigations required for the care of women and infants, with
participation in the relevant External Quality Assessment programmes.
2. Staffing
Both Sharon Campbell and Miriam Blesa returned from Maternity leave in
November.  Stephanie Lynch, a long term locum was appointed to a Medical
Scientist post at Temple Street Children’s University Hospital.
3. In-house workload 
The total number of Biochemistry tests requested during 2015, comparing test for
test increased by 1.6%, offsetting the decrease of 0.5 % in 2014. This increase was
partially due to the inclusion of creatinine measurement in the renal profile.
However, there was a general increase of approximately 1.0% in routine
biochemistry testing.
The repertoire of tests performed in-house did increase due to the repatriation of a
number of relatively high and low volume tests.  These included AMH, Bile acids,
blood lactate, γ-glutamyltransferase (GGT) , LDH and CK.  These will all be included
in the scope for INAB accreditation in 2016.
Twenty percent of the investigations were performed ‘On Call’ with 40% of these
coming from NICU and the Emergency Room.  There was an overall 12% increase in
the number of requests for CRP but this increase rose sequentially through the
year. Over a third of these requests were performed ‘On Call’ and this is likely to
further increase during 2016 with the roll out of the septic work-up.
4. Referred workload 
Table 1 shows that there was an 18% increase in the amount of samples referred
to external laboratories for analysis, comparing like for like.  However, there was
an overall 47% reduction in the total number of samples referred as a number of
tests were repatriated back into the laboratory.  These included AMH, Bile acids,
CK, lactate, LDH and GGT. This resulted in a significant cost saving to the hospital
and an improvement in the turnaround time to resulting.  This was only possible
as we were able to maintain the current staffing levels and partially cover
maternity leave with locums.
In late 2015, the Hospital entered a service level agreement with Temple Street to
refer all hypoglycaemic work-ups.  This has significantly reduced the time around
time for the completion of this investigation from over a week to less than 24 hours,
greatly improving the management of babies presenting with hypoglycaemia.
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TABLE 14: Referral Workload in 2015 compared with 2014
Test 2014 2015 Difference % Difference
17OH Progesterone (Adult) 10 15 5 50
25(OH)Vitamin D 76 133 57 75
Acylcarnitine Profile 43 48 5 11.6
Alpha Feto-Protein (Adult) 21 20 -1 -4.8
Ammonia 53 67 14 26.4
Androstenedione 49 47 -2 -4.1
Blood Amino acids 73 74 1 1.4
CA 19-9 60 86 26 43.3
CEA 64 89 25 39.1
Cortisol (Adult) 24 16 -8 -33.3
DHEAS 20 27 7 35
Free T3 14 57 43 307.1
Insulin/C-Peptide 56 116 60 107.1
Iron 21 40 19 90.5
Lamotrigine 24 32 8 33.3
Phenobarbitone (Paediatric) 44 35 -9 -20.5
Primark Test 17 1 -16 -94.1
PTH (Adult) 33 38 5 15.2
PTH (Paediatric) 13 23 10 76.9
Thyroid Receptor Ab (TRAb) 172 162 -10 -5.8
Tissue TransglutaminaseAb 13 15 2 15.4
Tri-iodoThyronine (T3) 27 15 -12 -44.4
Troponin- I 1 8 7 85.7
Troponin-T 57 22 -35 -61.4
Urine Drug screen 167 169 2 1.2
Urine Organic acids 87 116 29 33.3
Zopiclone (Urine) 27 30 3 11.1
Total 1266 1501 235 18.6
56846 Rotunda Clinical Report 2015 26/10/16 v3_Clinical Rep  26/10/2016  15:51  Page 131
HISTOPATHOLOGY DEPARTMENT
STAFF
Consultants: Dr. Deirdre Devaney, 
Dr Eibhlis O’Donovan, 
Dr Emma Doyle
Locum Consultant: Dr Sean O’Briain
Chief Medical Scientist: Colma Barnes
Senior Medical Scientist: Ms Phil Bateson, 
Medical Scientists: Ms Aderanti Morenigbade, 
Mr Michael Smith, 
Ms Tokiko Kumasaka, 
Ms Miriam Hurley
Lorna Thomas
Laboratory Aide Fiona Minogue
Mortuary Manager Bill O Neill
Anatomical Technician Martin Fitzpatrick
PERINATAL PATHOLOGY
The perinatal autopsy service in 2015 was similar to the previous year (90 cases
compared to 97 cases in 2014). Turnaround times (TATs) for these cases remained in
line with previous years in that the majority of cases were reported within the
recommended 8 weeks allowing the clinicians to interface with grieving parents in
a timely fashion. In conjunction with this, there were no organs retained in 2014.
A full autopsy includes external examination, radiology, cytogenetics and
internal examination of all three body cavities (Chest, abdomen and cranium) in
conjunction with placental examination.  Limited autopsy examinations are in
keeping with the wishes of the parents, as expressed on the consent form eg,
external examination and cytogenetics only or examination of a single body
cavity – as in a case of a known congenital heart disease, the family may only
wish to have the chest cavity opened. We endeavour to examine all placentas
associated with fetal demise, as in a large number of cases the placenta will reveal
a significant pathology which may be the cause of death.
90 cases had some form of autopsy examination in 2015(39>500g and 51<500g)
leading to overall autopsy rate (AR) of 43% (39+51=90 / 209 cases through
mortuary) in comparison to 37.6% in 2014 and 47.2% in 2013. The AR (Full, limited
and coroners cases) for >500g was 43%(39/90) which is slightly less than last year
(46.9%).The AR for the <500g was 40% (full and limited – 51/128) which is slightly
higher than last year (33%).  When reviewing this figure we must remember that
40/128 weighed 10g or less and were not suitable for autopsy examination. If we
were to exclude cases less than 10g we would have an autopsy rate of 58% in the
<500g category. Our overall autopsy rate takes into account some external
transfers and late neonatal deaths. 
The AR for the Rotunda cases (perinatal mortality figures) is 46.5% (33/71cases)
which is in keeping with last year (45.7%) and may reflect the continued
improvements in antenatal diagnostic imaging with amniocentesis confirming
congenital malformations.
132
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There were 8 limited examinations (3 in the >500g group and 5 in the <500g
group).This is in comparison to 5 and 8 last year respectively. We performed 9 post
mortems for the Coroner over the period, 4 of which were for outside cases (i.e. not
included in the Rotunda figures). One of these cases was performed with the
assistance of the State Pathology Department.  This is similar to the figure of8 last year.
As mentioned above, it is our policy to examine the placenta on all cases of
perinatal deaths. There were 71> 500g, 70 of these cases had placental
examination. In the case that had no placental examination, the baby had an
uneventful birth and was discharged well on day 5. She died in the community on
day 6 of life and a coroner’s case was performed.
Tulip Classification of Perinatal Mortality:
This is a Dutch Classification system that separates cause and mechanism of
perinatal mortality for the purposes of counselling and prevention.  The goal of
the system was to identify an unambiguous single cause system aiming to
identify the initial demonstrable pathophysiological entity initiating the chain of
events that irreversibly led to death based on a combination of clinical findings
and diagnostic tests including pathological findings. The causes of death are
stratified into 6 major categories:
1. Congenital Anomaly
2. Placenta
3. Prematurity / Immaturity
4. Infection
5. Other
6. Unknown
Cause of Death: (perinatal figures Rotunda only  > 500g)
We have used a modified version of the Tulip classification to classify our causes
of death.
Congenital Malformation 29 (40.8%)
Placental causes: 20 (28.1%)
Cord 7
Parenchyma 13
Prematurity / Immaturity 4 (5.7%)
Infection 8 (11.3%)
Other 4 (5.6%)
Unexplained 6 (8.5%)
The 29 congenital malformations included 13 babies with chromosomal
abnormalities (5 had trisomy 18, 3 had Trisomy 21, 2 had Trisomy 13, 2 had
Monosomy X (Turners Syndrome) and 1 had an abnormal chromosome 7 and
13).There were 3 babies with congenital diaphragmatic hernias. There were 3
babies with skeletal dysplasia (1 osteogenesis imperfect, 1 thanatophoric
dysplasia and 1 camptomelicdysplasia ).3 babies were born with genitourinary
tract abnormalities (1 bladder outlet obstruction, 1 renal agenesis and 1 multicystic
renal dysplasia). There were 2 babies born with neural tube defects (1 with
anencephaly and 1 with a lumbosacral spina bifida with an Arnold Chiari
malformation). And there was one baby born with a hypoplastic left heart, one
baby with an omphalocoele, one baby with a congenital arthrogryposis and a
baby born with Cornelia de Lange. One baby was born with non immune hydrops.
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In the placental category, there were 20 deaths attributed to placental pathology.
These included 7 cord accidents,  4 cases of Twin to Twin transfusion syndrome, 3
cases of a fetal thrombotic vasculopathy,3 cases of chronic uteroplacental
insufficiency, 2 cases of retroplacental haemorrhage and a single case of villitis of
unknown aetiology.
8 deaths were attributed to infection. Of these cases, 6 were stillbirths and 2 were
neonatal deaths.  7 of these were due to ascending infection. Three of these cases
cultured BHS group B at post mortem (2 stillbirths and 1 neonatal death). One case
cultured diptheroids and three of these cases had negative cultures at post
mortem but there was histological evidence of ascending infection with a fetal
response (i.e. umbilical vessel vasculitis +/- a congenital pneumonia). In our use
of the Tulip classification we have modified this category – if we were to adhere
to the strict classification guidelines, these 3 cases would be relegated to the
unexplained category despite the fact there is histological evidence of infection.
There was one case of transplacental infection by CMV.
There were 4 neonates who were assigned to the prematurity category.
The miscellaneous category included 4 cases.  One case of massive fetomaternal
haemorrhage. One case of a ruptured uterus.One case of an intrauterine vascular
accident leading to bilateral schizencephaly and arthrogryposis and a case of
sudden unexplained death in infancy.
There were 6 cases that had no identifiable cause of death giving an unexplained
rate of 8.5%( in comparison to 10% last year).Only one of these cases did not have
post mortem examination but had a comprehensive examination of the placenta.
Cause of Death (<500g)
128 cases:
Congenital Malformation: 10 (7.8%)
Placental: 33 (25.8%)
Cord: 8
Parenchyma 25
Infection: 22(17.2%)
Unexplained: 63 (49.2%)
This cohort shows a much lower rate of congenital malformation with ascending
infection and placental categories as the most prominent cause of death. The high
unexplained rate reflects the fact that a significant number of these cases only
had a placental examination (i.e. did not consent to a full post mortem
examination and also reflects the small size of the foetuses (0.5 grams –
499grams) with 40 (31%) of these cases being 10grams or less.
Placental Examination:
The placental work load was modified in 2012. During the year we introduced a
triage system for placental examination following The Royal College of
Pathologists Guidelines. A protocol detailing which placentas should be examined
is available on the Labour ward and includes the examination of placentas from
babies admitted to the NICU, from all mothers with pyrexia, PPROM,  PET,
gestational diabetes mellitus, multiple gestations and as alluded to earlier,  all cases
of stillbirths and neonatal deaths. These placentas are sent to the laboratory and are
then stratified into two groups. Group One placentas are those that require both 134
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gross and histological examination. Whereas Group Two placentas are those cases
that gross examination only is deemed as sufficient. Should the clinician
specifically require a microscopic examination of these cases, it is available on
request.1500 placentas were referred to the laboratory for examination in 2015. 548
(36.5%) fulfilled the criteria for gross examination only. The remaining 952 had both
macroscopic and microscopic examination.  The introduction of this triage system
has been very beneficial in that it has succeeded in reducing the histology workload
of placental examination by approximately one third, affording us extra time to
devote to the cases that require a more detailed examination.  Placental
examination continues to reflect a significant workload for the department.
The following Tables indicate the number of autopsies (full, limited, and Coroner’s)
performed in 2015.
*This table includes 4 autopsies from infants born in another institution (1 stillbirth
and 3 early NNDs) which are not included in the Rotunda figures.
TABLE 15: AUTOPSY WORKLOAD >500GRAMS
Full
Postmortem 
Limited
Postmortem
Coroners
case Total
Stillbirths 21 2 1 24
Early Neonatal deaths 5 1 8 14
Late Neonatal deaths 1 0 0 1
Total 27 3 9 39
Outside cases* 0 0 4 4 
% of Total PMs 30% 3% 10% 43%
TABLE 16: AUTOPSY WORKLOAD <500GRAMS
Full
Postmortem
Limited Post
mortem
Coroners
case Total
No. of PMs 46 5 0 51
% of Total PMs 51% 6% 0 57%
TABLE 17: ROTUNDA PERINATAL MORTALITY FIGURES: 2015 (0-7 DAYS)
No
examination
Limited
examination
Full Post
Mortem
Coroners
Cases Total
Stillbirths 20 2 21 1 44
Early Neonatal deaths 18 1 4 4 27
Total 38 3 25 5 71
TABLE 19:  LLETZ & COLPOSCOPIC BIOPSY GRADING 2015
CASES CIN1/HPV
Dysplasia
/NOS
CIN
2
CIN
3
CGIN/AIS
/Adenoca
SCC incl
microinvasion Neg Insufficient Total
LLETZ 72 0 83 196 9 5 15 0 380
COLCBX 676 9 325 297 4 3 124 31 1469
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TABLE 18:  ANALYSIS OF THE SURGICAL PATHOLOGY WORKLOAD 
FROM 2010-2015
Surgical Pathology:
136
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SUMMARY OF KEY ACHIEVEMENTS DURING 2015
There was one episode of MRSA Bacteraemia
There were two episodes of Clostridium Difficile Infection in the hospital.
There were no outbreaks in the NICU affecting 4 infants
The IPC Team reviewed the outstanding actions from the review of  the HIQA
standards for prevention and control of healthcare associated infections done in 2014
and incorporated these quality improvement plans into their service plan for 2015
The IPC Team continues to work with the neonatal team  to reduce infection
The IPC team continues to support and appreciate the role of the IPC Link
midwife/nurse, as providers of local training and education and local auditors. 
The IPC Team have worked with the Quality Manager, Support Services Manager and
Household Manager to monitor standards of cleanliness throughout the hospital
The IPC Team have significantly supported major capital developments that have
improved patient experience.
The IPC team have incorporated new national guidance on MRSA Screening into IPC
Policy.
The IPC team helped with the roll out of the electronic “track and trace “ system for
reusable invasive medical devices(RIMDs)
SERVICE OVERVIEW
The vision of this service is to provide an environment in which our patients can receive
safe and effective care, in the knowledge that appropriate measures have been put in
place to minimise the risk of healthcare associated infections (HCAIs). We aim to put the
woman, her child and their family at the centre of everything that we do. We can put
this in place by ensuring that:
• The facilities in which care is received are kept in a manner to prevent HCAIs
• Staff are educated with respect to key elements of infection control practice 
• A robust and effective Infection Prevention and Control team (IPCT)  is in place to
assist staff in managing and preventing HCAIs
• The Health Information and Quality Authority (HIQA) National Standards for
the Prevention and Control of Health Care Associated Infections 2009 are
embedded into the culture of the organisation and act as a structure on which to
base our continual improvement in IPC. 
I N F E C T I O N  P R E V E N T I O N  A N D  C O N T R O L
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The Team
During 2015 the Infection prevention and Control Team (IPCT) has undergone
further change. Ms Anu Binu joined the team in a .5WTE position of IPC Midwife
incorporating the role of Decontamination Coordinator.
The IPCT is represented at the following Hospital Committees
• Hygiene Committee
• Quality and Safety 
• Procurement
• All Departmental Patient Safety Meetings
• Clinical Midwife Managers Meetings
• Drugs and Therapeutics
• Building Planning
Role of the Infection Prevention and Control Team
The following roles are undertaken by the IPC Team:-
➢ Education
➢ Surveillance of hospital infection
➢ Investigation and control of outbreaks
➢ Development of Infection Prevention and Control policies
➢ Implementation and monitoring of Infection Prevention and Control policies
➢ Audit
➢ Assessment of new items of equipment
➢ Assessment and input into service development and buildings / estate works
➢ Reference source for hospital personnel
QUALITY INITIATIVES
HIQA Standards 
The HIQA PCHAI standards were reviewed and form the basis of the Service Plan
and the reports for the Infection Prevention and Control Committee.
In June 2015 an unannounced inspection by HIQA was undertaken on the Lillie
Suite. The inspectors also revisited the areas they had inspected in 2014 to assess
if the quality improvements necessary identified last year had been addressed. 
The inspection  focused on:
1. Hand hygiene compliance, and the systems in place in the hospital to 
suppport good practice with hand hygiene
2. The cleanliness of the environment and equipment.
3. The effectiveness in implementation and monitoring in use of infection 
prevention care bundles. 
The IPC team assisted in developing the Quality Improvement Plan to address
non conformances identified.
Education
The IPCT has provided 23 general training sessions. There were also hand hygiene
training sessions held at lunch time monthly from March 2015, plus 2 hand
hygiene awareness days with training for all staff.138
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Monthly in service education programmes for midwifery  nursing and care
assistant staff were undertaken by the IPCT in collaboration with others
including the Occupational Health Nurse and the Infectious Diseases Liaison
Midwife. 
This includes presentations on hand hygiene and all the standard and
transmission based precautions
The IPCT also give education to all staff at induction.
Mandatory training every two years in hand hygiene is a requirement for all
staff.  Although the majority of this education is given directly by the Infection
Prevention and Control Midwives  link staff also provide this training in their
own departments. Staff are also encouraged to use the HSELanD hand hygiene e
learning tool and the SureWash machine.
Reports of staff who have received hand hygiene education are returned to the
HSE monthly. 
• % of healthcare staff with patient contact  that have received mandatory 
induction hand hygiene training.
Guidelines
The IPCT team have incorporated new national guidance on MRSA screening and
management of affected patients into IPC policy. Other policies and guidelines (10
in total) due for renewal were reviewed and updated by the Team
Environmental and Hand Hygiene Audits
The IPCT with the link midwife/nurses carried out 52 audits on the
decontamination of medical equipment. The average score ranged from 84% to
98%. The target is 90%.
Hand Hygiene audits were carried out in all areas. In total 30 audits were
recorded. Audits done in May and October were returned to the HSE and
published as part of the National Hand Hygiene Audit. The results of these
audits continue to improve on previous years and achieve the HSE target.
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MAY-11 78.60%
OCT-11 86.70%
MAY-12 83.30%
OCT-12 86.10%
MAY-13 87.60%
OCT-13 89%
MAY-14 91.40%
OCT-14 91.90%
MAY-15 92.80%
OCT-15 90%
SERVICE DEVELOPMENTS
Infection Prevention and Control Committee
The IPC Committee meets quarterly and is chaired by the Master of the Rotunda.
Terms of reference of the committee were reviewed. The Committee receives
regular reports on infection prevention and control activities from clinical and
non-clinical departments.
The IPC team (IPCT) report quarterly to IPC Committee (IPCC)
Throughout the year many changes in practice have been initiated, facilitated,
supported or demanded through the work of the IPCT and IPCC.
The following detail some of the changes facilitated throughout the year.
• Introducing the electronic “track and trace system” for reusable invasive 
devices throughout the hospital.
• The introduction of rapid influenza PCR testing using the GeneXpert platform.
• Production of a revised MRSA screening policy  which incorporates national 
guidelines 
• Development of a quality improvement plan to address issues from the HIQA 
inspection
PRIORITIES FOR 2016
• Revision of the water policy to incorporate the new national guidelines.
• Production of antimicrobial consumption at a sufficient frequency to inform 
clinical practice
• Incorporate new national guidelines on hand hygiene into local policy
• Carry out gap analysis on National Guidelines for MRSA and C Difficile.
• Set up surveillance for deep incisional and organ space infections
• Carry out surveillance on women with  antenatal and postnatal pyelonephritis 
• Continue to address any outstanding issues on the quality improvement plan to 
rectify issues outlined at the HIQA inspection.
140
56846 Rotunda Clinical Report 2015 26/10/16 v3_Clinical Rep  26/10/2016  15:51  Page 140
141
CONSULTANTS:
PROF. FERGAL MALONE DR. CAROLE BARRY
DR. FIONNUALA BREATHNACH DR. SHARON COOLEY
DR. RONAN GLEESON DR. BARRY GAUGHAN
DR. JENNIFER DONNELLY DR. KAREN FLOOD  
MATERNAL FETAL MEDICINE FELLOW:
DR. JENNY WALSH DR. HALA ABU SUBEIH
MIDWIFE SONOGRAPHERS:
IRENE TWOMEY CMS DEIRDRE NOLAN CMS
GEMMA OWENS CMS (PENDING) ALLYSON LAWLESS
HILDA O’KEEFFE (Perinatal Ireland Research Sonographer)
SUZANNE GILLEN (from December)
RADIOGRAPHERS:
MABEL BOGERABATYO
FIONA CODY (Perinatal Ireland Research Sonographer)
FETAL MEDICINE MIDWIVES:
NOLLAIG KELLIHER CMM2 JANE DALRYMPLE CMS
JOAN O’BEIRNES CMM2 LAURA MCBRIDE S/M
MARY DEERING CMM3  Antenatal Inpatients, Day Services, Incorp. Fetal Medicine
MEDICAL SOCIAL WORKER:
DEIRDRE KEEGAN SINEAD DEVITT
ADMINISTRATION
ANITA O’REILLY SUZANNE LARKIN MARY MAGUIRE
2015 was another busy year in the Ultrasound, Fetal Assessment (FAU) and
Prenatal Diagnosis (PND) clinics. 
The core ultrasound services in The Rotunda Hospital in 2015 were provided by
midwife sonographers Irene Twomey, Deirdre Nolan, Gemma Owens, Allyson
Lawless, Laura McBride, Hilda O’Keeffe and radiographers Mabel Bogerabatyo,
and Fiona Cody. Once again their dedication, hard work and commitment are
recognised and appreciated. All patients are offered a departmental fetal
anatomic survey at 20 weeks. Serial scanning services were provided for patients
attending the Diabetes, Twin and Medical Clinics, as well as for patients with
fetal growth restriction or fetal abnormalities. Non routine or emergency
ultrasound requisitions are accommodated in addition to the scheduled
workload.  
U LT R A S O U N D, F E TA L  A S S E S S M E N T  &
P R E N ATA L D I AG N O S I S  C L I N I C S
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DEVELOPMENTS IN 2015
• S/M Laura McBride commenced her Masters in Ultrasound.
• S/M Suzanne Gillen commenced as trainee sonographer in December
• Prof. Fionnuala Breathnach and Dr. Orla Franklin commenced a Combined 
Fetal Cardiac Clinic in the FAU in July.
NUMBER OF OBSTETRIC SCANS
20 Week Scan Fetal Anatomic Survey 8,499
Growth Scan 8,472
Echocardiogram  322   
Others 1,388
NUMBER OF GYNAECOLOGICAL SCANS 1,663
Total 20,344  
PRENATAL DIAGNOSIS CLINIC
In 2015 1,290 new patients attended for Prenatal Diagnosis.  Drs. Barry, Breathnach,
Cooley, Donnelly, Flood and Prof. Malone with CMS Jane Dalrymple, CMM2 Nollaig
Kelliher, S/M Joan O’Beirnes and S/M Laura McBride operated 8 clinics per week.
There were 3,089 attendances as some patients were followed longitudinally. All
patients had an ultrasound scan.  In addition the following tests were performed:
Combined First Trimester Screening 416
Non Invasive Prenatal Testing (Cell Free Fetal DNA) 651
Amniocentesis 114
Chorionic Villus Sampling 80
Of the 194 diagnostic procedures performed, there were 63 abnormal results
representing 32.5% of invasive tests.
Abnormality CVS Amnio Total
Trisomy 21 13 7 20
Trisomy 18 8 8 16
Trisomy 13 0 3 3
45X 3 1 4  
Triploidy 2 2 4
Mosaic 2 3 5
Translocation 0 1 1
Deletion 0 1 1
Di George 0 1 1
Sickle Cell 1 0 1
Klienfelter 0 1 1
Pallister Killian 0 1 1
Inversion 0 1 1
SMA 1 0 1
Cystic Fibrosis 1 0 1
RYR1 Mutation 0 1 1
Smith Lemi Opitz 1 0 1
Total 32 31 63
Failed Culture 2 0 2142
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Note: Six patients with positive NIPT results declined invasive testing but the
following results were confirmed postnatally:
Trisomy 21 4
Klienfelters 1
Trisomy X 1
There was 1 false positive for T13 on NIPT which was a normal result on CVS .
Twenty seven invasive procedures other than amniocentesis or CVS were
performed. These included: 
Intrauterine Transfusion 8
Laser Ablation  19
Total 27
Dublin Fetal Surgery Group:
Since 2010, the fetal surgical teams at the National Maternity Hospital Dublin, and the
Rotunda Hospital Dublin have collaborated jointly for the management of all cases of
twin-to-twin transfusion syndrome referred to either centre. This has resulted in a
single team approach to all such cases, regardless of which of the two hospital
locations at which such patients are seen. Dr Stephen Carroll, Professor Fionnuala
McAuliffe and Professor Fergal Malone jointly perform all such procedures.
During 2015, a total of 19 cases of severe TTTS were managed by the Dublin Fetal
Surgery Group by means of fetoscopic laser ablation of placental vessels. By the end
of 2015, our group had completed 136 cases of laser surgery for severe TTTS, with at
least one survivor occurring in 82% of cases (112/136). These results are in line with
international published experience for this complex condition and our results have
been recently published (Outcome following selective fetoscopic laser ablation for
twin to twin transfusion syndrome: an eight year national collaborative experience.
Eur J Obstet Gynecol Reprod Biol. 2015 Aug;191:125-9).
This approach to a complex, but relatively rare, fetal problem is an excellent example
of a joint collaborative management strategy that successfully optimises care for
these patients. Patients are currently referred from obstetric units throughout Ireland
for fetoscopic laser ablation and, where appropriate expertise is available, patients
are referred back to their original obstetric centre for subsequent fetal surveillance
and delivery. It is hoped that, as referral pathways become more established, the
number of cases of fetoscopic laser ablation will increase further.
Major Fetal Structural Abnormality:
Excluding soft markers and chromosomal abnormalities, 209 cases of major
structural abnormalities were detected and followed. These include:-
Abnormalities detected based on RCOG/RCR Classification
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CNS (excluding choroid plexus cyst) 32
Head & Neck  (including hygromata) 27
Cardiovascular system (excluding echogenic foci and 
untreated arrhythmias) 43
Renal (excluding pelvic dilatation of<10mm) 48
Renal (excluding pelvic dilatation of<10mm) 48
Abdominal contents  (Including anterior abdominal 
wall defects and excluding echogenic bowel) 17
Skeletal 24
Thoracic (excluding cardiac abnormalities) 16
Others 2
Total 209
Targeted fetal echocardiograms were performed in women deemed high risk
according to a specific departmental protocol or where a routine structural scan
was suspicious for a cardiac abnormality.  Prof. Fionnuala Breathnach performed
the majority of fetal echocardiograms. A total of 322 targeted fetal
echocardiograms were performed within the Department in 2015. 
Where fetal congenital heart disease was identified or suspected, women were
seen at our Combined Fetal Cardiology clinic which commenced in the Rotunda
Hospital in July 2015, staffed by Consultant Paediatric Cardiologist Dr. Orla Franklin
and Prof. Fionnuala Breathnach.  
Structural Lesions
Hypoplastic Left Heart 6
Hypoplastic Right Heart 4
Complete AVSD 3
Transposition of the Great Arteries 4
VSD 7
Coarctation 1
Tetralogy of Fallot 1
Aortic Stenosis 1
Left SVC to coronary sinus 1
Total 28
Arrhythmia
SVT 1
This is a diagnostic clinic with 60 dedicated fetal cardiac scans performed in 45
pregnancies.  Most women who attend the service have already been screened
by a sub-specialist fetal medicine obstetrician in the hospital. 
As such 28/45 (62%) of presenting women had a major cardiac structural defect
identified that required surgical intervention in the postnatal period. 
In 5 additional pregnancies major extra-cardiac structural lesions all of which
required postnatal surgical intervention were identified. 
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Multiple Pregnancy:
Dr Ronan Gleeson runs the weekly twin clinic which is conducted as part of the
Team D antenatal clinic. Both mono and dichorionic twins are managed in this
antenatal clinic. Twins that are considered to be higher risk –eg. monochorionic
twins that develop complications are usually referred for management to the
Fetal Medicine Unit. Higher order multiples are usually managed in the FAU.
Eighty one multiple pregnancies were referred to the Prenatal Diagnosis Clinic
in particular high risk circumstances.  These included:
Multiple Pregnancy
Monoamniotic Twins 2
Structural Anomaly 1
Normal Outcome 1
MCDA Twin Pregnancies 57
TTTS 13
Discordant growth 24 
Structural anomaly 1
Normal Outcome 19
Dichorionic Twin Pregnancies 12
Discordant growth 7
Structural Anomaly 4
Normal Outcome 1
MCTA Triplet Pregnancies 1
DCTA Triplet Pregnancies  6 
Discordant Growth 2
Structural Abnormality 1
Normal Outcome 3
TCTA Triplet Pregnancies 2
Structural Abnormality 1
Normal Outcome 1
Quadruplet Pregnancies 1
Total 81
MCDA = Monochorionic Diamniotic;  MCTA = Monochorionic Triamniotic;  
DCTA = Dichorionic Triamniotic;                TCTA = Trichorionic Triamniotic
Additional Cases Followed in Prenatal Diagnosis Clinic:
PPROM 1st & 2nd Trimester 5
IUGR (Severe 2nd trimester) 48
Polyhydramnios 13
Oligohydramnios/Anhydramnios 2
Antibodies/Rhesus 20
CMV 2
Soft Marker Normal Outcome 13
High Risk Screen Normal Outcome 13
Total 116
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DR GERALDINE CONNOLLY DEBORAH BROWN RM
Antenatal care is provided to all teenage pregnant mothers up to age 17 in the
Rotunda hospital in the teenage pregnancy clinic.  Girls who are older and
deemed vulnerable, such as those with special needs, also attend the clinic as we
feel they may benefit from continuity of care. Comparative figures for the past 9
years for the clinic are presented.
Number booked
2007 120
2008 132
2009 145
2010 116
2011 124
2012 110
2013 112
2014 119
2015 104
Primiparous Multiparous
2007 113 7
2008 123 9
2009 131 6
2010 109 7
2011 115 9
2012 100 10
2013 98 14
2014 101 18
2015 91 10
Onset of Labour
Spontaneous % Induction %
2007 72 26
2008 70 30
2009 68 30
2010 69 27
2011 66 24
2012 68 31
2013 66 33
2014 68 30
2015 70 27
Mode of Delivery %
SVD Instrumental C Section C section 
Emergency No labour
2007 64.7 20.7 12 2.6
2008 59.8 28.8 11.4 0
2009 64.2 23.3 10.9 1.6
2010 58.4 19.7 17.9 3.7
2011 63.6 20 10.9 5.5
2012 61.1 21.3 15.5 1.9
2013 62 23 15 1
2014 56 27 16 1
2015 63.6 29.5 4.5 2.2
T E E N A G E  P R E G N A N C Y  C L I N I C
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Epidural rates %
2007 78.5
2008 71
2009 74.4
2010 66.3
2011 68
2012 66
2013 72
2014 73
2015 75
Premature delivery % low birth wt %
2007 5.8 3.3
2008 7.8 6.8
2009 7.6 6.5
2010 4.7 2.8
2011 7.3 9.1
2012 2.9 4.8
2013 2 3
2014 2.6 3.7
2015 6.3 5.7
Chlamydia positive (%) Third degree tear (n)
2007 15 1
2008 6.4 1
2009 16 3
2010 12.2 3
2011 9.6 3
2012 14.1 2
2013 9.6 4
2014 4.3 1
2015 9.18 2
Adverse baby outcome (n)
intrauterine neonatal
2007 0 1
2008 1 0
2009 2 2
2010 0 1
2011 0 2
2012 0 1
2013 0 0
2014 1 0
2015 3 1
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Attendance at
Antenatal Classes % Postnatal Clinic (%)
2007 52 50
2008 66 67
2009 55 37
2010 48 48
2011 54 41
2012 45 55
2013 40 49
2014 45 51
2015 50 50
Comment
The caesarean section rate in the teenage population is 6.7%.  Our induction rate
was 28% and 4% of these had an emergency caesarean section.
One patient had monochorionic twins who delivered at 20 weeks gestation. One
pregnancy ended with an intrauterine death at 24 weeks gestation. There was a
neonatal death of a baby born at 23+5 weeks gestation 3 weeks post delivery 
Seventy one percent of attendees at the clinic were Irish. Roma patients
contributed to 11.5% of the total attending the clinic and 13.5% of patients were
from other ethnic groups.
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DR. JOHN SHEEHAN, UCD Associate Clinical Professor 
and Consultant in Perinatal Psychiatry
MS. KATHLEEN O’DONOHOE, Mental Health Support Midwife
MS. URSULA NAGLE, Mental Health Support Midwife
The mental health service at the Rotunda is a multidisciplinary service
run by a part-time consultant psychiatrist and 1.5 WTE support midwives.
Pre-pregnancy counselling is offered as well as assessment and
management of perinatal mental health problems. As well as their
clinical duties, the midwives act as a resource for information and advice
and offer a telephone consultation service mainly to mothers, GP’s and
Public Health Nurses. 
In 2015, 1599 women reported a positive history of mental health
problems at their booking visit.  135 new patients were seen by Dr.
Sheehan as well as 200 review/follow-up patients.  The support midwives
saw 335 new patients in the Health Promotion Clinic and 251 patients for
follow-up.  On the wards, the support midwives saw 1676 mothers and
saw 236 for follow-up. 
In July, Dr. Yvette Giblin, SpR in Psychiatry, started a special interest
session with Dr. Sheehan in order to gain experience in perinatal
psychiatry.  She commenced an audit on the prevalence of antidepressant
use in pregnant women attending the Rotunda.
Two research projects commenced in 2015.  As part of her TCD Doctorate
in Clinical Psychology,  Ms. Aifric O’Kane began a study on “Exploring the
effects of metacognitive processes on the development and maintenance
of postnatal depression”.   Ms. Janet Malone, as part of her TCD Masters in
Counselling Psychology, started a study on “the impact of maternal
postnatal depression on men’s experiences of fathering and fatherhood”.
Both studies were facilitated by the Rotunda Perinatal mental health
service.
With regards to on-going education, the support midwives provided
educational sessions to Rotunda staff on the use of the Edinburgh
Postnatal Depression Scale.  Prof. Sheehan provided lectures to UCD
medical students and midwifery students and chaired the weekly
educational Continuing Professional Development meetings. 
M E N T A L  H E A L T H  S E R V I C E S
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DR FIONNUALA BREATHNACH Consultant Obstetrician, 
Maternal-Fetal Medicine Specialist
DR MARIA BYRNE Consultant Endocrinologist
DR SIOBHAN BACON Specialist Registrar, Endocrinology
DR NAJIA SIDDIQUE Research Registrar, Endocrinology
DR SIOBHAN CORCORAN Research Registrar, Obstetrics & 
Gynaecology
MS JACKIE EDWARDS CMM Specialist Diabetes Midwife
MS AILEEN FLEMING Specialist Diabetes Midwife
MS CLAIRE KEARNEY Specialist Diabetes Midwife
MS LAURA HARRINGTON Senior Dietician
MS AILBHE MCCARTHY CNM1 Research
INTRODUCTION:
The Combined Obstetric Endocrine service for care of women with Diabetes
Mellitus continues to represent one of the highest-risk areas of clinical care in
this hospital. The population with pregestational type II diabetes now exceeds
that with type I disease, and the extent to which each subgroup with diabetes
(type I, type II and gestational diabetes) contributes to the population whose
prenatal care is conducted through this clinic is illustrated in Figure 1:
FIGURE 1: WOMEN WITH PREGNANCIES COMPLICATED 
BY DIABETES AT THE ROTUNDA 2007 - 2015
C O M B I N E D  O B S T E T R I C - E N D O C R I N E
S E R V I C E  F O R  D I A B E T E S  M E L L I T U S
The exponential increase in our Gestational Diabetes population observed in 2014
as a consequence of the transition in February 2014 from the 100g 3-hour
screening test to the IADPSG-endorsed 75g 2-hour Oral Glucose tolerance test with
its accompanying lower thresholds for GDM diagnosis, was sustained for 2015.
The International Association of Diabetes in Pregnancy Study Group (IADPSG) 150
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does not apply the term Impaired Glucose Tolerance (IGT) in pregnancy, and thus
any deviation from threshold norms constitutes a diagnosis of GDM. Therefore, an
IGT category is not considered to represent a distinct entity for this year’s report.
In recent years, recognition of the expanding numbers in the GDM/ IGT category,
and of the high-risk nature of our group with pre-existing diabetes, led to a
decision in 2012 to establish a new model of care for this service. This model
involves monitoring and surveillance for diet-controlled GDM in a midwifery-
led service, with obstetric care for these women being provided through routine
antenatal clinics. Attendance at the Combined Obstetric Endocrine clinic is only
required for women with pregestational diabetes (type I or type II) or with
gestational diabetes who require therapy beyond diet. Women with a history of
gestational diabetes in a prior pregnancy attend the midwifery-led unit for
regular surveillance from the first trimester of pregnancy; again with transfer to
the Combined Obstetric Endocrine service only in the event that gestational
diabetes is confirmed and is not adequately responding to dietary therapy.
TREATMENT FOR GESTATIONAL DIABETES:
We are hopeful in the future that resources may be provided to allow the women
with more minor degrees of carbohydrate intolerance to avail of tailored
specialist dietetic consultation and self-glucose monitoring in pregnancy, which
is widely recognised as representing the optimal standard in pursuit of
glycaemic control. Unfortunately in 2013 the HSE withdrew temporary long-term
illness card coverage for the diagnosis of gestational diabetes, such that women
who develop GDM and require insulin must now self-fund insulin, glucometers
and glucose-strips. These costs render the condition unaffordable for a large
proportion of our patient population.  This team is advocating strongly for the
HSE to reverse this decision and invest in maternal-fetal health for substantial
long-term gain.
TABLE 1: Pregestational Diabetes: Maternal Characteristics
TYPE 1 TYPE II
N 23 33
Age 30.9 ± 6.5 34.1 ± 4.4
DM duration (yrs) 17.9 ± 10.0 4.8 ± 3.2
DM Complications: (Expressed in ongoing viable pregnancies)
• Chronic hypertension 3/23 (18%) 1/33 (3.03%)
• Retinopathy 1/23 (4.34%) 0/33 (0%)
• Nephropathy 0/23 (19%) 0/33 (0%)
• Neuropathy 0/23 (0%) 0
Preeclampsia 2/23 (8.7%) 2/33 (6%)
Gestation at booking 7.6 ± 4.4 8.6 ± 5.6
HbA1c at booking/IFCC 53.8± 9.9 44 ± 8
HbA1c at delivery/IFCC 51 ± 20 40 ± 6
Fructosamine at booking 323 ± 52 247 ± 32
Fructosamine at delivery 260 ± 63 227 ± 24
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TABLE 2: Pregestational Diabetes: Perinatal Outcome
TYPE 1 TYPE II
N 23 33
Spontaneous Fetal Loss (<24 weeks) 4/23 (17.39%) 6/33(18.1%)
Preterm delivery 24+0 – 36+6 weeks 4/23 (17.39%) 3/33 (9.03%)
Liveborn 19/23 (82.6%) 27/33 (81.8%) 
Stillbirth 0 1 (see below)
Neonatal death 0 0
Delivered Elsewhere 0 0 
Caesarean Delivery 11/23* (47.8%) 14/33* (42.23%)
Gestational age at delivery 37.9 ± 1.3 37.5 ± 3.0
Birthweight (g) 3600 ± 600 3300 ± 700
Macrosomia ≥99th centile for 
gestational age 4/23 (17.4%) 2/33 (6.1%)
Shoulder dystocia 0/23 (0%) 0/33 (0%)
Major congenital anomaly 0/23 (0%) 0/33 (6%) 
*Ongoing viable pregnancies delivered at the Rotunda
TABLE 3: Gestational Diabetes (GDM):
Diet-controlled GDM GDM ONINSULIN
N 609 166
Age 34.1 ± 5.6 33.9 +/- 1.4
Gestational age at delivery 38.6 ± 2.8 38.0 ± 1.5
Birthweight (g) 3430 ± 545 3383 ± 580
Caesarean delivery 145/609 80/166 (48.2%)
Stillbirth 1/609 0/166
Spontaneous fetal loss <24 weeks 4/609 1/166
Delivered Elsewhere 1/609 3/169
RESEARCH:
Citations from Obstetric Diabetes Service in 2015:
Bacon S, et al.The clinical management of hyperglycemia in pregnancy
complicated by maturity-onset diabetes of the young. Am J Obstet Gynecol. 2015
Aug;213(2):236.e1-7. doi: 10.1016/j.ajog.2015.04.037. Epub 2015 Apr 30.
The clinical management of hyperglycemia in pregnancy complicated by
maturity-onset diabetes of the young
Bacon, S, Byrne, MM et al.
Oral Scientific Presentation, NASOM, Banff, Canada, 2015
Less Favourable Outcomes in Women with Type 2 Diabetes Mellitus than Type 1
Diabetes Mellitus. Findings from a large multicentre Cohort.
Bacon, S, Kinsley, BT et al.
Oral Scientific Presentation, NASOM, Banff, Canada, 2015
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The clinical management of hyperglycemia in pregnancy complicated by
maturity-onset diabetes of the young
Bacon, S, Byrne, MM et al.
ENDO, 2015, San Diego
Halling C, Malone FD, Breathnach FM, Stewart M, McAuliffe F, Morrison JJ, Dicker
P, Manning F, Corcoran JD. Neurodevelopmental outcome of a large cohort of
growth discordant twins. Eur J Pediatr (Sept 2015)
Corcoran S, Breathnach FM, Burke G, McAuliffe F, Geary M, Daly S, Higgins J,
Hunter A, Morrison JJ, Higgins S, Mahony R, Dicker P, Tully E, Malone FD.
Dichorionic twin ultrasound surveillance: sonography every 4 weeks
significantly underperforms sonography every 2 weeks: results of the
Prospective Multicenter ESPRiT Study. Am J Obstet Gynecol. 2015 Oct; 213(4):551.e1-
5. Epub 2015 Aug 7.
Murphy NC, Diviney MM, Donnelly JC, Cooley SM, Kirkham CH, Foran AM,
Breathnach FM, Malone FD, Geary MP. The effect of maternal subclinical
hypothyroidism on IQ in 7- to 8-year-old children: A case-control review. Aust N
Z J Obstet Gynaecol. 2015 Oct; 55(5):459-63. Epub 2015 Jun 8.
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LAURA HARRINGTON, RD, MINDI- SENIOR DIETITIAN
ANNA-CLAIRE GLYNN, SENIOR NEONATAL DIETITIAN
The Clinical and Nutrition service in the Rotunda strives to provide a patient-
centred, evidenced based service for Diabetes, Obstetrics, Gynaecology and
Paediatrics/Neonatology. Staffing increased from 1.0 WTE to 2.0 WTE in April
2015 with the addition of the Senior Neonatal Dietetic post. 
In 2015 the Maternity Dietitian saw a total of 1053 new patients and 360 follow-
up visits. This is similar to activity levels in 2014. The types of patients cared for
can be classified as follows:
Referring Service New Patient Follow-up Total Percentage
Visits Patient Patient of Total
Visits Encounters Patient
Activity
Obstetrics 205 107 312
Diabetes 824 240 1064
Gynaecology 9 0 9
Postnatal 2 0 2
Paediatrics (up to April 2015) 13 13 26
TOTAL 1053 360 1413
In 2015, the Neonatal Dietitian saw a total of 155 new paediatric/neonatal
patients and had 826 follow-up contacts. The below table only reflects outpatient
and inpatient activity from May 2015.
Referring Service New Patient Follow-up Total Percentage
Contacts Contacts Patient of Total
Contacts Caseload
Neonatal 
Inpatients (includes 
NICU, HDU & SCBU)
From May 2015 98 775 873 89.0%
Paediatric 
Outpatients 
From May 2015 57 51 108 11.0%
TOTAL 155 826 981
C L I N I C A L  N U T R I T I O N
154
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In April 2015 we welcomed Anna-Claire Glynn, the first Neonatal Dietitian in the
Clinical Nutrition Department.  Anna-Claire took over and expanded the
paediatric outpatients as well as creating the new service in the Neonatal Unit. 
This year, Laura Harrington, Senior Dietitian, took up the role of Dietetic AHP
Representative on the National Clinical Programme for Obstetrics and
Gynaecology in addition to maintaining the full-time Obstetrics/Gynaecology
dietetic service in the Rotunda.  
Diabetes referrals continue to dominate the Obstetrics/Gynaecology dietetic
services. There was an increase of over 170% in the number of new patients with
gestational diabetes, in the past 2 years. This is mainly due to the adoption of
new diagnostic criteria for gestational diabetes with lower thresholds. Services
to general obstetrics, gynaecology and postnatal patients had to be limited in
order to prioritise high risk patients with diabetes. Group patient education
classes for general antenatal patients and patients with gestational diabetes
were the key to accommodating large patient numbers with limited staffing
levels. 
The majority of dietetic referrals were for the following conditions:
• Antenatal: Overweight or obesity, underweight, poor weight gain, 
hyperemesis, multifoetal gestation, anaemia, eating disorders, IBS and 
Crohn’s disease
• Diabetes: Gestational diabetes, type 1 and 2 diabetes in pregnancy
• Gynaecology: Polycystic ovary syndrome, poor wound 
healing/postoperative infection and infertility linked to 
overweight/obesity or underweight
• Postnatal: Poor wound healing, infection, underweight, constipation, IBS 
and incontinence
• Paediatrics (outpatients): poor growth, food intolerances and allergy, 
behaviour related feeding issues and vitamin/mineral deficiencies
• Neonatology (inpatients): parenteral and enteral nutrition support for 
ELBW and VLBW infants, post-surgical nutritional support, poor growth, 
food intolerances and allergy, biochemical and vitamin/mineral 
imbalances
The current level of activity in the department does not reflect the true demand
for dietetic services. However, the Maternity and Neonatal Dietitian endeavours
to provide a quality service within the confines of limited staffing resources. 
The Maternity and Neonatal dietitian regularly gives presentations to
midwifery, nursing and medical staff locally and nationally. Guidelines have also
been developed locally to promote best practice. Links are maintained with the
Maternity and Neonatal Dietitians in maternity services nationwide to
contribute to the National Clinical Guidelines, the build of the new electronic
patient health record, to create and share patient education materials and to
facilitate continuing professional education.
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DR MARY HOLOHAN
At the Epilepsy Clinic in 2015 there were 124 patients seen.  For all of the patients
a delivery plan was determined and if on treatment, medication optimised in
conjunction with the Clinical Nurse Specialist - Epilepsy.  Monitoring of the
therapeutic drug levels in each trimester has significantly assisted in patient care.  
During 2015, 85 of these patients delivered in the Rotunda Hospital with 6
patients transferring care to other unit in late pregnancy and 2 patients reviewed
in early pregnancy had early 2nd trimester loss. 31 had continuing pregnancy at
end of 2015.
30 had not required anti-convulsant treatment for some time before pregnancy
and 34 patients needed anti-epilepsy drug treatment for the duration of the
pregnancy. One of these patients had a dyskinesia and another an underlying
metabolic disorder. 12 patients had discontinued treatment shortly before this
index pregnancy. 3 of these women had a recurrence of aura or myoclonic jerks
and recommenced treatment. 2 patients were under neurology review at
beginning of pregnancy with treatment not deemed necessary during pregnancy.
Seizure activity in 5 patients were associated with use of Benzodiazepines in the
context of substance abuse.
There was 4 complications in the group of 30 patients - including 2 multiple
pregnancies - not on treatment. One patient had intra-uterine fetal death at 26
weeks which was associated with placental mosaicism. There were 2 deliveries at
31 - 34 weeks. There was 1 case of significant fetal growth restriction.
Of the 34 patients on anti-epilepsy treatment regimes throughout pregnancy - 30
were on mono-therapy, 3 required 2 medications and 1 needed 3 anti-epileptic
drugs.  2 of the patients had monotherapy with Sodium Valproate.  1 patient using
Sodium Valproate changed to Levetiracetam in second trimester.
There were 6 pregnancy complications in patients using anti-epilepsy
medications
- Microcephaly and Intra-uterine growth restriction on Valproate 
- Noonans Syndrome on Levetiracetam
- Intra-uterine growth restriction on Levetiracetam
- Intra-uterine Fetal death at 28 weeks on Levetiracetam (Triploidy)
- Preterm delivery at 26 weeks on Levetiracetam 
- Intra-uterine growth restriction on Levetiracetam (metabolic disorder)
One patient who required 2 medications for her epilepsy had not achieved
complete seizure control before pregnancy and had a number of seizures in
pregnancy, a single seizure in labour and seizures in the post natal period.
E P I L E P S Y  C L I N I C
156
56846 Rotunda Clinical Report 2015 26/10/16 v3_Clinical Rep  26/10/2016  15:51  Page 156
157
Provision of standardised care for Women with Epilepsy has been further enabled
and enhanced with the development of the National Clinical Programme on
Epilepsy under the direction of Dr. C. Doherty (National Clinical Lead). The
national Standard Operating Procedure supporting integrated care pathways for
maternity patients with epilepsy has been approved by Clinical Care Programme
on Obstetrics and Gynaecology and Health Service Executive and implementation
planned for 2016.
The Irish Epilepsy Association Nurse Specialist, Sinéad Murphy, attends the
Epilepsy Clinic on alternate weeks and has an individual consultation with each
of the patients on anti-epilepsy medications. Changing from Sodium Valproate is
actively encouraged even after first trimester in view of the developmental
challenges now linked to treatment with Valproate. The support, advice and care
plans offered in the clinic have been enhanced by the appropriate  access by the
Specialist Nurse to the electronic patient record of patients attending Beaumont.
The record is updated at patient visits and a printed summary placed in antenatal
notes.
I am very grateful to the neurology service in the Dublin hospitals for their
support in assisting with the care of the patients attending this clinic and in
particular to Professor Norman Delanty and Clinical Nurse Specialist Sinéad
Murphy.
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MS CINNY CUSACK, PHYSIOTHERAPY MANAGER
The Physiotherapy Department’s vision is to be a centre of excellence, leading
the way in the field of Women's health, Neonatology and Paediatrics within the
RCSI Hospital group. 
STAFFING
Our current staff compliment has increased to 5 WTE as a new senior post was
created  in November 2015. The increased hours will enable provision of a
physiotherapy service to NICU and In house manual handling training. 
The current staff are: 
Cinny Cusack     Manager
Anne Duignan   Senior Physiotherapist (NICU)
Brona Fagan      Senior physiotherapist
Anna Hamill       Senior physiotherapist (Paediatrics)
Niamh Kenny     Senior physiotherapist
Sinead Lennon  Physiotherapist
Grainne Sheil    Physiotherapist
Our departmental working hours have increased from 7.30 am to 6 pm. This
facilitates full use of the limited departmental space and offers increased
flexibility of appointment times for outpatients. 
CLINICAL ACTIVITY
Antenatal  classes
Health promotion and ante natal education forms a key part of our women’s
health service. Mothers are empowered to take an active role in their
management of pregnancy related musculoskeletal conditions, promotion of
continence and the physical preparation for labour. Guidelines on participating
in a healthy exercise programme  during pregnancy and beyond are given
through multidisciplinary patient education sessions  for all mothers and
specifically those with gestational diabetes. 
Preparation for parenthood classes are jointly run with the Parent Education
midwife. Approximately 20% of first time mothers attend these 6 classes. This
year a total of 1,554 mothers commenced the course. Partners are welcome to
attend classes 2 to 6.
311 attended the refresher classes provided for multigravida mums. Mothers
with any special needs are catered for on an individual basis.
In 2015 there was no physiotherapy input into the Domino antenatal education
classes. However,  as part of the new senior post and increase in clinical hours, It
is planned to introduce a physiotherapy class in 2016 to ensure equal access to
all mothers attending antenatal education in the Rotunda Hospital.
P H Y S I O T H E R A P Y
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INPATIENT PHYSIOTHERAPY
Prenatal physiotherapy. 
Pelvic girdle pain affects approximately 20% of mothers and during 2015, 133  in patients
on the prenatal ward were treated for pelvic girdle pain and difficulty mobilising. 
Post natal physiotherapy
Physiotherapy is prioritised to the high risk mothers who have obstetric anal sphincter
tears,  an instrumental delivery , caesarean section , delivered a baby over 4kg or who
have any incontinence. Mothers are encouraged to attend the postnatal class in the
first 6-8 weeks post partum and to self refer to physiotherapy as an outpatient with
ongoing issues of incontinence or dyspareunia in the first 6 months post partum.
In 2015, 7,249 post natal mothers  were seen for advice, pelvic floor and abdominal
exercises, treatment of pelvic girdle pain and mobility issues.  
Gynae In patients  
204 patients were seen following major surgery for advice, pelvic floor and abdominal
exercises, management of reducing risk of future prolapse and how to safely return to
exercise. Post op physiotherapy as an outpatient is available if required.
Urinary retention 
47 patients with urinary retention were seen by physiotherapy for advice on bladder
management. Those requiring self intermittent catheterisation or further treatment
were followed up as an outpatient.
In 2015,there were 28 patients requiring 42 treatments for respiratory conditions. 
Babies are referred as inpatients to physiotherapy for the following conditions,
Torticollis, Talipes, Erbs and Plagiocephaly. 74 babies were reviewed requiring 133
treatments. 
NICU: In September, a  neonatal neurodevelopment, positioning and handling course
was provided from  Consultant Physiotherapist Adare Brady to all the physiotherapy
staff. This has up skilled the staff generally and particularly for the senior
physiotherapist in NICU.Training has also been completed in the Lacy Assessment of
Pre term Infants (LAPI) which can be used as a predictor for cerebral palsy.
As a result of this training and increased clinical hours, 15-18 hours per week  of
physiotherapy clinical time is now allocated to  NICU. The service includes assessment
and analysis of movement patterns and postural dysfunctions, working within the
neonatal individualised development care and assessment framework. (NIDCAP ).
Discharge planning meetings with parents for home exercise programmes to
facilitate transition to outpatient physiotherapy  have been set up. Links have been
established with the dietician for advice on positioning for feeding and non
nutrientive sucking. 
OUTPATIENT PHYSIOTHERAPY
In 2015, there were 2,382 new patients appointments given with  4,167 follow up
attendances. There were 553 DNA's.
The post natal class runs weekly and is open to all postnatal patients up to 8
weeks postpartum. It is an opt in service and 255 patients plus babies attended
the classes held during 2015. The aim of the class is to provide an opportunity for
questions, support and advice. We review pelvic floor exercises and assess for a
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diastasis rectus abdominus so that exercises can be progressed to enable the mother
safely return to fitness and so reduce the risk of future back pain and incontinence.
Patients suffering from post partum urinary, faecal incontinence and
dyspareunia can self refer for physiotherapy during the first 6 months post
partum.  By using a variety of manual therapy techniques for scar release,
abdominal breathing for pelvic floor release and down training, physiotherapy
can have a significant positive impact on normalising pelvic floor function. 
Urinary incontinence: 359
Faecal incontinence: 11  
Prolapse: 76
Carpal tunnel syndrome: 56
Dyspareunia/pelvic floor pain: 32
Obstetric anal sphincter injuries  (OASI): 167 patients who sustained an OASI were
given a 2 week and 6 week postnatal physiotherapy follow up appointment in
accordance with the 2012 HSE guideline on Management of OASI. Ongoing
appointments were given as required.  15 patients who had had previous tears were
also followed up during their subsequent pregnancy for advice and sphincter
exercises. The physiotherapy department works closely with the perineal clinic to
provide an integrated care pathway for patients with ongoing issues.
Pelvic Girdle pain (PGP) class
1,333 patients suffering with pelvic girdle pain or low back pain were referred to
physiotherapy. The referrals are triaged based on their gestation and pelvic girdle
questionnaire score. Patients are then given an appointment for the pelvic girdle
class (818 patients) or an individual appointment (515). The aim is to give an
appointment for the class within 2-3 weeks of referral. Significantly urgent
patients are seen within the week. The class provides advice on ergonomics,
management of activities of daily living, pacing and specific stabilising abdominal
and pelvic floor exercises.  Patients are assessed for use of pelvic supports and
walking aids and offered one to one treatment as required.
Paediatric Patients
295 babies were referred as outpatients requiring 969 attendances for the
following conditions: 
Plagiocephaly and Torticollis: 97
Brachial plexus injury and upper limb: 17
Talipes and lower limb: 94
Developmental delay: 66
To facilitate links with paediatric outpatients and liaison with paediatric staff, we
now run a physiotherapy clinic once a week in paediatric outpatients. 
The Continence Promotion Clinic is led by Dr. Mary Holohan and Cinny Cusack
Physiotherapy Manager. This clinic is aimed at providing specialised conservative
management to women suffering from urinary incontinence. The clinic offers a
comprehensive assessment and treatment programme including referral for
physiotherapy, medication, use of pessaries and life style advice. Approximately 80%
of patients can be successfully managed by the clinic with only a small percentage
needing consideration for surgery. 126 patients were referred to physiotherapy from
the clinic.160
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DEPARTMENT ACTIVITY
Physiotherapy students
The physiotherapy department has taken undergraduate students from RCSI
School of Physiotherapy and Trinity School of Physiotherapy. 3 placements were
offered for 3 final year students and one observational placement for a first year.
The placements were successful with all key learning objectives from the
placement achieved to a high standard. 
A post graduate placement for the final practical assessment was also given to a
student from Bradford University completing the Post graduate Physiotherapy
Diploma in Continence.  
Clinical research
The physiotherapy department with Deirdre Daly of the MAMMI (Maternal
health and Maternal Morbidity in Ireland) are currently researching  Women’s
knowledge and practice of Pelvic Floor Muscle Exercises (PFME) and their
opinions of PFME education at the Rotunda Hospital. 
Presentations
• Third prize winner of Rotunda Hospital Biannual Audit and Research 
Meeting for Clinical Audit  9-01-15 : Re audit of urinary retention C Cusack,
M O'Reilly, M Holohan 
• Poster presentation:  Re audit of urinary retention. 
Beaumont Hospital Research and Audit day 14-05-15 C Cusack, M O'Reilly, 
M Holohan
• Poster presentation:  Re audit of urinary retention 
St. James's Hospital 8th Annual Multidisciplinary Research, Clinical Audit
& Quality Improvement Seminar  21-05-15 
• Poster presentation : Re audit of urinary retention: C Cusack, M O'Reilly, 
M Holohan
ISCP Annual Conference 6, 7-11-15 Croke Park
• Oral presentation: Challenges and Changes in Women's Health. 
Cinny Cusack SMISCP
ISCP Annual Conference 6, 7-11-15 Croke Park
• Podium presentation: Improving patient safety by early recognition and 
intervention for Urinary Retention in the Rotunda Hospital re audit from 
January 2014 to July 2014. 5th National Patient Safety Conference 12 -11-15 
Aviva Stadium. C Cusack, M O'Reilly
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Continuous professional development (CPD)
The department actively engages in regular CPD in the form of journal club and
joint treatment sessions.
Post graduate short courses attended. 
• Neonatal neurodevelopment, positioning and handling course: Adare 
Brady Consultant Neonatal Physiotherapist June - November 2015
• Advanced manual therapy for the pelvic floor  Brona Fagan
• Physiotherapy Management of patients suffering from sexual abuse. 
Anna Hamill
• Pelvic floor and female athlete. March 2015 Sinead Lennon
• Physiotherapy Management of endometriosis. 
Sinead Lennon/Niamh Kenny
• HMI Annual Conference Change for the better 20-09-15
• Peri/post natal bladder and bowel dysfunction 16-10-15
• ISCP conference November 2015
• Bradford Diploma in Continence 2015-6 Niamh Kenny
• Rotunda Hospital /RCSI Leadership course Anne Duignan
The physiotherapy department have actively participated in the 
• Epidural study days
• Manual handling training programme
I would like to acknowledge the hard work, enthusiasm and dedication that the
Physiotherapy staff has put in over the past year. The smooth running of this
extremely busy department could not happen without the significant
contribution of the physiotherapy secretary Karen Chillingworth Finan. 
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DR MAEVE EOGAN
Introduction
The Rotunda SATU is one of 6 HSE supported SATUs around the country, with units
established in Cork, Waterford, Mullingar, Galway and Letterkenny. Each unit
provides responsive patient centred care underpinned by national interagency
guidelines. This ensures that all men and women who seek care after sexual crime
receive the same standard of care regardless of which SATU they present to. In 2015
the SATU at the Rotunda Hospital provided care for 317 men and women after rape
or sexual assault, an increase of 31 (11%) from 2014. In total, the national SATU
services saw 685 new patients in 2015. 
Most patients (82%) presented within 7 days of an incident of sexual assault, and
early presentation is optimal in terms of provision of appropriate care as well as
collection of forensic evidence. In 13 cases, the incident had occurred outside of
Ireland. Of the 304 cases where the incident was reported to have taken place in
the Republic of Ireland, 242 (80%) of these took place in Dublin city or county. 10
other counties were also represented in the figures. In 2015, August was the
busiest month and Monday was the busiest day for the unit. While 76% of
attendees reported that the incident took place between 9pm and 9am, the
majority of patients (218, 69%) actually attended for care within daytime hours
(9am-9pm). Nevertheless approximately one third of our patients were seen
between the hours of 9pm and 8.59am, which emphasises the continued need
for a round-the-clock service.  
The age and gender profiles of all patients is shown in Figure 2, the age range
was from 13 to over 85 years. Although the remit for the Adult SATU services is for
patients over 14 years, in 2015 the unit provided care for 3 female patients less
than 14 years. These were instances where acute care in a paediatric service
could not be arranged. Considerable developments in paediatric services remain
anticipated which will mean that such patients should be appropriately
accommodated in the future. 
S E X UA L  A S S AU LT  T R E AT M E N T  U N I T
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119 (39%) patients were students, 91 (30%) were in employment and 97 (31%) were
unemployed. The majority of patients (267, 84%) were single. 265 (84%) patients
reported a single assailant, and 101 (32%) patients reported that the assailant was a
stranger. In 23 cases the alleged assailant was reported to be an intimate (or ex-
intimate) partner, and in an additional 13 cases reported to be a family member. 183
patients (57%) disclosed that they had consumed alcohol in the 12 hours preceding
the assault, 8 units of alcohol being the mean number of units ingested, although
many patients had an imprecise recall of the amount of alcohol ingested. 49
patients were unsure if a sexual assault had taken place, in 36 of these patients this
lack of recall was due to memory loss associated with alcohol ingestion. 41 (13%)
patients were concerned that drugs had been used to facilitate sexual assault and of
these 39 (95%) had consumed alcohol prior to the alleged assault.
Emergency contraception (EC) was given to 141 of 238 women seen with 120 hours
of an incident (the upper timeframe limit for hormonal EC). There were a range of
reasons (including previous effective contraception, hysterectomy) why the
remaining patients did not require EC.  All SATU attendees were offered follow-up
screening for sexually transmitted infections. 285 men and women accepted this
offer, and 188 actually attended for screening. Such low return rates are not
uncommon, both nationally and internationally, and have encouraged continued
provision of routine prophylaxis for Chlamydia at the time of the patient’s initial
attendance. The rates of identification of Chlamydia have fallen precipitously
since the introduction of routine prophylaxis. All patients are also offered a
course of Hepatitis B Vaccination, and we can also offer HIV prophylaxis on-site if
required following risk assessment. In 2015 41 patients received post-exposure
prophylaxis for HIV. 
Since 2009 we have been providing care for men and women who have
experienced sexual violence but who preferred not to report the incident to An
Garda Síochána. Of the 317 patients that attended the SATU, 69 (22%) patients
attended without reporting the incident to An Garda Síochána. It is a welcome
development that patients seek care and attention following an incident which
will hopefully have a positive impact on their recovery. 
A postgraduate certificate in Sexual Assault Forensic Examination was run by UCD
for doctors aspiring to work in the adult and paediatric SATU services. This course
provided training in care provision, and educational components were delivered
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by many Rotunda SATU staff. In 2015 5 nurses completed a higher diploma
programme in Sexual Assault Forensic Examination for nursing and midwifery
staff at RCSI. All SATUs now depend greatly on clinical nurse/midwife
specialists, and we look forward to all the trainee nurse/midwife specialists
joining the SATU workforce on completion of the programme. 
SATU staff remain committed to outreach education within Emergency
Departments & General Practice, Mental Health Services, Prison Services, schools
& universities, An Garda Síochána, and Dublin Rape Crisis Centre to raise
awareness and increase understanding and recognition and to equip people
better to respond to incidents of sexual violence. The strong Interagency Links
that have traditionally existed, particularly with An Garda Síochána, Forensic
Science Laboratory and Rape Crisis Centre were maintained over this year.  The
SATU Liaison group met quarterly during the year.  These meetings are a
valuable opportunity to discuss relevant issues pertaining to SATU facilities and
care and ensure that all staff from the various agencies are aware of changes
and developments, and indeed challenges, as they arise.  At a national level, the
6 SATUs are a vibrant and motivated community of practitioners, who work
with each other and our partner agencies to progress our services to provide the
optimum response at a time when our patients are in crisis. 
A definite highlight of 2015 was that the national SATU programme finally
received a funding commitment to facilitate secure storage (for up to one year) of
forensic evidence within the SATUs, for men and women who are uncertain as to
whether or not they wish to engage with criminal justice agencies. In keeping
with international best practice, we have been aspiring to offer this option to
patients, as it can be difficult for them to make a decision regarding reporting to
an Garda Síochána when they first present. Unfortunately, DNA evidence
deteriorates quickly, so implementation of this option means that a delay in
reporting may not adversely influence detection of the incident.  We acknowledge
COSC and the Department of Justice for their commitment to this project. 
We continue to experience challenges staffing our assisting nurse/midwife rota.
This meant that there were occasions when we were unable to provide an out-
of-hours service and have to refer patients to the SATU at Midland Regional
Hospital, Mullingar. This is not ideal for patients or An Garda Síochána and a
recruitment drive has been initiated which will hopefully remedy this issue. 
We acknowledge the support of the executive management, board and staff of
the Rotunda, who understand and accept the nuances of the SATU services and
aim to go above and beyond the call of duty to make every interaction in the
Rotunda as positive as it can be for our patient cohort. In particular I would like
to acknowledge the patient services staff at reception as well as the security
team.  Maintenance of a responsive service is only possible due to the dedication
of the unit staff. All staff are extremely committed to providing exemplary care
at all times and but for them the SATU of the Rotunda Hospital would not be a
centre of excellence. This report highlights the significant amount of work done
by a small but highly committed team, and their continued availability to
provide holistic care to patients at a time of crisis does not go unnoticed.
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MS. SINEAD DEVITT, HEAD MEDICAL SOCIAL WORKER
INTRODUCTION
In 2015, the Rotunda’s team of social workers continued to provide a comprehensive
social work service to patients, their partners and their families.  Those who used
the service had a broad range of needs and issues of concern.  These included:
bereavement, domestic violence, addiction, relationship issues, mental health
issues, underage pregnancy, the birth of a baby with special needs, child protection
issues, concealed pregnancy, crisis pregnancy and intellectual disability.
The Rotunda’s social work service is extremely proactive and broad in its remit.  It
operates from the rationale that addressing problems in a timely manner can
prevent there escalation and can serve to minimise the distress experienced by
patients.  To exploit the potential of preventative interventions, there is a social
worker attached to each of the hospital’s four obstetric teams and to all the larger
specialist clinics and units.  Patients are typically met during pregnancy so that
issues of concern can be identified and alleviated.
DEMOGRAPHICS
It is interesting to note the correlation between the trend in national demographics
and the Rotunda’s patient profile.  According to figures released by the Central
Statistics office (CSO) there were 65,909 babies born in Ireland in 2015, a decrease of
1,553 on 2014.  8,362 of these babies were born in the Rotunda Hospital, which
represent 12.7 per cent of the overall births in Ireland. 
Nationally, more than three-quarters of the births were to Irish mothers, with just
over 6 per cent to mothers from non-EU countries.  In the Rotunda Hospital, there
were over 870 births to non-EU mothers, over 10 per cent of total births. In Ireland
in 2015 there were 224 children born to mothers who were aged 45 and over.  43 of
these babies were born to patients attending the Rotunda. 
Last year saw a decline in the number of teenage pregnancies in Ireland – which
dropped from 1,253 in 2014 to 1,187 in 2015.  42 of these young mothers were aged
under 16. 4 mothers under the age of 16 delivered in the Rotunda.
In 2015, over a third (36.4 per cent) or 23,990 births were outside marriage.  The
highest number of births registered was in Dublin city with 7,557 (11.5 per cent of the
births in the country).  3,352 births or 40 per cent of the overall births in the Rotunda
occurred outside marriage. 
FAMILY TYPE
In 2015, 40.5 per cent  of births outside marriage were to one parent households.
Almost 215,300 children in Ireland live with a lone parent.    A number of factors,
including the introduction of the unmarried mother’s allowance in the 1970s, made
unmarried parenthood a realistic alternative to a pregnancy which previously 
M E D I C A L  S O C I A L  W O R K
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had tended to precipitate a marriage.  However, solo parents continue to face
particular income challenges.  Lone parents’ deprivation rate stands at 33% above
those of unemployed people and 230 per cent above that of the general population.
Changes to the one parent family payment, introduced in 2013, were among the
most controversial welfare reforms, with recipients becoming compelled to take
up work when their youngest child reached the age of 7.  The reforms led to
heated protests and debate.  The Budget in 2015 adjusted this decision so that
recipients may still receive support until their youngest child is 14 years old
without having to seek work. 
The increasing fluidity and diversity of family forms has been the catalyst for the
passing in 2015 of the Children and Family Relationship Act, which offers greater
protection for children in all family types.  The Act represents the most
significant change in family law in a generation, reflecting the reality of modern
family life in Ireland.  It provides various new and different pathways to
parentage and created new rights for parents, both biological and social and,
most critically, for children.
One of the major developments in legislation is in the area of guardianship.  For
the first time, non-marital father’s cohabitating for a specific period of time with
the child’s mother will be entitled to automatic guardianship once this section of
the Act is commenced.  This will directly affect many unmarried fathers of babies
born in the Rotunda Hospital, where sometimes there is an incorrect assumption
that having their names on their child’s birth certificate gives them automatic
guardianship rights, which it does not.  It will also become possible under the
legislation for a person other than the parent to apply to court to be appointed as
a guardian of a child   
CHILDREN 
The Children First Act was enacted on 19th November 2015 and the removal of the
defence of reasonable chastisement was commenced on 11th December 2015.  It is
expected that the Minister will be signing commencement Orders on a phased
basis.  The Act aims to provide greater protection to children in vulnerable
positions.  This means that anyone who comes into contact with children for any
amount of time, especially where they provide care, will be subject to much more
stringent measures to protect them.
The Child and Family Agency (Tusla) has the overall statutory responsibility for
child protection in the state.  They had 26,655 cases open as of the end of 2015 and
6,718 cases remained unallocated, including 999 high priority cases.  However,
despite some adverse findings, the Health Information and Quality Authority
(HIQA) did note that management of high priority child protection cases had
improved compared with 2014.
Within the Rotunda Hospital the medical social work team were involved in 96
child protection cases within the first 6 months of 2015 (1/01/15-30/06/15).  During
this period the medical social work team made 63 child protection referrals to
local Tulsla teams.  When a patient has Tusla social work involvement already, a
medical social work referral may not be required.  However, a patient’s Tusla
social worker may request regular updates about a patient’s attendance at the
hospital, which the medical social worker will provide.  The medical social  
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worker will always inform the patient that this information is being shared with
their Tusla social worker, unless a child is deemed to be in immediate danger.  
Between January and June 2015, 17 of the serious cases were reviewed at a
multidisciplinary Child Protection Case Conference.   The main types of concerns
where a referral was made or received from Tusla were drug use (39), domestic
violence (13), underage pregnancy (19), mental health (8) and child welfare (17). 
DOMESTIC VIOLENCE
In 2015, the staff in the Rotunda Hospital continued to routinely enquire about
domestic violence in keeping with best national and international
recommendations.  Domestic violence in pregnancy is more common than
gestational diabetes and hypertension and can actually begin or increase during
pregnancy. It may lead to miscarriage, pre-term labour, low birth weight, fetal
injury and can pose a significant health risk for both the woman and her baby.  
According to Safe Ireland, almost 80 per cent of women who suffer abuse in the
home never report it.  Routinely asking all women during the antenatal period if
they are experiencing domestic violence is a model that supports women to
disclose abuse and seek support.  It also serves to reduce the stigma associated
with domestic violence and has the value of highlighting the prevalence of this
issue to women.  Research shows that many women were asked about domestic
violence 11-12 times before disclosing.  Women are asked about domestic violence
without their partner present to ensure their safety is not compromised. 
In 2015 the medical social work department audited 4 months (01/02/15 to
31/05/15) documentation of domestic violence enquiry in patient’s charts to
ensure there was appropriate medical social work follow up.  
Of the 12 women who disclosed a history of domestic violence, 10 had a social
work record created in the medical social work department. The remaining 2
women advised midwives that they were in counselling elsewhere and so
referrals were not made by the midwife at the time. Subsequently the medical
social work department made contact with these women and so all 12 were
followed up according to the guidelines.
The medical social work team priorities all domestic violence referrals.  They can
assist a woman explore her options, such as, a referral to a refuge or Woman’s Aid
and a safety plan can be discussed.  Not all domestic conflicts warrant the
involvement of statutory child protection services.  The level of risk to children is
assessed by the medical social worker with the patient.  A woman, in the
majority of the cases, is the best judge of her family’s safety.  
HOMELESSNESS
The medical social work team continues to work with parents who are homeless
and living in emergency accommodation.  The Department of Environment
reported that from 20 -26 April 2015 there were 504 families who were statutorily
homeless in Ireland. Of that number, 322 households, or 66 per cent, were one-parent
families.  Not only do these children suffer materially, The Growing Up in Ireland
study found that mothers under serious economic pressure had an 84 per cent 168
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risk of suffering clinical levels of depression compared with other mothers.  This
stress is further increased when mothers, who have just given birth, return to
emergency accommodation with a new baby.  In June 2015 The Dublin Region
Homeless Executive reported that the number of families being accommodated
in hotels had jumped to 388 compared to 149 in June 2014.
The social, legal and economic changes which have taken place in Ireland over this
year have given rise to many challenges for patients attending the hospital.  This
has led to an increase in the number of referrals to the social work department and
has rendered the nature of our work more complex and varied.  The following
reports of social work involvement in the hospital’s specialist clinics and units
during 2015 provide a summary of the services offered by the department.
TEENAGE PREGNANCY CLINIC
In 2015, there were 166 deliveries to teenagers booked into the Teenage Clinic. This
included 14 deliveries to teenagers who were 16 years of age and 4 deliveries to
teenagers who were 15 years of age. In these cases, a referral is always sent by the
medical social worker to the appropriate office of the Child and Family Agency
(CFA). Underage consensual non-abusive sexual activity continues to be
investigated by the CFA in conjunction with An Garda Siochana to satisfy relevant
legal requirements.
In Ireland, the age of consent has been 17 years of age since the Criminal Law
Amendment Act 1935. Ireland has one of the highest ages of consent in the EU.
Sweden, Denmark, Poland, France and Greece have all set the ages of consent at 15-
the most common in the Union. The Germans and Italians have opted for a year
lower at 14 while the British, Dutch, Portuguese and Belgians have set the age at 16.
While ministers have discussed lowering the age of consent from 17 to 16 in Ireland,
in recognition that people are having sex at a younger age, it has been argued that
the age of consent permits the State to continue to intervene in a way that is
suitable for a teenage child. 
Teenagers aged 18 and 19 years can also attend the teenage clinic if required and
can be referred by the medical social worker and midwifery staff if they require the
extra support the clinic provides young mothers.
For many young people, their pregnancy is unplanned and the medical social
worker provides support and counselling to the young person to assist them to
come to terms with the news and to provide ongoing support and assistance
throughout the pregnancy. Becoming a mother at any age can be a daunting
experience and young people, in particular, can feel overwhelmed about
becoming parents. Attendance and participation in the antenatal class is also
encouraged. The Teen Parents’ Support Programmes in the young person’s local
area offer continued support for the mother and baby following delivery. 
The medical social worker attached to the Teenage Clinic works closely with the
Clinic’s specialist midwife in order to provide a holistic and consistent service. 
BEREAVEMENT SOCIAL WORKER
In 2015 the bereavement social worker offered a service to all women who had
experienced the loss of a baby through miscarriage, ectopic pregnancy, stillbirth
or neonatal death. The role of the bereavement social worker is to visit these
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patients and their partners while they are in hospital or to contact them when
they go home. The number of pregnancies which resulted in the involvement of
the bereavement support team in 2015 was 207. The bereavement social worker,
where possible, met with these patients in the hospital or made written contact
with patients following their discharge home. A service was also provided to the
Early Pregnancy Unit and the Recurrent Miscarriage Clinic.
Patients and their partners were offered emotional and practical support,
counselling, advice on explaining the death of a baby to children, and follow-up
care. They were also offered counselling and support during subsequent
pregnancies and after the birth of their new baby. This follow-up care was
offered both in the Rotunda Hospital and on home visits if requested. The
bereavement social worker also continued to develop educational information
for parents and staff regarding children and loss, this included meeting with
bereaved children for bereavement counselling following the loss of a sibling.
The bereavement social worker worked with the bereavement support team in
providing education and training within the Rotunda Hospital and also to
colleagues from the two other maternity hospitals in Dublin, The Coombe and The
National Maternity Hospital. She presented at Bereavement Study Days facilitated
by the bereavement support team to improve and develop awareness and
understanding around working with bereaved families in a maternity setting. 
The bereavement social worker represented the hospital at remembrance
services organised by A Little Lifetime Foundation, The Miscarriage Association
and Feileacain. These support groups offer invaluable assistance to our bereaved
patients and we aim to continue to build strong links with them. 
FETAL ASSESSMENT AND PRENATAL DIAGNOSIS CLINICS
2015 was another very busy year for these Clinics, where care is provided for
women with high-risk pregnancies, as well as the diagnosis of chromosomal and
major structural abnormalities.  The yearly number of fetal anomalies looked
after in Fetal Assessment Unit (FAU) has increased from 137 in 2005 to 499 in
2015.  The initial effect of hearing during your pregnancy that your baby is not
the healthy baby you anticipated can be traumatic.  The focus is on meeting the
patient where they are at.  These expectant parents can have the very real
human need to be cared for and receive support when facing a difficult prenatal
diagnosis.
A multi-disciplinary team approach is essential so that parents do not endure
loneliness, isolation and a lack of information. Fetal medicine midwives, Nollaig
Kelleher, Jane Dalrymple and Joan O’Beirnes work closely with the medical
social worker in identifying patients who have been given difficult news about
their baby and may need additional emotional and practical support at the time
of a diagnosis and in the weeks and months that follow.  Patients report how
comforting it is for them to meet with the same midwives and doctors at each
visit, as well as it being invaluable to have a quiet space to meet with the medical
social worker and explore their feelings in confidence.
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SUBSTANCE MISUSE
2015 2014 2013 2012 2011
Deliveries to Substance 68 73 81 71
Using Women
Number of Referrals to CFA 52(84%) 52 (76%) 50 (68%) 64 (79%) 41 (57.7%)
Discharge Meeting 20 19 11 19 21
Child Protection Case 21 19 21 19 8
Conferences
Voluntary Care 3 7 1 6 4
Care – Court Orders 7 4 12 4 1
Mothers returned home 
under supervision of a 
non-drug using relative 8 7 11 17 14
In 2015, the medical social worker attached to the DOVE team continued to provide
emotional and practical support to all women attending this specialist clinic.  From
an addiction perspective, this included all women who were on a methadone
maintenance programme, or using illicit substances during pregnancy. 
Referrals were received from the Drug Liaison Midwife and other departments
within the hospital as well as from other external agencies, including
community social work.  The highest percentage of referrals received in 2015 was
from the Drug Liaison Midwife (DLM).  The DLM introduces the Social Work
Department to women attending the DOVE clinic - this in turn assists in
reducing women’s fears and anxiety about meeting a social worker. 
The DOVE medical social worker carried out psycho-social assessments with
women attending the clinic and their partners, focusing on the environmental,
social, emotional and physical factors in their lives.  A special emphasis is placed on
drug use in pregnancy and the risk this carries for a newborn baby.  There is a
known increase in the potential risk for harm and neglect to children whose parents
misuse substances. Therefore, the medical social worker endeavours to establish
whether there is a need to refer pregnancies to the Child and Family Agency.
The Child and Family Agency (CFA) is the statutory body responsible for
improving wellbeing and outcomes for children.  In 2016 the medical social
worker referred 52 pregnancies to the Child and Family Agency – in some cases
families were already known to this agency and the medical social worker
liaised with their social workers during and after the birth of the baby.
The social worker attached to the CFA may convene meetings prior to the birth or
discharge of a baby from the hospital, which the medical social worker is obliged
to attend. The medical social worker and/or the DLMW attended 21 Child Protection
Conferences during 2015 – these conferences are an interagency meeting and
involve facilitating the sharing and evaluation of information between
professionals and parents.  The medical social worker also attended 20 discharge
meetings to discuss the care of a baby in advance of discharge from the hospital.  
10 babies did not return home with their biological parents immediately after
discharge – 3 babies went into foster care under voluntary care orders, 7 babies
went into care under Interim Care Orders and 1 baby went into care under a
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private family arrangement.   Three babies went with their mother’s to an
inpatient stabilisation centre when discharged from the hospital. The number of
babies going into voluntary care has decreased since last year.  However, the
number of babies going into care under an Interim Care Order has increased.
Overall there has been a slight decrease in the number of babies received into
foster care compared with figures in 2014.  
In addition to care orders, a number of babies went home with varying levels of
family and community supports in place, 22 women had some form of family or
community support in place as part of their care plan prior to discharge.  In 6
cases mothers returned home under supervision of a non-drug using relative.
NEONATAL UNIT
The role of the medical social worker attached to the Neonatal Unit is to help
families cope with the stressful experience of having a premature or sick baby.
The social worker provides emotional support, information and practical
assistance to parents while their baby is in the hospital and also after their baby
has been discharged home.  In addition, bereavement support is offered to
parents if their baby dies while in neonatal care.
The social worker liaises closely with medical colleagues to ensure that parents
receive holistic family-centred care.  There is particularly close collaboration
with the NICU Discharge Co-ordinator and with public health nurses and
community-based support services to ensure continuity of care from the
hospital to the home environment.
At a time when many families are experiencing financial difficulties, the social
worker is involved in informing parents of their welfare entitlements and in
enabling them to secure financial assistance with medical and other expenses.
Grateful appreciation is expressed to community welfare officers for their support
of parents and to the HSE Client Registration Unit for their assistance in processing
medical cards for babies who require equipment or medication on discharge.
During 2015, there continued to be an increase in the number of babies
transferred from hospitals outside Dublin to the Neonatal Unit in the Rotunda.
These families had to cope with the practical and emotional difficulty of
commuting long distances or of finding somewhere to stay in Dublin.  The lack
of supports for such families, particularly in terms of assistance with their
expenses, constitutes major problem.  For some parents, the transfer of their
babies to Dublin means that they are unable to visit their babies as often as they
would like because they can’t afford the travel costs or the expense of childcare
for their older children.  In some instances, mothers are unable to provide their
babies with expressed breast milk because they don’t have the money to make
the journey to Dublin on a sufficiently frequent basis.
A very welcome development over the past year was the provision of
accommodation for parents from outside Dublin in Hugh’s House which is
situated close to the Rotunda.  This charitable initiative has been set up by Ade
and Marty Stack.  The availability of accommodation for parents with babies in
the NICU has been a source of invaluable support.  The feedback from parents
who have stayed there is overwhelmingly positive, with many emphasizing that
the facility was vital in enabling them to cope with the difficult experience of 
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having a baby in neonatal care.  Sincere gratitude is expressed to everyone involved
in Hugh’s House, most especially to Ade Stack.
Regrettably, there continues to be a lack of statutory supports for parents of
premature babies.  Of particular note is the fact that there is no provision for the
extension of paid maternity leave beyond 26 weeks when a baby is born
prematurely.  This means, for example, that when a baby is born at 24 weeks’
gestation, the baby’s mother is expected to return to work when the baby’s
corrected age is only 10 weeks.  Since many premature babies have a range of
medical needs and require a high level of care, this is profoundly problematic.  It is
neither possible nor desirable for a child so young to be placed in a crèche or with
a child-minder.  The failure to allow mothers to have an extended period of paid
maternity leave when their baby is born prematurely causes considerable
hardship and impacts negatively on the wellbeing of these vulnerable children.
TRAINING - STAFF
Professional Development
S. Devitt, Interdisciplinary C.P.D. Conference – 22/06/15 – 1 day 
S. Devitt, Children First Implementation Committee Meeting, RCSI – 14/09/15
R. Power, HIV Ireland (formally Dublin Aids Alliance) – HIV and STIs one day
workshop – 3/11/15
R. Power, Women and Substance Use, Urrus, Ireland’s Community Addiction
Studies Training Centre - 17/11/15
S. Devitt, Manual Handling Training, Rotunda Hospital – 30/11/2015
S. Devitt, Always Children First: Foundation Training, HSE – 3/12/15 - 1 day
TRAINING
Training for Midwifery Students on Miscarriage, Stillbirth and Neonatal Loss –
07/04/15. D. Kirk
‘Medical Social Work in the Rotunda Hospital’ – talk given to graduate/post-
graduate social work students, The College of Health and Human Services,
University of New Hampshire, New Hampshire, USA – 26/05/15. S. Devitt
Training Day on Stillbirth and Neonatal Loss, Centre of Midwifery Education –
28/05/15 . D. Kirk
Specialist Midwifery services sessions for PHN students – Medical Social Work
role/ Children First – 14/09/15. S. Devitt
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AUDIT
An audit on the documentation of domestic violence enquiry at ante-natal visits
and the associated Medical Social Worker – December 2015. S.Devitt
ACKNOWLEDGEMENTS
The Medical Social Work team would like to acknowledge their grateful
appreciation of the following:
• The Friends of the Rotunda and the Samaritan Fund for their financial 
support;
• The various charitable organisations which respond so generously to our
requests for assistance for families in need;
• All the voluntary community-based agencies which provide invaluable 
services and expertise;
• The lab staff in the Rotunda who generously donate hampers for 
families every Christmas;
• All our co-workers throughout the hospital, especially the midwives in 
Bereavement Liaison, DOVE, Drugs Liaison, Teenage Clinic, FAU and the 
staff of NICU and POPD
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CONSULTANTS: Dr Sam Coulter-Smith 
Dr. Karen Flood
ADMINISTRATIVE SUPPORT: Ms Olivia Boylan
Ms Judith Mulligan
MIDWIFERY: Ms Suzanne Gillen
REGISTRARS: January to December 2015
Dr Noor Mohammed Dr Irum Farooq
Dr Kate Glennon Dr Sahar Ahmed
Dr Nor ‘Azie’ Wahab Dr Sandhya Ramesh Babu
Dr Cathy Mc Nestry Dr Rachel Elebert
Dr Aoife Freyne Dr Niamh Maher
Dr Gillian Ryan Dr Nada Warreth
Dr Mashour Nansan Dr Sanchila Talukdar
Dr Adeola Adewole Dr Brendan Mc Donnell
Dr Tara Rigney Dr Niamh Keating
Dr Hala Abu Dr.Mark Hehir
The Early Pregnancy Assessment Unit (EPAU) continues to be an essential
component of the Rotunda with the provision of specialized care to women in
early pregnancy. In 2015, this compromised 4,305 new, return and reassurance
appointments in the EPAU.  Updated referral pathways, efficient appointment
scheduling and continuous staff training allow the delivery of a dedicated
service that manages patients in a safe, timely and supportive manner. The new
separate reassurance scan list dedicated to patients with a history of previous
miscarriages, ectopic pregnancy or gestational trophoblastic disease has proven
to be very beneficial. This new sub-clinic has increased the availability of
emergency appointments for symptomatic patients. It also serves as a focussed
ultrasound list for training of junior NCHDs under direct supervision. 
Other achievements in 2015 include:
• Updated support documentation for patients 
(also available on hospital intranet).
• Continued provision of Registrar training in Viewpoint® and early 
pregnancy undertaken by Dr Karen Flood and Dr. Jennifer Donnelly.
• Continued training of Senior House Officers in basic ultrasound in 
conjunction with the Royal College of Physicians Basic Specialist Training
facilitated by Professor Fionnuala Breathnach.
• Participation in regular clinical auditing of early pregnancy key 
performance indicators.
E a r l y  P r e g n a n c y
A s s e s s m e n t  U n i t
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Clinical activity:
2015 (%) 2014 (%) 2013 (%) 2012 (%)
Total number of patients seen 3861 4106 4191 3106
Repeat EPAU reviews 2197 (57) 3067 (75) 2587 (62) 231 (80)
Failure to attend for first 
appointments 90 (5) 63 (6) 145 (4) 200 (7)
Failure to attend for follow-up 
appointment 350 (16) 277 (9) 270 (10) 144 (6)
Miscarriages 1528 1260 1661 1551
Surgical management of 
miscarriage 497 (33) 545 (43) 531 (32) 590 (38)
Expectant or medical management 1031 (67) 715 (57) 1130 (68) 961 (62)
Ectopic pregnancy or pregnancy 
of unknown location 169 187 192 123
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CONSULTANTS: Dr Karen Flood
MIDWIFE: Ms Patricia Fletcher
The recurrent pregnancy loss clinic was developed to provide thorough
investigation and follow-up of couples with three or more consecutive
miscarriage. This clinic continues to deliver an expanded service with the
provision of dedicated early pregnancy support with frequent ultrasound
monitoring and counselling. To ensure continuity of care, patients are then
followed from their booking appointment until delivery. 
All patients with histological confirmation of gestational trophoblastic disease
following a miscarriage also attend this clinic for counselling and close serum
βhCG monitoring with rapid access for review if complications occur.
2015 % 2014 % 2013 (%) 2012 (%)
Total number of patient visits 735 667 499 376
Return visits 599 (81) 510 (83) 390 (78) 292 (78)
Failure to attend for first 27 (20) 21 (19) 26 (24) 18 (21)
appointments
Failure to attend for follow-up 56 (9) 47 (8) 45 (12) 39 (13)
appointment
Total number of pregnant 88 65 62 55
women seen
Livebirth rate 61 (69) 44 (67) 39 (63) 43 (78)
R e c u r r e n t  p r e g n a n c y  
l o s s  s e r v i c e
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MS CLAIRE O’MAHONY, CLINICAL RISK & CLAIMS MANAGER
CONTEXT
The Clinical Risk Department is responsible for the ongoing development of a
comprehensive clinical risk management programme across the hosptal
including risk identification, analysis and support in incident investigation and
reviews. The department manintains the clinical incident management system,
notifies insures of reported incidents, produces trend reports and provides
feedback to departments and committees in respect of incident trends.
Claims management is also a key function within the department and the risk
management team is the key point of contact for the hospitals solicitors and the
Clinical Indeminity Scheme (CIS) in this regard. The risk and claims team also
analyse claims data in order for learning to be implemented within the hospital.
ACHIEVEMENTS
• Pilot use of National Incident Report form
• Lectures were continued in 2015 as part of the “Learning from Incidents, 
Claims, Complaints” sessions scheduled on a quarterly basis.
• Learning also continued to be shared through Clinical Risk staff training 
sessions and Departmental Patient Safety Meetings throughout the year.  
• The hospital welcomed and analysed the State Claims Agency’s report on 
“Clinical Incidents and Claims Report – Maternity and Gynaecology 
Services” in October 2015.
• Complied with regular requests for updates from both the HSE and RCSI 
hospital group regarding the escalation of Serious Reportable Events and 
updates on progress of incident investigation
SERVICE DEVELOPMENTS 
National Incident Report Form/National Incident Management System
The Rotunda had commenced use of the NIMS database in September 2014 and
continued to use this system throughout 2015. Significant work was carried out by
the risk team to achieve meaningful report writing this time. In-house template
reports and guidance were written to maximise local use of the reports function,
to complement advice provided by our colleagues in the State Claims Agency.
Suggestions were provided out of this experience to the State Claims Agency to
inform system development and to try to encourage ease of report writing
amongst other hospitals using the system.
Between January 26th and October 5th 2015 the Rotunda piloted two versions of
the National Incident Report form. A three day training programme was provided
by the Clinical Indemnity Scheme to roll out the implementation of the form and
this was followed through with in-house training by the clinical risk and health &
safety teams. Over 207 staff were trained as part of this initiative.
Clinical  Risk Management &
Claims Department Activity
178
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Feedback was sought from staff following use of the National Incident Report form
and significant and detailed commentary and suggestions for improvement and
modification were provided to the State Claims Agency. While some amendments
were made, the hospital continued to provide feedback throughout 2015 both to
the State Claims Agency and the National Implementation Steering Group on
NIMS in respect of both the incident form and the content of the database,
highlighting in particular the broad categories available through the taxonomy in
use, the need for more specific clarity and guidance on reportable criteria in the
maternity setting and the importance of local organisations being facilitated with
meaningful data. In October 2015 the Rotunda took the decision to withdraw from
use of the NIRF form and returned to the local incident form with plans in place to
upgrade the local form in collaboration with improvements from the national
form and local maternity requirements.
INCIDENT INVESTIGATIONS
Various recommendations for improvement or indeed acknowledgement of the need
for on-going effort in various training initiatives were made through 2015. These
initiatives continue to be hugely supported by the hospital’s Practice Development
Unit. The following are examples of quality initiatives introduced in 2015:
➢ The need for training for midwifery preceptors was supported as 
part of a review and training was implemented by the Practice 
Development Team in this regard.
➢ The Practice Development Team also updated the Early Warning 
Score tool and associated training.
➢ A Classification of Caesarean section guideline was made available 
to clinical staff across the hospital and on-going attention was 
drawn to the need to comply with this guideline.
➢ Training needs in foetal monitoring and use of Syntocinon were 
identified out of reviews completed in 2015 and specific measures for
education, support and monitoring were put in place as a result.
➢ Audits were also recommended and conducted in 2015, including an
audit of the discharge process and compliance with the Syntocinon 
guideline.
➢ The neonatal observation chart was updated in 2015 to support close
monitoring and documentation of changes to IV sites.
PRIORITIES FOR 2016
➢ Progress communication workshops,
➢ Improvements to the patient handover process
➢ A scheduled audit to assess completion of the new neonatal IV 
template
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DR. JOANNA GRIFFIN Director of Research and Academic Affairs
DR. ELIZABETH TULLY National Network Manager
COLIN KIRKHAM, B,SC  Research Officer 
JESSICA COLBY MILLEY, M.SC Research Manager
FIONA CODY, M.SC Senior Research Sonographer
LISA MCSWEENEY, M.SC, Senior Research Assistant
RACHEL MCDERMOTT, B.SC Research Assistant
ROBIN GEORGE, B.SC Research Assistant
The Rotunda research department  continued to expand in 2015 with the
appointment of a new research manager and several research assistants. The
Research department’s main remit is to facilitate and develop the hospital research
programme and to assist and promote research activity. 
RESEARCH INFRASTRUCTURE
Research infrastructure remains of paramount importance in order continue to
develop our vision for the department as a national centre of research excellence.
Designated research space within the School of Midwifery building was allocated
to house the department offices, research data centre and a small dedicated
research laboratory. In 2015, further cooperation between the Rotunda research
department and the RCSI Department of Obstetrics & Gynaecology was promoted,
as a strategic alliance to develop the growing research environment within the
Rotunda. This unique partnership with our academic partner in the RCSI Hospital
group has allowed the Research department to expand and progress both
nationally and internationally as a centre of excellence in Perinatal research.
STRATEGIC COLLABORATIONS
An important function of the Research Department is  forming key strategic
collaborations with academic centres, other hospitals and industry. 2015 saw the
signing of a Memorandum of Understanding  (MOU) with DIT with regard to
analytical research.  The development of a MOU with Children’s University
Hospital Temple St as well as with a number of other external partners was also
undertaken.
2015 saw the appointment of the first honorary research positions with our
academic partners at RCSI. Together RCSI and the Rotunda have developed an
agreed framework for the provision of support and conditions associated with the
administration and management of research funding. We also aim to co-operate in
establishing closer research and clinical links.
Department of Research
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CLINICAL TRIALS AND CLINICAL RESEARCH STUDIES
The Rotunda hospital has a longstanding reputation for the conduct of quality
clinical research and is home and headquarters to two national clinical research
networks Perinatal Ireland and the newly funded HRB Mother & Baby Clinical
Trials Network. 
Our current portfolio of research studies span the broad fields of  obstetrics,
neonatology, maternal medicine, infectious disease, fetal medicine and paediatric
follow up and we have over 30 ongoing studies. These include national and
international Randomised Controlled Trials, prospective observational cohort
studies as well as a number of patient registries.
ROTUNDA BUSINESS DEVELOPMENT UNIT (BDU)
The Rotunda business development unit was established in 2015 to solidify and
promote the Rotunda Hospital’s key research themes. The BDU acts as a liaison
between the hospital and corporate partners including the pharmaceutical and
biotechnology industries, charitable offices of large enterprises, and academic
institutions. 
The over-arching aim of the BDU is to build a reputation for the Rotunda Hospital
as a valuable centre for research partnerships. In turn, these efforts will materialize
into an increase in the quantity and diversity of research funding sources within
the hospital.
THE FRIENDS OF THE ROTUNDA
The Friends of the Rotunda are generous supporters of research and researchers in
the Rotunda. They continue to provide financial and other supports to researchers
whose projects fit within the hospital’s research ambition. The Friends of The
Rotunda are committed to providing seed funding for projects with a view to
funding start-ups that may then progress to applications for larger grants from
outside agencies.
RESEARCH ETHICS COMMITTEE
The department plays an important role in assisting the hospital Research Ethics
Committee on both an advisory and administrative capacity. In 2015, a total of 39
applications were reviewed by the hospitals Research Ethics Committee and the
Research Advisory group reviewed 14 applications.
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Friends of
the Rotunda
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THE FRIENDS OF THE ROTUNDA
The Friends of the Rotunda is the official fundraising arm of the Rotunda
Hospital and a registered charity (CHY20091). It was established in 1971 and
incorporated as a Limited Company by Guarantee and Not Having a Share Capital. 
The Charity has a firm commitment to transparency, accountability and an
adherence to good governance, best practice and performance. It publishes
audited accounts approved by KSi Faulkner Orr which are submitted annually to
the Revenue Commissioners.  
- Charities Regulatory Authority (Registration Number 20079529) 
- Tax Clearance Certification 
- Tax Exemption effective for the purpose of the Charitable Donation Scheme. 
In December 2015, the Directors of the Friends of the Rotunda with the consent
of the Rotunda Hospital’s Board of Governors, agreed to schedule an
Extraordinary General Meeting in June 2016, for the purpose of adopting a new
constitution and change of name of the organisation to The Rotunda Foundation.
OBJECTIVES 
The Charity aims to provide a sustainable funding base for:-
➢ Research into aspects of Maternal and Child Health; 
➢ Additional and vital equipment for the Hospital’s Specialist Units, 
Services and Clinics; and 
➢ Improved amenities for patients, their families and hospital staff.
HOW WE USE DONATIONS
The Friends of the Rotunda relies on revenue it generates annually from
fundraising activities and donatio giving as it does not receive any funding from
the State.
Research Projects Funded:
➢ HRB/Medical Research Charities Group (MRCG) – Joint Funding Scheme
The HANDLE Study – YR.2 Grant
Haemodynamic Assessment in Pregnancy and Neonatal 
Echocardiography Assessment
RCSI Rotunda Hospital, Principal Investigator – Professor Fergal Malone
Year 2 of the study identifying abnormal haemodynamic profiles in 
pregnancy as a predictor of adverse obstetric outcome and 
characterisation of neonatal myocardial performance in infants
184
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➢ A comparison of the rapid GeneXpert PCR system to traditional bacterial
culture for the identification of S.aureus in breast milk samples from 
patients with mastitis with or without breast abscess: a diagnostic 
accuracy study
Dr. Richard Drew – Consultant Microbiologist, Rotunda Hospital and Temple
Street Children’s Hospital
➢ A Pilot Study Assessing Feasibility and Impact of Maternal Group B 
Streptococcus Screening at the outset of Labour
Dr. Maeve Eogan, Infectious Disease Research Group
RESEARCH POSTS FUNDED: 
• Siobhan Corcoran
PEAR Study
To complete the laboratory element of PEAR Study by processing over 300
samples collected for adiponectin testing
• Louise Rafferty - YR.2 Post 
Maternal Health And Maternal Morbidity in Ireland (MAMMI Study)
Research based at Trinity College, Dublin
Research study exploring the health and the health problems experienced by
first-time mothers during pregnancy and up to 12 months after the baby’s
birth
• Adam James – 1 YR Research Post (NICU)
The Use of Targeted Neonatal Echocardiography to Predict Short Term
Clinical Sequelae Associated with a Patient Ductus Arteriosus
• Colm Breatnach – 1YR Research Post (NICU)
Assessment of Cardiac Function in Preterm and Term Infants with Twin to
Twin Transfer Syndrome, Intra-uterine Growth Restriction and Congenital
Diaphragmatic Hernia Using Novel Echocardiography Techniques
• Medical Safety in Neonatal Intensive Care Targeted Research Programme 
Pharmacist Post – 1YR
Lead Investigators: Prof Brian Carey, Prof. Naomi McCallion, Prof. Paul
Gallagher
• Business Development Manager – 1YR Post 
Department of Research & Academic Affairs, Rotunda
EQUIPMENT PURCHASED:
➢ Echocardiography Machine for NICU
Dr Afif EL-Khuffash
A new state of the art piece of equipment for the Neonatal Unit provides a
better way to care for sick infants on a daily basis and continues to provide
a platform for conducting on-going novel research in the field of neonatal
cardiovascular medicine.
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➢ Non-Invasive Continuous Cardiac Output Assessment and Real Time 
Cerebral Perfusion Monitoring in Term Infants with Neonatal 
Encephalopathy: The effect of Therapeutic Hypothermia
NICOM Monitor and Sensors plus NIRS Sensors (NICU)
Dr. Afif EL-Khuffash and Dr. Adrienne Foran
This equipment has been purchased for the NICU and will be used as part of
this research study to determine whether a NICOM monitor to accurately
and continuously monitor a baby’s heart function during a cooling process.
➢ INVOS Cerebral / Somatic Oximeter System (NICU)
This system provides real-time monitoring of changes in regional oxygen
saturation (rSO2) in the brain and other body tissues beneath the sensor for
effective oxygen monitoring in neonates. This unique equipment allows our
NICU Clinicians to measure site-specific oxygen levels rather than requiring
them to infer the data from systemic, whole body measures such as blood
pressure and pulse oximetry. Our NICU Clinicians can now conveniently
monitor multiple brain and body areas.
➢ Video Intubation Unit (NICU)
This highly dedicated device will be used in the NICU for neonatal video-
intubation and transillumination to improve patient outcome. Our tiny
babies who have difficulty in breathing will be hugely aided by this
equipment. It will also be used by our Consultants to provide valuable visual
training support for our junior doctors.
➢ TCM Combi Monitor & Consumables (NICU)
The condition of an infant can take a turn for the
worse in a matter of minutes. By continuously
monitoring ventilation and oxygenation, our NICU
Staff can detect and quickly react to these changes,
avoiding adverse patient outcomes. The TCM CombiM
also provides a valuable trending tool in monitoring tcpCo2 and tcpO2
levels in the incubator or at the beside.
➢ Developmental products for our tiny infants to assist sleep, comfort and
improved positioning within incubators (NICU)
➢ Therapy Bench 
Rotunda Hospital’s Physiotherapy Department
A small adjustable therapy bench for the treatment of the Hospital’s
developmental delay babies. This piece of equipment helps by being part of
their developmental physiotherapy. The Hospital’s Physiotherapy staff
continually work at improving movement patterns for these babies which
includes sit to stand, stepping and turning in preparation for walking.
➢ Bereavement Support Services 
- 2 wall-mounted TVs for rooms 5&6 within the Delivery Suite
- Oak Glass Cabinet for the Mortuary Chapel to display 
the Hospital’s Books of Condolence
- Framed Painting for Mortuary Chapel
- External planting for Mortuary Chapel
- A recliner armchair 
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➢ Lasting Memories - These bags have been
commissioned following feedback from
bereaved parents and paid for from donations
received to the Bereavement Support Services
Fund. They are given to bereaved parents so that
they can carefully transport baby’s precious
possessions and belongings home when leaving
hospital. 
HOW TO MAKE A DONATION
Donors can give directly to their designated fund which is managed by the
Friends of the Rotunda Charity by using our On-line payments facility for
Donations onwww.friendsoftherotunda.ie
GOVERNANCE
The Friends of the Rotunda Board is committed to adopt the Principles of Good
Governance as outlined in The Governance Code - A Code of Practice for Good
Governance of Community, Voluntary and Charitable Organisations in Ireland.
• Directors: Andrew Wortley (Chairman) Marie Malone (Secretary), 
Sylvia Graham.
The Management Executive is run by Sheila Thompson who is responsible
for the administration, marketing and strategic development of the
organisation.
The Friends of the Rotunda Charity is a member of The Medical Research
Charities Group (MRCG), Fundraising Ireland, Philanthropy Ireland,
MyCharity.ie, ICTR and the Wheel. 
FUNDRAISING & EVENTS:
The Charity does not receive any State funding and generates revenue each year
by actively encouraging Rotunda staff, patients, their families and friends, to
participate in fundraising activity:-
• KMS 4 Kids – 12 hours Charity Cycle Challenge 
• Rotunda Golf Classic – The Masters’ Cup
• Supermarket Bag Packing
• Christening Party Fundraisers
• Laughter Lounge Comedy Fundraiser in aid of 
Rotunda SATU
• Coffee Morning Fundraisers
• Birthday Party Fundraisers
• Sponsored Charity 5K, 10K Walks/Runs
• Vhi Women’s Mini Marathon 
• Hell and Back Challenge in aid of NICU
• Dublin City Marathon
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• NY City Marathon
• The Mark Anthony Leo Laycock Annual 5 Aside Football Fundraiser for 
NICU ‘Leave Your Mark!’ 
• Sale of Easter Eggs
• Coin Box Collections and Raffles 
• Rotunda Ball Raffle in aid of Rotunda Research
• Sale of Publications gifted to Rotunda Hospital by Artists / Authors
• Sale of Football Shirts in aid of Rotunda Research Fund 
• Sale of Christmas Cards
• Sale of Art illustrating the Rotunda Hospital
• Sale of Designer Silver Jewellery Collection
• Sale of  Memorabilia of the Rotunda Hospital
• Tango Fiesta Annual Charity Fundraiser
• Young European Strings Chamber Orchestra Performance in the Pillar Room
• Christmas Swim Fundraiser
• Sky Dive Fundraisers
• Friends of the Rotunda Annual Membership Subscriptions
• Introduction to being a Registrar in Neonatology 
• Charity Collaboration with Feileacain
• Charity Partner Collaboration with Park Rite Parnell Street Car Park
• Charity Partner Collaboration with TESCO Parnell & Winner Tesco 
Community Fund
www.everydayhero.ie hosts the Friends of the Rotunda Charity registration on
its website. Fundraisers can set up a Fundraising Page with links to mobile and
social media platforms.
THE ROTUNDA KNITTERS VOLUNTEER GROUP
Continue to supply the Friends of the Rotunda Charity with their amazing hand
crafted knitwear for newborn and premature babies born at the Rotunda.
Complimentary Gift Packs are frequently distributed to new parents in
celebration of memorable events such as World Prematurity Day, National
Breastfeeding Week, St Patricks Day, Spring Awakening, Summer Joy, Winter
Warmth and Merry Christmas!
DONATIONS APPEAL FOR MOTHERS & BABY
Supports the Rotunda’s Medical Social Work Team who each year, need to
provide support to pregnant Mothers who find themselves in a crisis situation
with little or no money to care for their new born infants. The Friends of the
Rotunda Donations Appeal asks for new or nearly new items of clothing and/or
general overnight toiletries for both Mother and baby.
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CAFÉ ROTUNDA
The Hospital Shop is located within the main reception of the Hospital and
provides a café and retail service to all in the Hospital. Annual rental income
from the Shop provides extra revenue to the Friends’ Charity to run its
administration costs. 
THE ROTUNDA PILLAR ROOM
Another substantial source of revenue in aid of Rotunda Research is generated
each year through the hire of The Pillar Room Complex as a facility for private
and corporate functions. It is used by the Hospital for teaching purposes and as
an examination hall.
The striking contemporary bar facility within the Pillar Room Complex. The
Venue offers Conferencing and Catering facilities and is equipped with a
modern PA Sound System and High-Speed Wi-Fi.
Bookings are managed by the Friends of the Rotunda office on 01 872 2377 or
email friends@rotunda.ie .
The Board of the Friends of the Rotunda wishes to extend its gratitude to all
those who organised and supported fundraising activities during 2015.
Sheila Thompson
Friends of the Rotunda 
www.friendsoftherotunda.ie
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Clinical Audit
Department
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Clinical Audit Team:
DR SHARON COOLEY Clinical Audit Lead
MARY WHELAN Clinical Audit Facilitator
VALERIE JACKSON Surveillance Scientist
COLIN KIRKHAM Statistician
The Rotunda Hospital Clinical Audit Department was established in June 2011
under the quality and safety initiative of the Rotunda’s Strategic Plan 2011-2013.
Clinical audit offers a structured approach to evaluating our care against local,
national and international standards.
The Clinical Audit Department functions include:
• Education and support at all stages of the clinical audit pathway. This 
includes topic selection, researching standards, the application process, audit
tool design, data analysis and report writing.
• Assistance in maintaining clinical audit experience which is an essential 
element of professional competence. 
• Monitor all clinical audit activity within the hospital and routinely report on
same.
• Monitor local and national audit standards and appraise hospital 
performance against these standards where appropriate. 
• Promote a high standard of practice amongst clinical staff and all healthcare
workers undertaking clinical audit.
• Provide a forum for the sharing and dissemination of clinical audit work in 
the Rotunda, which is facilitated by the use of the clinical audit database, the
Biannual Rotunda Audit and Research Day and quarterly audit results 
meetings.
• Encourage presentation of audit results at inter-hospital meetings e.g. JOGS, 
SJH Annual Audit Day and TSH Biannual Audit Day.
• Forge professional links with other clinical audit units nationally.
Clinical Audit Group Weekly Meeting
The core group within the Clinical Audit Department meet weekly to discuss and
approve audit applications.
Clinical Audit Steering Group
The Clinical Audit Steering Group meets quarterly. Membership of the steering group
includes the executive management team, clinical risk department, departmental
patient safety representatives, heads of departments and allied health professionals.  
Other Internal Meetings
Clinical audit activity reports are submitted to the Quarterly meeting of the Board
of Governors, the Patient Safety Meetings and the Monthly Quality and Safety
Committee meeting. These reports include details of new audits, completed audits
and any immediate actions arising from audits. In addition, any clinical audit with
a plan that requires immediate action is highlighted to the Executive Management
Team. Since the establishment of the Risk Subcommittee of the Board of Governors
in the latter half of 2015 Clinical Audit also report to this group annually on audit
activity. 
C L I N I C A L  A U D I T
D E PA R T M E N T
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Clinical Audit Database
The database of clinical audit activity in the hospital facilitates the production of
weekly and quarterly reports on topics audited; departments and clinicians
involved, action plans and dates for re-audit. All clinical audits conducted in the
hospital are registered on the database. All health professionals who participate
in completed clinical audits that have been registered with the hospital receive
a certificate of participation in conjunction with their supervisors. 
In total, 58 clinical audits were registered in 2015 (45 first audits, 11 re-audits
and 2 continuous audits).
Clinical Audit Training
The clinical audit team regularly delivers educational sessions in-house on the
clinical audit cycle across all disciplines. In 2015 there were 7 information
sessions held and a total of 61 staff members attended with representatives from
all clinical areas. 
Rotunda Audit and Research Day
Two successful audit and research days were held within the hospital during the
year and kindly sponsored by AbbVie. The Rotunda Medals were awarded to Dr
Catherine Finnegan for her audit into the use of methotrexate in the
management of ectopic pregnancy and Dr Siobhan Neville for her audit on
enteral feeding in very low birthweight infants.
Congratulations also to all our other winners and to all who took presented and
took part.
Presentations at External Meetings and Interhospital links:
Several audits were presented at national and cross-border meetings in 2015
including:
• Hospital representation at Adelaide and Meath Hospital Audit day April 2015
• A reaudit and completion of the audit cycle into the management of urinary
retention by Cinny cusack , Dr Mary Holohan and Mary O Reilly was
presented in poster format at the Beaumont Hospital Audit Day in May 2015
• An audit on peri -operative prevention of maternal and neonatal
hypothermia was presented by  Aliona Vilinsky at Beaumont Hospital Audit
Day May 2015
• Hospital representation at the National Office of Clinical Audit Conference
May 2015
• Hospital representation at the St James Hospital Audit Day May 2015
• Hospital representation and posters at the National Patient Safety
Conference November 2015
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• Clinical Audit Database and Activity posters sent to North South Audit
Meeting in Armagh in October 2015
• Congratulations to Debbie Browne and the Teenage Clinic service which has
evolved to meet the need of our patients, a fact recognised in a recent WHO
publication: Nurses and midwives: a vital resource for health. European
Compendium of Good Practices in Nursing and Midwifery towards Health
2020 goals. 
New Initiatives in 2015
• Appointment of an NCHD representative to the Department. This year we
welcomed the input of Dr Sandhya Babu into issues relating to clinical audit
in the NCHD group
• Engagement with the Risk Subcommittee of the Board of Governors with a
focus on developing links not only with other Clinical Audit Departments
nationally but internationally.
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TABLE OF CLINICAL AUDITS REGISTERED IN 2015
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CONCLUSION
The team would like to commend the clinical staff for their enthusiasm for
clinical audit and look forward to working with them towards their clinical audit
goals in 2016.
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